1	The	DT	O	the	det	3	SENT_1	[p1l459t88r503b110],
2	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_1	[p1l512t88r741b117],
3	Joumal	NNP	O	Joumal	nsubj	5	SENT_1	[p1l750t88r834b115],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l844t88r920b116],
5	2007	CD	DATE	2007	_	0	SENT_1	[p1l844t88r920b116],
6	)	NN	O	)	nsubj	17	SENT_1	[p1l844t88r920b116],
7	7	CD	NUMBER	7	num	6	SENT_1	[p1l931t89r950b114],
8	,	,	O	,	_	0	SENT_1	[p1l931t89r950b114],
9	362-365	CD	NUMBER	362-365	num	16	SENT_1	[p1l961t88r1053b110],
10	©	CD	NUMBER	©	number	11	SENT_1	[p1l349t120r365b139],
11	2007	CD	DATE	2007	num	16	SENT_1	[p1l373t120r420b139],
12	Nature	NNP	O	Nature	nn	16	SENT_1	[p1l429t120r491b139],
13	Publishing	NNP	O	Publishing	nn	16	SENT_1	[p1l501t119r594b145],
14	Group	NNP	O	Group	nn	16	SENT_1	[p1l603t120r661b145],
15	All	NNP	O	All	nn	16	SENT_1	[p1l669t119r691b139],
16	rights	NNS	O	rights	appos	6	SENT_1	[p1l700t119r751b145],
17	reserved	VBD	O	reserve	rcmod	5	SENT_1	[p1l760t119r835b139],
18	1470-269X	NN	O	1470-269x	dobj	17	SENT_1	[p1l845t119r980b141],
19	/	:	O	/	punct	23	SENT_1	[p1l845t119r980b141],
20	07	CD	NUMBER	07	dep	23	SENT_1	[p1l845t119r980b141],
21	$	$	MONEY	$	dep	20	SENT_1	[p1l989t119r1054b140],
22	30.00	CD	MONEY	30.00	num	21	SENT_1	[p1l989t119r1054b140],
23	www.nature.com/tp]	NN	O	www.nature.com/tp]	parataxis	5	SENT_1	[p1l858t170r1053b195],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l1665t234r1919b273],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l1939t234r2149b273],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_3	[p1l16t367r771b466],
2	analysis	NN	O	analysis	_	0	SENT_3	[p1l810t367r1135b466],
3	of	IN	O	of	_	0	SENT_3	[p1l1175t367r1259b442],
4	paclitaxel	NN	O	paclitaxel	nn	5	SENT_3	[p1l1298t367r1698b466],
5	transport	NN	O	transport	prep_of	2	SENT_3	[p1l1741t376r2138b466],
6	and	CC	O	and	_	0	SENT_3	[p1l12t492r169b567],
7	metabolism	NN	O	metabolism	nn	8	SENT_3	[p1l216t492r716b567],
8	genes	NNS	O	gene	conj_and	5	SENT_3	[p1l761t514r1011b591],
9	in	IN	O	in	_	0	SENT_3	[p1l1054t494r1123b566],
10	breast	NN	O	breast	nn	11	SENT_3	[p1l1170t492r1430b567],
11	cancer	NN	O	cancer	prep_in	2	SENT_3	[p1l1467t514r1753b567],

1	S	NN	O	s	nn	3	SENT_4	[p1l11t678r31b713],
2	Marsh	NNP	O	Marsh	nn	3	SENT_4	[p1l53t672r241b721],
3	”	NNP	O	”	dep	7	SENT_4	[p1l53t672r241b721],
4	,	,	O	,	_	0	SENT_4	[p1l53t672r241b721],
5	G	NNP	O	G	nn	6	SENT_4	[p1l263t678r293b713],
6	Som	NNP	O	Som	appos	3	SENT_4	[p1l315t673r476b721],
7	|	VBZ	O	|	_	0	SENT_4	[p1l315t673r476b721],
8	o3	NN	O	o3	dobj	7	SENT_4	[p1l315t673r476b721],
9	,	,	O	,	_	0	SENT_4	[p1l315t673r476b721],
10	X	NN	O	x	nn	12	SENT_4	[p1l498t678r526b713],
11	Li	NNP	PERSON	Li	nn	12	SENT_4	[p1l547t673r608b721],
12	‘	NNP	O	‘	dobj	7	SENT_4	[p1l547t673r608b721],
13	,	,	O	,	_	0	SENT_4	[p1l547t673r608b721],
14	P	NN	O	p	nn	15	SENT_4	[p1l12t737r32b771],
15	Franke	NNP	PERSON	Franke	appos	12	SENT_4	[p1l54t731r230b779],
16	|	CD	NUMBER	|	number	17	SENT_4	[p1l54t731r230b779],
17	4	CD	NUMBER	4	dep	15	SENT_4	[p1l54t731r230b779],
18	,	,	O	,	_	0	SENT_4	[p1l54t731r230b779],
19	CR	JJ	O	cr	amod	21	SENT_4	[p1l252t737r309b772],
20	King	NNP	O	King	nn	21	SENT_4	[p1l329t731r452b783],
21	‘	NN	O	‘	conj_and	8	SENT_4	[p1l329t731r452b783],
22	,	,	O	,	_	0	SENT_4	[p1l329t731r452b783],
23	WD	NNP	O	WD	nn	25	SENT_4	[p1l8t795r86b829],
24	Shannon	NNP	O	Shannon	nn	25	SENT_4	[p1l105t789r351b838],
25	”	NNP	O	”	dobj	7	SENT_4	[p1l105t789r351b838],
26	,	,	O	,	_	0	SENT_4	[p1l105t789r351b838],
27	HL	NN	O	hl	nn	28	SENT_4	[p1l374t795r426b829],
28	McLeod	NNP	PERSON	McLeod	dobj	7	SENT_4	[p1l445t789r691b830],
29	"	``	O	"	punct	28	SENT_4	[p1l445t789r691b830],
30	2	CD	NUMBER	2	dep	28	SENT_4	[p1l445t789r691b830],
31	'	''	O	'	_	0	SENT_4	[p1l445t789r691b830],
32	5	CD	NUMBER	5	dobj	7	SENT_4	[p1l445t789r691b830],
33	and	CC	O	and	_	0	SENT_4	[p1l10t852r85b888],
34	T	NN	O	t	conj_and	8	SENT_4	[p1l104t853r175b888],
35	\	CD	NUMBER	\	num	37	SENT_4	[p1l104t853r175b888],
36	N	NN	O	n	nn	37	SENT_4	[p1l104t853r175b888],
37	Synoldz	NN	O	synoldz	nsubj	7	SENT_4	[p1l193t848r353b900],

1	1	CD	NUMBER	1	_	0	SENT_5	[p1l10t943r17b957],
2	Department	NNP	ORGANIZATION	Department	dep	1	SENT_5	[p1l25t947r192b979],
3	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l202t946r231b971],
4	Medicine	NNP	ORGANIZATION	Medicine	nn	8	SENT_5	[p1l238t946r367b976],
5	,	,	O	,	_	0	SENT_5	[p1l238t946r367b976],
6	Washington	NNP	ORGANIZATION	Washington	appos	8	SENT_5	[p1l384t946r548b979],
7	University	NNP	ORGANIZATION	University	nn	8	SENT_5	[p1l561t946r696b979],
8	School	NNP	ORGANIZATION	School	prep_of	2	SENT_5	[p1l11t983r101b1009],
9	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l111t983r140b1009],
10	Medicine	NNP	ORGANIZATION	Medicine	prep_of	8	SENT_5	[p1l147t983r277b1014],
11	,	,	O	,	_	0	SENT_5	[p1l147t983r277b1014],
12	St	NNP	LOCATION	St	nn	13	SENT_5	[p1l291t984r318b1009],
13	Louis	NNP	LOCATION	Louis	appos	10	SENT_5	[p1l329t984r404b1014],
14	,	,	O	,	_	0	SENT_5	[p1l329t984r404b1014],
15	MO	NNP	DURATION	MO	nn	17	SENT_5	[p1l418t984r476b1014],
16	,	,	O	,	_	0	SENT_5	[p1l418t984r476b1014],
17	USA	NNP	LOCATION	USA	appos	13	SENT_5	[p1l492t984r555b1014],
18	;	:	O	;	_	0	SENT_5	[p1l492t984r555b1014],
19	2Siteman	NNP	O	2Siteman	nn	21	SENT_5	[p1l566t980r693b1008],
20	Cancer	NNP	O	Cancer	nn	21	SENT_5	[p1l11t1022r108b1046],
21	Center	NNP	O	Center	dep	13	SENT_5	[p1l119t1022r214b1051],
22	,	,	O	,	_	0	SENT_5	[p1l119t1022r214b1051],
23	St	NNP	LOCATION	St	nn	24	SENT_5	[p1l230t1022r257b1046],
24	Louis	NNP	LOCATION	Louis	appos	21	SENT_5	[p1l269t1021r343b1051],
25	,	,	O	,	_	0	SENT_5	[p1l269t1021r343b1051],
26	MO	NNP	DURATION	MO	appos	21	SENT_5	[p1l359t1022r417b1051],
27	,	,	O	,	_	0	SENT_5	[p1l359t1022r417b1051],
28	USA	NNP	LOCATION	USA	appos	21	SENT_5	[p1l435t1022r498b1051],
29	;	:	O	;	_	0	SENT_5	[p1l435t1022r498b1051],
30	3Department	NN	O	3department	dep	13	SENT_5	[p1l511t1018r693b1054],
31	of	IN	O	of	_	0	SENT_5	[p1l10t1058r39b1083],
32	Medical	NNP	MISC	Medical	nn	33	SENT_5	[p1l48t1058r157b1083],
33	Oncoloqy	NNP	MISC	Oncoloqy	prep_of	30	SENT_5	[p1l169t1058r301b1086],
34	and	CC	O	and	_	0	SENT_5	[p1l311t1058r365b1083],
35	Therapeutics	NNP	ORGANIZATION	Therapeutics	nn	36	SENT_5	[p1l378t1058r551b1086],
36	Research	NNP	ORGANIZATION	Research	prep_of	30	SENT_5	[p1l564t1058r691b1086],
37	,	,	O	,	_	0	SENT_5	[p1l564t1058r691b1086],

1	City	NNP	O	City	_	0	SENT_6	[p1l11t1171r65b1204],
2	of	IN	O	of	_	0	SENT_6	[p1l75t1171r104b1196],
3	Hope	NNP	O	Hope	nn	6	SENT_6	[p1l114t1172r185b1204],
4	Comprehensive	NNP	O	Comprehensive	nn	6	SENT_6	[p1l198t1161r407b1204],
5	Cancer	NNP	O	Cancer	nn	6	SENT_6	[p1l420t1161r517b1196],
6	Center	NNP	O	Center	prep_of	1	SENT_6	[p1l528t1172r623b1201],
7	,	,	O	,	_	0	SENT_6	[p1l528t1172r623b1201],
8	Duarte	NNP	PERSON	Duarte	prep_of	1	SENT_6	[p1l11t1209r111b1239],
9	,	,	O	,	_	0	SENT_6	[p1l11t1209r111b1239],
10	CA	NNP	LOCATION	CA	prep_of	1	SENT_6	[p1l128t1209r171b1238],
11	,	,	O	,	_	0	SENT_6	[p1l128t1209r171b1238],
12	USA	NNP	LOCATION	USA	prep_of	1	SENT_6	[p1l188t1209r242b1233],
13	and	CC	O	and	_	0	SENT_6	[p1l255t1208r309b1233],
14	4Division	NN	O	4division	conj_and	6	SENT_6	[p1l319t1205r442b1233],
15	of	IN	O	of	_	0	SENT_6	[p1l455t1208r484b1233],
16	Information	NNP	ORGANIZATION	Information	nn	17	SENT_6	[p1l493t1208r655b1233],
17	Sciences	NNP	ORGANIZATION	Sciences	prep_of	1	SENT_6	[p1l10t1246r129b1276],
18	,	,	O	,	_	0	SENT_6	[p1l10t1246r129b1276],
19	City	NNP	ORGANIZATION	City	appos	17	SENT_6	[p1l146t1246r199b1278],
20	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l210t1245r239b1271],
21	Hope	NNP	ORGANIZATION	Hope	nn	23	SENT_6	[p1l248t1246r319b1279],
22	Comprehensive	NNP	ORGANIZATION	Comprehensive	nn	23	SENT_6	[p1l332t1245r542b1279],
23	Cancer	NNP	ORGANIZATION	Cancer	prep_of	19	SENT_6	[p1l555t1246r652b1271],
24	Center	NNP	ORGANIZATION	Center	nn	30	SENT_6	[p1l11t1283r106b1313],
25	,	,	O	,	_	0	SENT_6	[p1l11t1283r106b1313],
26	Duarte	NNP	PERSON	Duarte	appos	30	SENT_6	[p1l122t1284r223b1313],
27	,	,	O	,	_	0	SENT_6	[p1l122t1284r223b1313],
28	CA	NNP	O	CA	appos	30	SENT_6	[p1l239t1283r282b1313],
29	,	,	O	,	_	0	SENT_6	[p1l239t1283r282b1313],
30	USA	NNP	LOCATION	USA	dep	1	SENT_6	[p1l300t1283r354b1308],

1	Correspondence	NN	O	correspondence	_	0	SENT_7	[p1l10t1440r271b1474],
2	:	:	O	:	_	0	SENT_7	[p1l10t1440r271b1474],
3	Dr	NN	O	dr	nn	4	SENT_7	[p1l11t1479r45b1503],
4	S	NN	O	s	dep	1	SENT_7	[p1l57t1479r71b1503],
5	Marsh	NNP	PERSON	Marsh	dep	1	SENT_7	[p1l86t1478r181b1508],
6	,	,	O	,	_	0	SENT_7	[p1l86t1478r181b1508],
7	Washington	NNP	ORGANIZATION	Washington	nn	9	SENT_7	[p1l195t1478r369b1511],
8	University	NNP	ORGANIZATION	University	nn	9	SENT_7	[p1l384t1478r525b1511],
9	School	NNP	ORGANIZATION	School	appos	1	SENT_7	[p1l538t1478r632b1503],
10	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l647t1478r675b1503],
11	Medicine	NNP	ORGANIZATION	Medicine	prep_of	9	SENT_7	[p1l11t1515r150b1546],
12	,	,	O	,	_	0	SENT_7	[p1l11t1515r150b1546],
13	Campus	NNP	O	Campus	nn	14	SENT_7	[p1l166t1516r284b1548],
14	Box	NNP	O	Box	appos	1	SENT_7	[p1l298t1516r350b1540],
15	8069	CD	NUMBER	8069	num	14	SENT_7	[p1l363t1516r445b1546],
16	,	,	O	,	_	0	SENT_7	[p1l363t1516r445b1546],
17	660	CD	NUMBER	660	num	14	SENT_7	[p1l460t1516r514b1541],
18	S.	NNP	O	S.	nn	20	SENT_7	[p1l529t1516r551b1541],
19	Euclid	NNP	O	Euclid	nn	20	SENT_7	[p1l567t1515r650b1541],
20	Avenue	NNP	O	Avenue	dep	14	SENT_7	[p1l8t1554r124b1583],
21	,	,	O	,	_	0	SENT_7	[p1l8t1554r124b1583],
22	St	NNP	LOCATION	St	nn	23	SENT_7	[p1l139t1553r166b1578],
23	Louis	NNP	LOCATION	Louis	appos	1	SENT_7	[p1l180t1553r259b1583],
24	,	,	O	,	_	0	SENT_7	[p1l180t1553r259b1583],
25	MO	NNP	DURATION	MO	appos	1	SENT_7	[p1l275t1553r328b1578],
26	63110	CD	NUMBER	63110	num	25	SENT_7	[p1l342t1553r442b1583],
27	,	,	O	,	_	0	SENT_7	[p1l342t1553r442b1583],
28	USA	NNP	LOCATION	USA	appos	1	SENT_7	[p1l459t1553r524b1578],
29	.	.	O	.	_	0	SENT_7	[p1l459t1553r524b1578],

1	E-mail	NN	O	e-mail	_	0	SENT_8	[p1l11t1590r105b1615],
2	:	:	O	:	_	0	SENT_8	[p1l11t1590r105b1615],
3	smarsh@im.wust	NN	O	smarsh@im.wust	nn	4	SENT_8	[p1l120t1590r435b1615],
4	|	NN	O	|	dep	1	SENT_8	[p1l120t1590r435b1615],
5	.	.	O	.	_	0	SENT_8	[p1l120t1590r435b1615],

1	edu	NN	O	edu	_	0	SENT_9	[p1l120t1590r435b1615],

1	5Current	JJ	O	5current	amod	2	SENT_10	[p1l9t2605r135b2633],
2	address	NN	O	address	_	0	SENT_10	[p1l152t2608r268b2633],
3	:	:	O	:	_	0	SENT_10	[p1l152t2608r268b2633],
4	UNC	NNP	ORGANIZATION	UNC	nn	5	SENT_10	[p1l289t2609r358b2633],
5	Institute	NNP	ORGANIZATION	Institute	dep	2	SENT_10	[p1l378t2608r493b2633],
6	for	IN	ORGANIZATION	for	_	0	SENT_10	[p1l510t2608r551b2633],
7	Pharmacogenomics	NNP	ORGANIZATION	Pharmacogenomics	prep_for	5	SENT_10	[p1l569t2608r688b2633, p1l9t2650r183b2682],
8	and	CC	O	and	_	0	SENT_10	[p1l225t2649r277b2675],
9	Individualized	NNP	O	Individualized	nn	10	SENT_10	[p1l322t2649r519b2675],
10	Therapy	NN	O	therapy	prep_for	5	SENT_10	[p1l561t2649r687b2683],
11	,	,	O	,	_	0	SENT_10	[p1l561t2649r687b2683],
12	University	NNP	ORGANIZATION	University	appos	2	SENT_10	[p1l11t2692r151b2724],
13	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l166t2691r194b2716],
14	North	NNP	ORGANIZATION	North	nn	15	SENT_10	[p1l210t2691r292b2716],
15	Carolina	NNP	ORGANIZATION	Carolina	prep_of	12	SENT_10	[p1l310t2691r437b2721],
16	,	,	O	,	_	0	SENT_10	[p1l310t2691r437b2721],
17	Chapel	NN	LOCATION	chapel	nn	18	SENT_10	[p1l454t2691r554b2724],
18	Hill	NNP	LOCATION	Hill	appos	2	SENT_10	[p1l572t2691r624b2721],
19	,	,	O	,	_	0	SENT_10	[p1l572t2691r624b2721],
20	NC	NNP	O	NC	appos	2	SENT_10	[p1l643t2692r688b2716],
21	27599	CD	NUMBER	27599	num	20	SENT_10	[p1l9t2733r110b2763],
22	,	,	O	,	_	0	SENT_10	[p1l9t2733r110b2763],
23	USA	NNP	LOCATION	USA	appos	2	SENT_10	[p1l126t2733r191b2758],
24	.	.	O	.	_	0	SENT_10	[p1l126t2733r191b2758],

1	Received	VBN	O	receive	_	0	SENT_11	[p1l11t2821r145b2847],
2	8	CD	DATE	8	dobj	1	SENT_11	[p1l167t2822r185b2847],
3	July	NNP	DATE	July	tmod	1	SENT_11	[p1l205t2821r261b2854],
4	2006	CD	DATE	2006	num	3	SENT_11	[p1l282t2822r364b2852],
5	;	:	O	;	_	0	SENT_11	[p1l282t2822r364b2852],
6	revised	VBN	O	revise	parataxis	1	SENT_11	[p1l388t2821r495b2847],
7	31	CD	DATE	31	dobj	6	SENT_11	[p1l519t2822r549b2847],
8	October	NNP	DATE	October	tmod	6	SENT_11	[p1l576t2821r702b2847],
9	2006	CD	DATE	2006	num	8	SENT_11	[p1l9t2859r92b2889],
10	;	:	O	;	_	0	SENT_11	[p1l9t2859r92b2889],
11	accepted	VBN	O	accept	parataxis	1	SENT_11	[p1l104t2859r242b2892],
12	4	CD	DATE	4	dobj	11	SENT_11	[p1l253t2860r272b2884],
13	November	NNP	DATE	November	tmod	11	SENT_11	[p1l284t2859r445b2884],
14	2006	CD	DATE	2006	num	13	SENT_11	[p1l455t2859r538b2889],
15	;	:	O	;	_	0	SENT_11	[p1l455t2859r538b2889],
16	published	VBN	O	publish	parataxis	1	SENT_11	[p1l551t2859r700b2892],
17	online	NN	O	online	prep	16	SENT_11	[p1l9t2896r104b2921],
18	16	CD	DATE	16	dep	17	SENT_11	[p1l119t2897r154b2921],
19	January	NNP	DATE	January	tmod	16	SENT_11	[p1l165t2897r282b2929],
20	2007	CD	DATE	2007	num	19	SENT_11	[p1l294t2897r368b2921],

1	Paclitaxel	NN	O	paclitaxel	nsubjpass	4	SENT_12	[p1l751t668r916b699],
2	is	VBZ	O	be	auxpass	4	SENT_12	[p1l935t668r957b699],
3	commonly	RB	O	commonly	advmod	4	SENT_12	[p1l974t668r1169b709],
4	used	VBN	O	use	_	0	SENT_12	[p1l1186t668r1266b699],
5	in	IN	O	in	_	0	SENT_12	[p1l1285t668r1314b699],
6	the	DT	O	the	det	7	SENT_12	[p1l1332t668r1390b699],
7	treatment	NN	O	treatment	prep_in	4	SENT_12	[p1l1406t671r1587b699],
8	of	IN	O	of	_	0	SENT_12	[p1l1602t668r1637b699],
9	breast	NN	O	breast	nn	10	SENT_12	[p1l1653t668r1762b699],
10	cancer	NN	O	cancer	prep_of	7	SENT_12	[p1l1777t677r1905b699],
11	.	.	O	.	_	0	SENT_12	[p1l1777t677r1905b699],

1	Variability	NN	O	variability	nsubj	6	SENT_13	[p1l1922t668r2102b709],
2	in	IN	O	in	_	0	SENT_13	[p1l2119t668r2148b699],
3	paclitaxel	NN	O	paclitaxel	nn	4	SENT_13	[p1l750t714r918b756],
4	clearance	NN	O	clearance	prep_in	1	SENT_13	[p1l952t714r1122b746],
5	may	MD	O	may	aux	6	SENT_13	[p1l1156t724r1232b756],
6	contribute	VB	O	contribute	_	0	SENT_13	[p1l1264t714r1451b746],
7	to	TO	O	to	_	0	SENT_13	[p1l1484t718r1520b746],
8	the	DT	O	the	det	9	SENT_13	[p1l1552t714r1610b746],
9	unpredictability	NN	O	unpredictability	prep_to	6	SENT_13	[p1l1644t714r1929b756],
10	of	IN	O	of	_	0	SENT_13	[p1l1961t714r1996b746],
11	clinical	JJ	O	clinical	amod	12	SENT_13	[p1l2027t714r2147b746],
12	outcomes	NNS	O	outcome	prep_of	9	SENT_13	[p1l749t765r936b793],
13	.	.	O	.	_	0	SENT_13	[p1l749t765r936b793],

1	We	PRP	O	we	nsubj	2	SENT_14	[p1l954t762r1013b793],
2	assessed	VBD	O	assess	_	0	SENT_14	[p1l1031t761r1178b793],
3	genomic	JJ	O	genomic	amod	4	SENT_14	[p1l1197t762r1356b803],
4	DNA	NN	O	dna	dobj	2	SENT_14	[p1l1375t763r1460b792],
5	from	IN	O	from	_	0	SENT_14	[p1l1475t761r1559b793],
6	the	DT	O	the	det	7	SENT_14	[p1l1578t761r1636b793],
7	plasma	NN	O	plasma	prep_from	2	SENT_14	[p1l1655t761r1779b803],
8	of	IN	O	of	_	0	SENT_14	[p1l1798t761r1833b793],
9	93	CD	NUMBER	93	num	10	SENT_14	[p1l1849t762r1892b793],
10	patients	NNS	O	patient	prep_of	7	SENT_14	[p1l1912t762r2054b803],
11	with	IN	O	with	_	0	SENT_14	[p1l2070t761r2148b793],
12	high-risk	JJ	O	high-risk	amod	13	SENT_14	[p1l750t808r904b849],
13	primary	JJ	O	primary	prep_with	10	SENT_14	[p1l932t809r1071b850],
14	or	CC	O	or	_	0	SENT_14	[p1l1098t817r1135b840],
15	stage	NN	O	stage	nn	18	SENT_14	[p1l1161t812r1255b849],
16	IV	CD	NUMBER	iv	num	18	SENT_14	[p1l1285t809r1318b839],
17	breast	NN	O	breast	nn	18	SENT_14	[p1l1345t808r1453b840],
18	cancer	NN	O	cancer	prep_from	2	SENT_14	[p1l1480t817r1608b846],
19	,	,	O	,	_	0	SENT_14	[p1l1480t817r1608b846],
20	who	WP	O	who	nsubj	21	SENT_14	[p1l1637t808r1715b840],
21	received	VBD	O	receive	rcmod	18	SENT_14	[p1l1745t808r1892b840],
22	dose-intense	JJ	O	dose-intense	amod	23	SENT_14	[p1l1921t808r2149b840],
23	paclitaxel	NN	O	paclitaxel	dobj	21	SENT_14	[p1l750t855r929b896],
24	,	,	O	,	_	0	SENT_14	[p1l750t855r929b896],
25	doxorubicin	NN	O	doxorubicin	dobj	2	SENT_14	[p1l950t855r1166b886],
26	and	CC	O	and	_	0	SENT_14	[p1l1187t855r1252b886],
27	cyclophosphamide	NN	O	cyclophosphamide	conj_and	25	SENT_14	[p1l1272t855r1626b896],
28	.	.	O	.	_	0	SENT_14	[p1l1272t855r1626b896],

1	Eight	CD	NUMBER	eight	num	2	SENT_15	[p1l1648t855r1739b896],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	14	SENT_15	[p1l1757t855r2036b896],
3	in	IN	O	in	_	0	SENT_15	[p1l2055t856r2084b886],
4	six	CD	NUMBER	six	num	5	SENT_15	[p1l2104t856r2150b886],
5	genes	NNS	O	gene	prep_in	2	SENT_15	[p1l749t911r853b943],
6	associated	VBN	O	associate	partmod	5	SENT_15	[p1l869t902r1053b933],
7	with	IN	O	with	_	0	SENT_15	[p1l1068t902r1146b933],
8	metabolism	NN	O	metabolism	prep_with	6	SENT_15	[p1l1165t902r1374b933],
9	and	CC	O	and	_	0	SENT_15	[p1l1392t902r1457b933],
10	transport	NN	O	transport	conj_and	8	SENT_15	[p1l1474t905r1640b943],
11	of	IN	O	of	_	0	SENT_15	[p1l1654t902r1689b933],
12	paclitaxel	NN	O	paclitaxel	prep_of	8	SENT_15	[p1l1704t902r1872b943],
13	were	VBD	O	be	auxpass	14	SENT_15	[p1l1888t911r1975b933],
14	analyzed	VBN	O	analyze	_	0	SENT_15	[p1l1991t902r2148b943],
15	using	VBG	O	use	xcomp	14	SENT_15	[p1l750t949r843b990],
16	Pyrosequencing	NN	O	pyrosequencing	dobj	15	SENT_15	[p1l869t949r1166b990],
17	.	.	O	.	_	0	SENT_15	[p1l869t949r1166b990],

1	We	PRP	O	we	nsubj	2	SENT_16	[p1l1190t950r1248b980],
2	found	VBD	O	find	_	0	SENT_16	[p1l1269t948r1375b980],
3	no	DT	O	no	det	4	SENT_16	[p1l1401t958r1445b980],
4	association	NN	O	association	dobj	2	SENT_16	[p1l1468t949r1663b980],
5	between	IN	O	between	_	0	SENT_16	[p1l1689t948r1842b980],
6	ABCB7	NN	O	abcb7	nn	17	SENT_16	[p1l1866t949r1991b987],
7	,	,	O	,	_	0	SENT_16	[p1l1866t949r1991b987],
8	ABCG2	NN	O	abcg2	nn	17	SENT_16	[p1l2015t949r2147b987],
9	,	,	O	,	_	0	SENT_16	[p1l2015t949r2147b987],
10	CYPiBi	NN	O	cypibus	nn	17	SENT_16	[p1l751t996r894b1033],
11	,	,	O	,	_	0	SENT_16	[p1l751t996r894b1033],
12	CYP3A4	NN	O	cyp3a4	nn	17	SENT_16	[p1l918t996r1063b1033],
13	,	,	O	,	_	0	SENT_16	[p1l918t996r1063b1033],
14	CYP3A5	NN	O	cyp3a5	conj_and	6	SENT_16	[p1l1086t996r1222b1027],
15	and	CC	O	and	_	0	SENT_16	[p1l1241t995r1306b1027],
16	CYPZC8	NN	O	cypzc8	conj_and	6	SENT_16	[p1l1329t996r1467b1027],
17	genotypes	NNS	O	genotype	prep_between	4	SENT_16	[p1l1485t999r1673b1037],
18	and	CC	O	and	_	0	SENT_16	[p1l1692t995r1758b1027],
19	paclitaxel	NN	O	paclitaxel	nn	20	SENT_16	[p1l1779t995r1947b1037],
20	clearance	NN	O	clearance	dobj	2	SENT_16	[p1l1968t995r2147b1027],
21	.	.	O	.	_	0	SENT_16	[p1l1968t995r2147b1027],

1	However	RB	O	however	advmod	11	SENT_17	[p1l751t1043r919b1080],
2	,	,	O	,	_	0	SENT_17	[p1l751t1043r919b1080],
3	patients	NNS	O	patient	nsubj	11	SENT_17	[p1l942t1043r1084b1083],
4	homozygous	JJ	O	homozygous	amod	3	SENT_17	[p1l1105t1042r1338b1083],
5	for	IN	O	for	_	0	SENT_17	[p1l1356t1042r1407b1074],
6	the	DT	O	the	det	10	SENT_17	[p1l1425t1042r1483b1074],
7	CYP1Bl	NN	O	cyp1bl	nn	10	SENT_17	[p1l1505t1043r1679b1074],
8	*	NN	O	*	nn	10	SENT_17	[p1l1505t1043r1679b1074],
9	3	CD	NUMBER	3	num	10	SENT_17	[p1l1505t1043r1679b1074],
10	allele	NN	O	allele	prep_for	4	SENT_17	[p1l1700t1042r1790b1074],
11	had	VBD	O	have	_	0	SENT_17	[p1l1811t1042r1876b1074],
12	a	DT	O	a	det	16	SENT_17	[p1l1897t1051r1915b1074],
13	significantly	RB	O	significantly	advmod	14	SENT_17	[p1l1935t1042r2150b1083],
14	longer	JJR	O	longer	amod	16	SENT_17	[p1l750t1164r866b1205],
15	progression-free	JJ	O	progression-free	amod	16	SENT_17	[p1l884t1164r1175b1205],
16	survival	NN	O	survival	dobj	11	SENT_17	[p1l1193t1164r1325b1195],
17	than	IN	O	than	_	0	SENT_17	[p1l1344t1164r1424b1195],
18	patients	NNS	O	patient	prep_than	11	SENT_17	[p1l1445t1165r1586b1205],
19	with	IN	O	with	_	0	SENT_17	[p1l1603t1164r1681b1195],
20	at	IN	O	at	quantmod	22	SENT_17	[p1l1700t1168r1734b1195],
21	least	JJS	O	least	mwe	20	SENT_17	[p1l1752t1164r1831b1195],
22	one	CD	NUMBER	one	num	26	SENT_17	[p1l1848t1173r1915b1195],
23	Valine	NN	PERSON	valine	nn	26	SENT_17	[p1l1931t1164r2041b1195],
24	allele	NN	O	allele	nn	26	SENT_17	[p1l2059t1164r2149b1195],
25	(	CD	NUMBER	(	num	26	SENT_17	[p1l749t1211r961b1250],
26	P	NN	O	p	prep_with	18	SENT_17	[p1l749t1211r961b1250],
27	=	JJ	O	=	amod	26	SENT_17	[p1l749t1211r961b1250],
28	0.037	CD	NUMBER	0.037	num	29	SENT_17	[p1l749t1211r961b1250],
29	)	NN	O	)	dep	27	SENT_17	[p1l749t1211r961b1250],
30	.	.	O	.	_	0	SENT_17	[p1l749t1211r961b1250],

1	This	DT	O	this	det	2	SENT_18	[p1l998t1211r1070b1242],
2	finding	NN	O	finding	nsubj	4	SENT_18	[p1l1106t1211r1233b1252],
3	could	MD	O	could	aux	4	SENT_18	[p1l1272t1211r1370b1242],
4	reflect	VB	O	reflect	ccomp	14	SENT_18	[p1l1410t1211r1520b1242],
5	altered	JJ	O	altered	amod	7	SENT_18	[p1l1556t1211r1678b1242],
6	paclitaxel	NN	O	paclitaxel	nn	7	SENT_18	[p1l1718t1211r1886b1252],
7	metabolism	NN	O	metabolism	dobj	4	SENT_18	[p1l1926t1211r2147b1249],
8	,	,	O	,	_	0	SENT_18	[p1l1926t1211r2147b1249],
9	however	RB	O	however	advmod	4	SENT_18	[p1l750t1257r914b1295],
10	,	,	O	,	_	0	SENT_18	[p1l750t1257r914b1295],
11	the	DT	O	the	det	12	SENT_18	[p1l931t1257r989b1289],
12	finding	NN	O	finding	nsubj	14	SENT_18	[p1l1003t1257r1131b1298],
13	was	VBD	O	be	cop	14	SENT_18	[p1l1147t1266r1215b1289],
14	independent	JJ	O	independent	_	0	SENT_18	[p1l1232t1257r1464b1298],
15	of	IN	O	of	_	0	SENT_18	[p1l1479t1257r1514b1289],
16	paclitaxel	NN	O	paclitaxel	nn	17	SENT_18	[p1l1530t1257r1697b1298],
17	clearance	NN	O	clearance	prep_of	14	SENT_18	[p1l1715t1257r1895b1289],
18	.	.	O	.	_	0	SENT_18	[p1l1715t1257r1895b1289],

1	Alternatively	RB	O	alternatively	advmod	11	SENT_19	[p1l1911t1257r2147b1298],
2	,	,	O	,	_	0	SENT_19	[p1l1911t1257r2147b1298],
3	the	DT	O	the	det	4	SENT_19	[p1l748t1304r806b1335],
4	role	NN	O	role	nsubj	11	SENT_19	[p1l822t1304r887b1335],
5	of	IN	O	of	_	0	SENT_19	[p1l902t1304r937b1335],
6	CYPlBl	NN	O	cyplbl	prep_of	4	SENT_19	[p1l953t1305r1081b1335],
7	in	IN	O	in	_	0	SENT_19	[p1l1102t1305r1131b1335],
8	estrogen	NN	O	estrogen	nn	9	SENT_19	[p1l1147t1308r1303b1345],
9	metabolism	NN	O	metabolism	prep_in	6	SENT_19	[p1l1321t1304r1530b1335],
10	may	MD	O	may	aux	11	SENT_19	[p1l1548t1313r1624b1345],
11	influence	VB	O	influence	_	0	SENT_19	[p1l1639t1304r1802b1335],
12	the	DT	O	the	det	13	SENT_19	[p1l1816t1304r1874b1335],
13	risk	NN	O	risk	dobj	11	SENT_19	[p1l1890t1304r1947b1335],
14	of	IN	O	of	_	0	SENT_19	[p1l1961t1304r1996b1335],
15	invasive	JJ	O	invasive	amod	20	SENT_19	[p1l2010t1305r2149b1335],
16	or	CC	O	or	_	0	SENT_19	[p1l749t1435r786b1457],
17	paclitaxel	NN	O	paclitaxel	npadvmod	18	SENT_19	[p1l802t1426r969b1467],
18	resistant	JJ	O	resistant	conj_or	15	SENT_19	[p1l989t1427r1137b1457],
19	breast	NN	O	breast	nn	20	SENT_19	[p1l1153t1426r1262b1457],
20	cancer	NN	O	cancer	prep_of	13	SENT_19	[p1l1277t1435r1396b1457],
21	in	IN	O	in	_	0	SENT_19	[p1l1412t1427r1441b1457],
22	patients	NNS	O	patient	prep_in	11	SENT_19	[p1l1460t1427r1602b1467],
23	carrying	VBG	O	carry	partmod	22	SENT_19	[p1l1618t1427r1762b1467],
24	the	DT	O	the	det	28	SENT_19	[p1l1779t1426r1837b1457],
25	CYPlB7	NN	O	cyplb7	nn	28	SENT_19	[p1l1856t1427r2030b1457],
26	*	NN	O	*	nn	28	SENT_19	[p1l1856t1427r2030b1457],
27	3	CD	NUMBER	3	num	28	SENT_19	[p1l1856t1427r2030b1457],
28	allele	NN	O	allele	dobj	23	SENT_19	[p1l2047t1426r2147b1457],
29	.	.	O	.	_	0	SENT_19	[p1l2047t1426r2147b1457],

1	The	DT	O	the	det	3	SENT_20	[p1l753t1472r812b1504],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_20	[p1l824t1472r1150b1514],
3	journal	NN	O	journal	dep	6	SENT_20	[p1l1158t1472r1281b1511],
4	(	CD	NUMBER	(	dep	3	SENT_20	[p1l1291t1473r1408b1512],
5	2007	CD	DATE	2007	dep	6	SENT_20	[p1l1291t1473r1408b1512],
6	)	NN	O	)	dep	12	SENT_20	[p1l1291t1473r1408b1512],
7	7	CD	NUMBER	7	dep	6	SENT_20	[p1l1423t1474r1451b1510],
8	,	,	O	,	_	0	SENT_20	[p1l1423t1474r1451b1510],
9	362-365	CD	NUMBER	362-365	appos	7	SENT_20	[p1l1468t1473r1639b1510],
10	;	:	O	;	_	0	SENT_20	[p1l1468t1473r1639b1510],
11	doizl0	CD	NUMBER	doizl0	num	12	SENT_20	[p1l1654t1472r2147b1514],
12	.1038	CD	NUMBER	.1038	_	0	SENT_20	[p1l1654t1472r2147b1514],
13	/	:	O	/	punct	12	SENT_20	[p1l1654t1472r2147b1514],
14	sj	NN	O	sj	dep	12	SENT_20	[p1l1654t1472r2147b1514],
15	.	.	O	.	_	0	SENT_20	[p1l1654t1472r2147b1514],

1	tpj	NN	O	tpj	_	0	SENT_21	[p1l1654t1472r2147b1514],
2	.6500434	CD	NUMBER	.6500434	num	1	SENT_21	[p1l1654t1472r2147b1514],
3	;	:	O	;	_	0	SENT_21	[p1l1654t1472r2147b1514],
4	published	VBN	O	publish	dep	1	SENT_21	[p1l750t1519r924b1561],
5	online	NN	O	online	prep	4	SENT_21	[p1l942t1519r1052b1551],
6	16	CD	DATE	16	dep	5	SENT_21	[p1l1072t1520r1114b1551],
7	January	NNP	DATE	January	tmod	4	SENT_21	[p1l1130t1521r1265b1561],
8	2007	CD	DATE	2007	num	7	SENT_21	[p1l1281t1520r1373b1551],

1	Keywords	NNPS	O	Keywords	_	0	SENT_22	[p1l749t1616r920b1649],
2	:	:	O	:	_	0	SENT_22	[p1l749t1616r920b1649],
3	breast	NN	O	breast	dep	1	SENT_22	[p1l940t1616r1027b1641],
4	cancer	NN	O	cancer	dep	3	SENT_22	[p1l1039t1623r1141b1646],
5	;	:	O	;	_	0	SENT_22	[p1l1039t1623r1141b1646],
6	pharmacogenetics	NNS	O	pharmacogenetic	dep	3	SENT_22	[p1l1157t1616r1430b1649],
7	;	:	O	;	_	0	SENT_22	[p1l1157t1616r1430b1649],
8	paclitaxel	NN	O	paclitaxel	dep	6	SENT_22	[p1l1446t1616r1589b1649],
9	;	:	O	;	_	0	SENT_22	[p1l1446t1616r1589b1649],
10	polymorphism	NN	O	polymorphism	dep	3	SENT_22	[p1l1605t1616r1822b1649],
11	;	:	O	;	_	0	SENT_22	[p1l1605t1616r1822b1649],
12	CYP1B1	NN	O	cyp1b1	dep	10	SENT_22	[p1l1837t1617r1944b1641],

1	Introduction	NN	O	introduction	_	0	SENT_23	[p1l749t1798r987b1826],

1	Paclitaxel	NN	O	paclitaxel	nsubj	3	SENT_24	[p1l749t1891r913b1919],
2	is	VBZ	O	be	cop	3	SENT_24	[p1l924t1892r949b1919],
3	one	CD	NUMBER	one	_	0	SENT_24	[p1l961t1899r1024b1919],
4	of	IN	O	of	_	0	SENT_24	[p1l1036t1890r1071b1919],
5	the	DT	O	the	det	9	SENT_24	[p1l1080t1891r1135b1919],
6	most	RBS	O	most	advmod	7	SENT_24	[p1l1147t1894r1232b1919],
7	active	JJ	O	active	amod	9	SENT_24	[p1l1243t1892r1343b1919],
8	single	JJ	O	single	amod	9	SENT_24	[p1l1355t1891r1454b1928],
9	agents	NNS	O	agent	prep_of	3	SENT_24	[p1l1466t1894r1575b1928],
10	in	IN	O	in	_	0	SENT_24	[p1l1587t1892r1622b1918],
11	the	DT	O	the	det	12	SENT_24	[p1l1633t1891r1688b1919],
12	treatment	NN	O	treatment	prep_in	9	SENT_24	[p1l1699t1894r1870b1919],
13	of	IN	O	of	_	0	SENT_24	[p1l1882t1890r1917b1919],
14	breast	NN	O	breast	nn	15	SENT_24	[p1l1925t1891r2027b1919],
15	cancer	NN	O	cancer	prep_of	12	SENT_24	[p1l2039t1899r2150b1919],
16	and	CC	O	and	_	0	SENT_24	[p1l749t1937r813b1966],
17	is	VBZ	O	be	cop	20	SENT_24	[p1l843t1939r868b1966],
18	an	DT	O	a	det	20	SENT_24	[p1l899t1946r940b1966],
19	important	JJ	O	important	amod	20	SENT_24	[p1l970t1939r1147b1975],
20	component	NN	O	component	conj_and	3	SENT_24	[p1l1177t1941r1377b1975],
21	of	IN	O	of	_	0	SENT_24	[p1l1408t1937r1443b1966],
22	many	JJ	O	many	amod	26	SENT_24	[p1l1471t1946r1570b1975],
23	commonly	RB	O	commonly	advmod	24	SENT_24	[p1l1600t1937r1789b1975],
24	used	VBN	O	use	amod	26	SENT_24	[p1l1818t1937r1896b1966],
25	combination	NN	O	combination	nn	26	SENT_24	[p1l1926t1938r2150b1966],
26	regimens	NNS	O	regimen	prep_of	20	SENT_24	[p1l748t1988r930b2029],
27	}	VBP	O	}	rcmod	26	SENT_24	[p1l748t1988r930b2029],
28	Despite	IN	O	despite	_	0	SENT_24	[p1l958t1993r1086b2029],
29	its	PRP$	O	its	poss	31	SENT_24	[p1l1112t1993r1151b2020],
30	clinical	JJ	O	clinical	amod	31	SENT_24	[p1l1178t1992r1302b2020],
31	activity	NN	O	activity	prep_despite	41	SENT_24	[p1l1329t1993r1463b2029],
32	,	,	O	,	_	0	SENT_24	[p1l1329t1993r1463b2029],
33	variability	NN	O	variability	nsubj	41	SENT_24	[p1l1490t1992r1667b2029],
34	in	IN	O	in	_	0	SENT_24	[p1l1691t1993r1726b2020],
35	toxicity	NN	O	toxicity	prep_in	33	SENT_24	[p1l1752t1993r1885b2029],
36	and	CC	O	and	_	0	SENT_24	[p1l1910t1992r1974b2020],
37	response	NN	O	response	conj_and	35	SENT_24	[p1l2000t2000r2149b2029],
38	remain	VBP	O	remain	cop	41	SENT_24	[p1l748t2040r870b2067],
39	a	DT	O	a	det	41	SENT_24	[p1l886t2047r903b2067],
40	major	JJ	O	major	amod	41	SENT_24	[p1l918t2040r1019b2076],
41	problem	NN	O	problem	ccomp	27	SENT_24	[p1l1033t2039r1179b2076],
42	for	IN	O	for	_	0	SENT_24	[p1l1194t2039r1242b2067],
43	patients	NNS	O	patient	prep_for	41	SENT_24	[p1l1257t2040r1395b2076],
44	receiving	VBG	O	receive	partmod	43	SENT_24	[p1l1410t2040r1568b2076],
45	paclitaxel	NN	O	paclitaxel	dobj	44	SENT_24	[p1l1582t2039r1757b2076],
46	.	.	O	.	_	0	SENT_24	[p1l1582t2039r1757b2076],

1	Significant	JJ	O	significant	amod	3	SENT_25	[p1l1775t2039r1960b2076],
2	variability	NN	O	variability	nn	3	SENT_25	[p1l1974t2039r2151b2076],
3	(	NN	O	(	nsubj	13	SENT_25	[p1l750t2086r793b2121],
4	4	CD	NUMBER	4	num	5	SENT_25	[p1l750t2086r793b2121],
5	—	NN	O	—	advmod	13	SENT_25	[p1l750t2086r793b2121],
6	to	TO	O	to	_	0	SENT_25	[p1l809t2089r843b2114],
7	10-fold	RB	O	10-fold	quantmod	8	SENT_25	[p1l861t2086r993b2121],
8	)	CD	NUMBER	)	prep_to	5	SENT_25	[p1l861t2086r993b2121],
9	in	IN	O	in	_	0	SENT_25	[p1l1010t2087r1044b2114],
10	paclitaxel	NN	O	paclitaxel	nn	11	SENT_25	[p1l1059t2086r1226b2123],
11	clearance	NN	O	clearance	prep_in	5	SENT_25	[p1l1242t2086r1402b2114],
12	may	MD	O	may	aux	13	SENT_25	[p1l1418t2094r1492b2123],
13	contribute	VB	O	contribute	_	0	SENT_25	[p1l1507t2086r1686b2114],
14	to	TO	O	to	_	0	SENT_25	[p1l1702t2089r1736b2114],
15	the	DT	O	the	det	16	SENT_25	[p1l1752t2086r1807b2114],
16	unpredictability	NN	O	unpredictability	prep_to	13	SENT_25	[p1l1822t2086r2102b2123],
17	of	IN	O	of	_	0	SENT_25	[p1l2117t2086r2152b2114],
18	clinical	JJ	O	clinical	amod	19	SENT_25	[p1l749t2139r873b2167],
19	outcomes	NNS	O	outcome	prep_of	16	SENT_25	[p1l893t2135r1087b2167],
20	?	.	O	?	_	0	SENT_25	[p1l893t2135r1087b2167],

1	However	RB	O	however	advmod	17	SENT_26	[p1l1106t2140r1265b2173],
2	,	,	O	,	_	0	SENT_26	[p1l1106t2140r1265b2173],
3	to	TO	O	to	aux	4	SENT_26	[p1l1286t2142r1320b2167],
4	date	VB	O	date	csubjpass	17	SENT_26	[p1l1340t2139r1412b2167],
5	the	DT	O	the	det	6	SENT_26	[p1l1431t2139r1486b2167],
6	contribution	NN	O	contribution	dobj	4	SENT_26	[p1l1506t2139r1726b2167],
7	of	IN	O	of	_	0	SENT_26	[p1l1745t2138r1780b2167],
8	genetic	JJ	O	genetic	amod	9	SENT_26	[p1l1798t2140r1922b2176],
9	variation	NN	O	variation	prep_of	6	SENT_26	[p1l1940t2140r2096b2167],
10	to	TO	O	to	_	0	SENT_26	[p1l2115t2142r2149b2167],
11	these	DT	O	these	det	13	SENT_26	[p1l748t2192r837b2220],
12	interindividual	JJ	O	interindividual	amod	13	SENT_26	[p1l849t2192r1110b2220],
13	differences	NNS	O	difference	prep_to	4	SENT_26	[p1l1122t2192r1308b2220],
14	has	VBZ	O	have	aux	17	SENT_26	[p1l1320t2192r1376b2220],
15	not	RB	O	not	neg	17	SENT_26	[p1l1388t2196r1448b2220],
16	been	VBN	O	be	auxpass	17	SENT_26	[p1l1458t2192r1541b2220],
17	deﬁned	VBN	O	deﬁned	_	0	SENT_26	[p1l1553t2192r1682b2220],
18	clearly	RB	O	clearly	advmod	17	SENT_26	[p1l1694t2192r1813b2229],
19	.	.	O	.	_	0	SENT_26	[p1l1694t2192r1813b2229],

1	In	IN	O	in	_	0	SENT_27	[p1l1827t2193r1862b2220],
2	particular	JJ	O	particular	prep_in	5	SENT_27	[p1l1874t2192r2047b2229],
3	,	,	O	,	_	0	SENT_27	[p1l1874t2192r2047b2229],
4	there	EX	O	there	expl	5	SENT_27	[p1l2061t2192r2149b2220],
5	is	VBZ	O	be	_	0	SENT_27	[p1l748t2247r773b2275],
6	a	DT	O	a	det	7	SENT_27	[p1l788t2254r805b2275],
7	paucity	NN	O	paucity	nsubj	5	SENT_27	[p1l819t2247r948b2284],
8	of	IN	O	of	_	0	SENT_27	[p1l961t2246r996b2275],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_27	[p1l1008t2246r1308b2284],
10	studies	NNS	O	study	prep_of	7	SENT_27	[p1l1323t2246r1441b2275],
11	focused	VBD	O	focus	rcmod	7	SENT_27	[p1l1455t2246r1586b2275],
12	on	IN	O	on	_	0	SENT_27	[p1l1601t2254r1645b2275],
13	paclitaxel	NN	O	paclitaxel	nn	14	SENT_27	[p1l1659t2246r1826b2284],
14	therapy	NN	O	therapy	prep_on	11	SENT_27	[p1l1840t2246r1973b2284],
15	for	IN	O	for	_	0	SENT_27	[p1l1986t2246r2035b2275],
16	breast	NN	O	breast	nn	17	SENT_27	[p1l2047t2246r2150b2275],
17	cancer	NN	O	cancer	prep_for	11	SENT_27	[p1l749t2307r866b2327],
18	.	.	O	.	_	0	SENT_27	[p1l749t2307r866b2327],

1	Paclitaxel	NN	O	paclitaxel	nn	2	SENT_28	[p1l786t2353r951b2381],
2	elimination	NN	O	elimination	nsubjpass	4	SENT_28	[p1l976t2353r1179b2381],
3	is	VBZ	O	be	auxpass	4	SENT_28	[p1l1204t2354r1228b2381],
4	regulated	VBN	O	regulate	_	0	SENT_28	[p1l1253t2353r1414b2390],
5	by	IN	O	by	_	0	SENT_28	[p1l1437t2353r1480b2390],
6	a	DT	O	a	det	8	SENT_28	[p1l1504t2361r1521b2381],
7	wide	JJ	O	wide	amod	8	SENT_28	[p1l1545t2353r1626b2381],
8	array	NN	O	array	agent	4	SENT_28	[p1l1652t2361r1738b2390],
9	of	IN	O	of	_	0	SENT_28	[p1l1762t2353r1797b2381],
10	genes	NNS	O	gene	prep_of	8	SENT_28	[p1l1820t2361r1915b2390],
11	involved	VBN	O	involve	partmod	10	SENT_28	[p1l1940t2353r2091b2381],
12	in	IN	O	in	_	0	SENT_28	[p1l2115t2354r2150b2381],
13	metabolism	NN	O	metabolism	nn	17	SENT_28	[p1l748t2407r951b2435],
14	and	CC	O	and	_	0	SENT_28	[p1l964t2407r1028b2435],
15	extracellular	JJ	O	extracellular	nn	17	SENT_28	[p1l1041t2407r1256b2435],
16	transport	NN	O	transport	nn	17	SENT_28	[p1l1267t2403r1452b2444],
17	.3	NN	NUMBER	.3	prep_in	11	SENT_28	[p1l1267t2403r1452b2444],
18	Oxidative	JJ	MISC	oxidative	amod	20	SENT_28	[p1l1466t2407r1633b2435],
19	paclitaxel	NN	O	paclitaxel	nn	20	SENT_28	[p1l1645t2407r1812b2444],
20	metabolism	NN	O	metabolism	nsubj	21	SENT_28	[p1l1824t2407r2028b2435],
21	occurs	VBZ	O	occur	rcmod	17	SENT_28	[p1l2041t2415r2149b2435],
22	via	IN	O	via	_	0	SENT_28	[p1l747t2461r798b2488],
23	the	DT	O	the	det	26	SENT_28	[p1l809t2460r865b2488],
24	cytochrome	NN	O	cytochrome	nn	26	SENT_28	[p1l877t2460r1083b2497],
25	P450	NN	O	p450	nn	26	SENT_28	[p1l1096t2461r1179b2488],
26	pathway	NN	O	pathway	prep_via	21	SENT_28	[p1l1191t2460r1345b2497],
27	.	.	O	.	_	0	SENT_28	[p1l1191t2460r1345b2497],

1	Data	NNS	O	datum	nsubj	5	SENT_29	[p1l1359t2461r1439b2488],
2	from	IN	O	from	_	0	SENT_29	[p1l1451t2460r1533b2488],
3	liver	NN	O	liver	nn	4	SENT_29	[p1l1545t2460r1621b2488],
4	microsomes	NNS	O	microsome	prep_from	1	SENT_29	[p1l1632t2461r1839b2488],
5	demonstrate	VBP	O	demonstrate	dep	37	SENT_29	[p1l1852t2460r2068b2488],
6	that	IN	O	that	complm	12	SENT_29	[p1l2080t2460r2150b2488],
7	CYP2C8	NN	O	cyp2c8	nsubj	12	SENT_29	[p1l749t2514r889b2542],
8	and	CC	O	and	_	0	SENT_29	[p1l902t2514r966b2542],
9	CYP3A4	NN	O	cyp3a4	nsubj	12	SENT_29	[p1l978t2514r1117b2542],
10	are	VBP	O	be	cop	12	SENT_29	[p1l1130t2522r1179b2542],
11	primarily	RB	O	primarily	advmod	12	SENT_29	[p1l1191t2514r1352b2551],
12	responsible	JJ	O	responsible	ccomp	5	SENT_29	[p1l1362t2514r1557b2551],
13	for	IN	O	for	_	0	SENT_29	[p1l1569t2513r1617b2542],
14	paclitaxel	NN	O	paclitaxel	nn	15	SENT_29	[p1l1628t2513r1794b2551],
15	metabolism	NN	O	metabolism	prep_for	12	SENT_29	[p1l1806t2510r2059b2548],
16	,	,	O	,	_	0	SENT_29	[p1l1806t2510r2059b2548],
17	“	NN	O	“	nsubj	20	SENT_29	[p1l1806t2510r2059b2548],
18	with	IN	O	with	_	0	SENT_29	[p1l2071t2514r2150b2542],
19	CYP2C8	NN	O	cyp2c8	prep_with	17	SENT_29	[p1l749t2567r889b2594],
20	demonstrating	VBG	O	demonstrate	dep	12	SENT_29	[p1l904t2566r1159b2603],
21	a	DT	O	a	det	25	SENT_29	[p1l1173t2574r1190b2594],
22	2.3-fold	RB	O	2.3-fold	advmod	23	SENT_29	[p1l1204t2566r1337b2594],
23	greater	JJR	O	greater	amod	25	SENT_29	[p1l1351t2570r1469b2603],
24	metabolite	NN	O	metabolite	nn	25	SENT_29	[p1l1482t2566r1667b2594],
25	production	NN	O	production	dobj	20	SENT_29	[p1l1681t2566r1875b2603],
26	than	IN	O	than	_	0	SENT_29	[p1l1889t2566r1969b2594],
27	CYP3A4	NN	O	cyp3a4	prep_than	20	SENT_29	[p1l1984t2563r2149b2594],
28	.5	CD	NUMBER	.5	num	27	SENT_29	[p1l1984t2563r2149b2594],
29	The	DT	O	the	det	34	SENT_29	[p1l747t2613r812b2641],
30	CY2C8	NN	O	cy2c8	nn	34	SENT_29	[p1l836t2614r990b2641],
31	*	NN	O	*	nn	34	SENT_29	[p1l836t2614r990b2641],
32	3	CD	NUMBER	3	num	34	SENT_29	[p1l836t2614r990b2641],
33	variant	JJ	O	variant	amod	34	SENT_29	[p1l1012t2614r1135b2641],
34	allele	NN	O	allele	dep	27	SENT_29	[p1l1158t2613r1247b2641],
35	has	VBZ	O	have	aux	37	SENT_29	[p1l1270t2613r1327b2641],
36	been	VBN	O	be	auxpass	37	SENT_29	[p1l1349t2613r1432b2641],
37	associated	VBN	O	associate	_	0	SENT_29	[p1l1455t2613r1629b2641],
38	with	IN	O	with	_	0	SENT_29	[p1l1650t2613r1729b2641],
39	decreased	VBN	O	decrease	amod	40	SENT_29	[p1l1752t2613r1918b2641],
40	paclitaxel	NN	O	paclitaxel	prep_with	37	SENT_29	[p1l1941t2613r2107b2650],
41	6	CD	NUMBER	6	num	43	SENT_29	[p1l2131t2614r2150b2641],
42	oc-hydroxylase	NN	O	oc-hydroxylase	nn	43	SENT_29	[p1l749t2660r988b2697],
43	activity	NN	O	activity	nsubjpass	37	SENT_29	[p1l1013t2661r1142b2697],
44	in	IN	O	in	_	0	SENT_29	[p1l1164t2661r1199b2687],
45	human	JJ	O	human	amod	47	SENT_29	[p1l1222t2660r1347b2688],
46	cell	NN	O	cell	nn	47	SENT_29	[p1l1371t2660r1429b2688],
47	lines	NNS	O	line	prep_in	37	SENT_29	[p1l1453t2660r1532b2688],
48	and	CC	O	and	_	0	SENT_29	[p1l1557t2660r1621b2688],
49	human	JJ	O	human	amod	51	SENT_29	[p1l1644t2660r1769b2688],
50	liver	NN	O	liver	nn	51	SENT_29	[p1l1793t2660r1869b2688],
51	microsomes	NNS	O	microsome	prep_in	37	SENT_29	[p1l1892t2656r2150b2688],
52	.	.	O	.	_	0	SENT_29	[p1l1892t2656r2150b2688],

1	“	NN	O	“	nn	3	SENT_30	[p1l1892t2656r2150b2688],
2	Functional	JJ	O	functional	amod	3	SENT_30	[p1l749t2706r935b2734],
3	variants	NNS	O	variant	nsubjpass	11	SENT_30	[p1l951t2708r1088b2734],
4	in	IN	O	in	_	0	SENT_30	[p1l1105t2708r1140b2734],
5	the	DT	O	the	det	8	SENT_30	[p1l1156t2706r1211b2734],
6	CYP3A	NN	O	cyp3a	nn	8	SENT_30	[p1l1230t2707r1345b2734],
7	gene	NN	O	gene	nn	8	SENT_30	[p1l1363t2714r1443b2743],
8	family	NN	O	family	prep_in	3	SENT_30	[p1l1460t2706r1571b2743],
9	have	VBP	O	have	aux	11	SENT_30	[p1l1587t2706r1667b2734],
10	been	VBN	O	be	auxpass	11	SENT_30	[p1l1683t2706r1766b2734],
11	identified	VBN	O	identify	_	0	SENT_30	[p1l1783t2706r1950b2734],
12	that	WDT	O	that	nsubj	15	SENT_30	[p1l1967t2706r2037b2734],
13	could	MD	O	could	aux	15	SENT_30	[p1l2054t2706r2150b2734],
14	potentially	RB	O	potentially	advmod	15	SENT_30	[p1l748t2753r938b2790],
15	impact	VB	O	impact	ccomp	11	SENT_30	[p1l948t2754r1068b2790],
16	drug	NN	O	drug	nn	17	SENT_30	[p1l1080t2753r1158b2790],
17	metabolism	NN	O	metabolism	dobj	15	SENT_30	[p1l1169t2753r1381b2781],
18	.	.	O	.	_	0	SENT_30	[p1l1169t2753r1381b2781],

1	A	DT	O	a	det	2	SENT_31	[p1l1394t2754r1419b2781],
2	polymorphism	NN	O	polymorphism	nsubj	37	SENT_31	[p1l1430t2753r1687b2790],
3	in	IN	O	in	_	0	SENT_31	[p1l1699t2754r1733b2781],
4	the	DT	O	the	det	6	SENT_31	[p1l1744t2753r1799b2781],
5	5	CD	NUMBER	5	num	6	SENT_31	[p1l1812t2752r1839b2781],
6	’	NN	O	’	prep_in	2	SENT_31	[p1l1812t2752r1839b2781],
7	regulatory	JJ	O	regulatory	amod	8	SENT_31	[p1l1851t2753r2030b2790],
8	region	NN	O	region	nsubjpass	19	SENT_31	[p1l2040t2754r2150b2790],
9	of	IN	O	of	_	0	SENT_31	[p1l749t2800r784b2828],
10	the	DT	O	the	det	11	SENT_31	[p1l792t2800r847b2828],
11	gene	NN	O	gene	prep_of	8	SENT_31	[p1l858t2808r947b2837],
12	,	,	O	,	_	0	SENT_31	[p1l858t2808r947b2837],
13	CYP3A4	NN	O	cyp3a4	nn	15	SENT_31	[p1l961t2800r1168b2834],
14	*	CD	NUMBER	*	num	15	SENT_31	[p1l961t2800r1168b2834],
15	1B	NN	O	1b	appos	11	SENT_31	[p1l961t2800r1168b2834],
16	,	,	O	,	_	0	SENT_31	[p1l961t2800r1168b2834],
17	has	VBZ	O	have	aux	19	SENT_31	[p1l1181t2800r1237b2828],
18	been	VBN	O	be	auxpass	19	SENT_31	[p1l1247t2800r1330b2828],
19	associated	VBN	O	associate	rcmod	6	SENT_31	[p1l1341t2800r1515b2828],
20	with	IN	O	with	prep	19	SENT_31	[p1l1525t2800r1604b2828],
21	significantly	RB	O	significantly	pcomp	20	SENT_31	[p1l1615t2800r1829b2837],
22	increased	VBN	O	increase	partmod	6	SENT_31	[p1l1839t2800r2001b2828],
23	CYP3A4	NN	O	cyp3a4	iobj	22	SENT_31	[p1l2012t2800r2150b2828],
24	transcriptional	JJ	O	transcriptional	amod	25	SENT_31	[p1l748t2846r1004b2883],
25	activity	NN	O	activity	dobj	22	SENT_31	[p1l1027t2843r1178b2883],
26	.7	CD	NUMBER	.7	dobj	22	SENT_31	[p1l1027t2843r1178b2883],
27	A	DT	O	a	det	29	SENT_31	[p1l1201t2847r1226b2874],
28	common	JJ	O	common	amod	29	SENT_31	[p1l1249t2854r1404b2874],
29	polymorphism	NN	O	polymorphism	dobj	22	SENT_31	[p1l1427t2846r1684b2883],
30	in	IN	O	in	_	0	SENT_31	[p1l1707t2848r1741b2874],
31	CYP3A5	NN	O	cyp3a5	nn	35	SENT_31	[p1l1765t2847r1911b2880],
32	,	,	O	,	_	0	SENT_31	[p1l1765t2847r1911b2880],
33	CYP3A5	NN	O	cyp3a5	dep	35	SENT_31	[p1l1937t2847r2147b2881],
34	*	CD	NUMBER	*	num	35	SENT_31	[p1l1937t2847r2147b2881],
35	3C	NN	O	3c	prep_in	22	SENT_31	[p1l1937t2847r2147b2881],
36	,	,	O	,	_	0	SENT_31	[p1l1937t2847r2147b2881],
37	causes	VBZ	O	cause	_	0	SENT_31	[p1l749t2901r855b2921],
38	a	DT	O	a	det	40	SENT_31	[p1l882t2901r899b2921],
39	splicing	NN	O	splicing	nn	40	SENT_31	[p1l926t2893r1059b2930],
40	defect	NN	O	defect	dobj	37	SENT_31	[p1l1085t2893r1188b2921],
41	leading	VBG	O	lead	partmod	40	SENT_31	[p1l1214t2893r1341b2930],
42	to	TO	O	to	aux	44	SENT_31	[p1l1366t2897r1400b2921],
43	significantly	RB	O	significantly	advmod	44	SENT_31	[p1l1427t2893r1642b2930],
44	decreased	VBD	O	decrease	xcomp	41	SENT_31	[p1l1667t2893r1833b2921],
45	CYP3A5	NN	O	cyp3a5	nn	47	SENT_31	[p1l1860t2894r1998b2921],
46	protein	NN	O	protein	nn	47	SENT_31	[p1l2023t2894r2150b2930],
47	expression	NN	O	expression	dobj	44	SENT_31	[p1l8t3084r437b3167],
48	?	.	O	?	_	0	SENT_31	[p1l8t3084r437b3167],

1	The	DT	O	the	det	5	SENT_32	[p1l469t3091r601b3149],
2	CYP3A5	NN	O	cyp3a5	nn	5	SENT_32	[p1l637t3093r1052b3149],
3	*	CD	NUMBER	*	num	5	SENT_32	[p1l637t3093r1052b3149],
4	3C	NN	O	3c	nn	5	SENT_32	[p1l637t3093r1052b3149],
5	allele	NN	O	allele	nsubj	19	SENT_32	[p1l1084t3091r1266b3149],
6	encoding	VBG	O	encode	partmod	5	SENT_32	[p1l1301t3091r1632b3167],
7	the	DT	O	the	dobj	6	SENT_32	[p1l1663t3091r1776b3149],
8	truncated	VBN	O	truncate	partmod	7	SENT_32	[p1l1810t3091r2152b3149],
9	CYP3A5	NN	O	cyp3a5	nn	10	SENT_32	[p1l9t3188r290b3245],
10	protein	NN	O	protein	nsubj	15	SENT_32	[p1l334t3190r594b3263],
11	is	VBZ	O	be	cop	15	SENT_32	[p1l634t3190r685b3245],
12	the	DT	O	the	det	15	SENT_32	[p1l726t3187r839b3245],
13	most	RBS	O	most	advmod	14	SENT_32	[p1l880t3194r1055b3245],
14	common	JJ	O	common	amod	15	SENT_32	[p1l1096t3204r1416b3245],
15	allele	NN	O	allele	ccomp	8	SENT_32	[p1l1457t3187r1639b3245],
16	in	IN	O	in	_	0	SENT_32	[p1l1680t3190r1751b3244],
17	Caucasian	JJ	LOCATION	caucasian	amod	18	SENT_32	[p1l1793t3188r2152b3245],
18	populations	NNS	O	population	prep_in	15	SENT_32	[p1l7t3279r431b3355],
19	(	VBP	O	(	_	0	SENT_32	[p1l472t3280r585b3355],
20	up	RP	O	up	prt	19	SENT_32	[p1l472t3280r585b3355],
21	to	TO	O	to	_	0	SENT_32	[p1l622t3287r692b3337],
22	95	CD	PERCENT	95	num	23	SENT_32	[p1l730t3272r964b3352],
23	%	NN	PERCENT	%	prep_to	19	SENT_32	[p1l730t3272r964b3352],
24	)	CD	NUMBER	)	number	25	SENT_32	[p1l730t3272r964b3352],
25	.8	CD	NUMBER	.8	num	23	SENT_32	[p1l730t3272r964b3352],
26	CYP1B1	NN	O	cyp1b1	nsubjpass	39	SENT_32	[p1l1004t3281r1278b3337],
27	is	VBZ	O	be	cop	32	SENT_32	[p1l1320t3282r1371b3337],
28	the	DT	O	the	det	32	SENT_32	[p1l1408t3280r1521b3337],
29	most	RBS	O	most	advmod	30	SENT_32	[p1l1558t3287r1733b3337],
30	prominent	JJ	O	prominent	amod	32	SENT_32	[p1l1769t3282r2152b3355],
31	human	JJ	O	human	amod	32	SENT_32	[p1l8t3374r263b3431],
32	cytochrome	NN	O	cytochrome	rcmod	23	SENT_32	[p1l315t3374r738b3449],
33	in	IN	O	in	_	0	SENT_32	[p1l790t3376r860b3430],
34	breast	NN	O	breast	nn	35	SENT_32	[p1l909t3373r1120b3431],
35	tissue9	NN	O	tissue9	prep_in	32	SENT_32	[p1l1171t3366r1400b3431],
36	and	CC	O	and	_	0	SENT_32	[p1l1453t3373r1584b3431],
37	is	VBZ	O	be	auxpass	39	SENT_32	[p1l1635t3377r1686b3431],
38	often	RB	O	often	advmod	39	SENT_32	[p1l1738t3373r1923b3431],
39	overexpressed	VBN	O	overexpress	conj_and	32	SENT_32	[p1l1975t3390r2151b3431, p1l8t3468r347b3544],
40	in	IN	O	in	_	0	SENT_32	[p1l393t3471r463b3525],
41	tumor	NN	O	tumor	nn	42	SENT_32	[p1l508t3475r729b3526],
42	cells	NNS	O	cell	prep_in	39	SENT_32	[p1l774t3461r1107b3526],
43	.1	CD	NUMBER	.1	number	44	SENT_32	[p1l774t3461r1107b3526],
44	°	CD	NUMBER	°	dobj	32	SENT_32	[p1l774t3461r1107b3526],
45	‘	NN	O	‘	dep	44	SENT_32	[p1l774t3461r1107b3526],
46	12	CD	NUMBER	12	num	45	SENT_32	[p1l774t3461r1107b3526],
47	There	EX	O	there	expl	48	SENT_32	[p1l1151t3468r1351b3526],
48	is	VBZ	O	be	rcmod	44	SENT_32	[p1l1398t3471r1448b3526],
49	some	DT	O	some	det	50	SENT_32	[p1l1496t3485r1677b3526],
50	evidence	NN	O	evidence	nsubj	48	SENT_32	[p1l1725t3468r2035b3526],
51	to	TO	O	to	aux	52	SENT_32	[p1l2081t3475r2151b3526],
52	suggest	VB	O	suggest	infmod	50	SENT_32	[p1l9t3571r264b3639],
53	that	IN	O	that	complm	61	SENT_32	[p1l327t3564r471b3621],
54	the	DT	O	the	det	56	SENT_32	[p1l535t3564r647b3621],
55	taxanes	NNS	O	taxane	nn	56	SENT_32	[p1l713t3571r979b3621],
56	paclitaxel	NN	O	paclitaxel	nsubj	61	SENT_32	[p1l1044t3564r1385b3639],
57	and	CC	O	and	_	0	SENT_32	[p1l1451t3564r1582b3621],
58	docetaxel	NN	O	docetaxel	conj_and	56	SENT_32	[p1l1647t3564r1984b3621],
59	are	VBP	O	be	cop	61	SENT_32	[p1l2049t3580r2150b3621],
60	competitive	JJ	O	competitive	amod	61	SENT_32	[p1l8t3660r429b3733],
61	inhibitors	NNS	O	inhibitor	ccomp	52	SENT_32	[p1l487t3657r835b3715],
62	of	IN	O	of	_	0	SENT_32	[p1l894t3657r965b3715],
63	CYP1B1	NN	O	cyp1b1	nn	64	SENT_32	[p1l1020t3659r1294b3715],
64	activity	NN	O	activity	prep_of	61	SENT_32	[p1l1358t3650r1684b3733],
65	”	CD	NUMBER	”	num	64	SENT_32	[p1l1358t3650r1684b3733],
66	and	CC	O	and	_	0	SENT_32	[p1l1744t3657r1876b3715],
67	recent	JJ	O	recent	amod	68	SENT_32	[p1l1932t3664r2152b3715],
68	data	NNS	O	datum	nsubj	70	SENT_32	[p1l8t3752r157b3810],
69	has	VBZ	O	have	aux	70	SENT_32	[p1l200t3752r316b3810],
70	identified	VBN	O	identify	ccomp	52	SENT_32	[p1l359t3752r702b3810],
71	docetaxel	NN	O	docetaxel	dobj	70	SENT_32	[p1l745t3752r1082b3810],
72	as	IN	O	as	_	0	SENT_32	[p1l1125t3770r1190b3810],
73	an	DT	O	a	det	74	SENT_32	[p1l1235t3770r1319b3810],
74	effector	NN	O	effector	prep_as	70	SENT_32	[p1l1362t3752r1630b3810],
75	of	IN	O	of	_	0	SENT_32	[p1l1672t3752r1744b3810],
76	CYP1B1	NN	O	cyp1b1	prep_of	74	SENT_32	[p1l1783t3745r2151b3810],
77	.14	CD	NUMBER	.14	num	76	SENT_32	[p1l1783t3745r2151b3810],

1	The	DT	O	the	det	5	SENT_33	[p2l6t33r139b90],
2	CYP1B1	NN	O	cyp1b1	nn	5	SENT_33	[p2l239t34r508b90],
3	*	NN	O	*	nn	5	SENT_33	[p2l520t34r591b90],
4	3	CD	NUMBER	3	num	5	SENT_33	[p2l520t34r591b90],
5	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_33	[p2l690t33r1216b108],
6	has	VBZ	O	have	aux	8	SENT_33	[p2l1314t33r1430b90],
7	been	VBN	O	be	auxpass	8	SENT_33	[p2l1527t33r1697b90],
8	associated	VBN	O	associate	dep	16	SENT_33	[p2l1795t33r2151b90],
9	with	IN	O	with	_	0	SENT_33	[p2l6t126r167b184],
10	increased	VBN	O	increase	amod	13	SENT_33	[p2l237t126r568b184],
11	CYP1B1	NN	O	cyp1b1	nn	13	SENT_33	[p2l640t128r910b184],
12	mRNA	NN	O	mrna	nn	13	SENT_33	[p2l987t128r1219b183],
13	expression	NN	O	expression	prep_with	8	SENT_33	[p2l1288t119r1748b202],
14	,	,	O	,	_	0	SENT_33	[p2l1288t119r1748b202],
15	”	NN	O	”	appos	13	SENT_33	[p2l1288t119r1748b202],
16	increased	VBD	O	increase	_	0	SENT_33	[p2l1821t126r2152b184],
17	catalytic	JJ	O	catalytic	amod	18	SENT_33	[p2l8t220r305b295],
18	activity16	NN	O	activity16	iobj	16	SENT_33	[p2l378t212r799b295],
19	‘	CD	NUMBER	‘	number	20	SENT_33	[p2l378t212r799b295],
20	18	CD	NUMBER	18	dobj	16	SENT_33	[p2l378t212r799b295],
21	and	CC	O	and	_	0	SENT_33	[p2l873t220r1004b277],
22	specifically	RB	O	specifically	advmod	23	SENT_33	[p2l1078t219r1469b295],
23	altered	JJ	O	altered	conj_and	16	SENT_33	[p2l1540t219r1780b277],
24	estrogen	NN	O	estrogen	nn	26	SENT_33	[p2l1853t227r2151b295],
25	hydroxylation	NN	O	hydroxylation	nn	26	SENT_33	[p2l8t316r516b392],
26	activity	NN	O	activity	dobj	23	SENT_33	[p2l552t319r817b392],
27	with	IN	O	with	_	0	SENT_33	[p2l848t316r1009b374],
28	the	DT	O	the	det	29	SENT_33	[p2l1045t316r1158b374],
29	potential	JJ	O	potential	prep_with	23	SENT_33	[p2l1194t316r1515b392],
30	to	TO	O	to	aux	31	SENT_33	[p2l1550t323r1620b374],
31	interfere	VB	O	interfere	xcomp	29	SENT_33	[p2l1656t316r1955b374],
32	with	IN	O	with	_	0	SENT_33	[p2l1990t316r2152b374],
33	tumor	NN	O	tumor	prep_with	31	SENT_33	[p2l7t416r228b466],
34	biology	NN	O	biology	dobj	31	SENT_33	[p2l255t401r776b484],
35	.17	CD	NUMBER	.17	num	34	SENT_33	[p2l255t401r776b484],
36	'	''	DATE	'	_	0	SENT_33	[p2l255t401r776b484],
37	19	CD	DATE	19	number	38	SENT_33	[p2l255t401r776b484],
38	‘	CD	NUMBER	‘	num	29	SENT_33	[p2l255t401r776b484],
39	21	CD	NUMBER	21	nsubj	16	SENT_33	[p2l255t401r776b484],

1	Overexpression	NN	O	overexpression	nsubj	19	SENT_34	[p2l86t506r631b580],
2	of	IN	O	of	_	0	SENT_34	[p2l687t504r758b562],
3	the	DT	O	the	det	4	SENT_34	[p2l808t504r921b562],
4	adenosine	NN	O	adenosine	prep_of	1	SENT_34	[p2l977t504r1335b562],
5	triphosphate-binding	JJ	O	triphosphate-binding	amod	8	SENT_34	[p2l1390t504r2153b580],
6	cassette	NN	O	cassette	nn	8	SENT_34	[p2l8t607r276b658],
7	transporters	NNS	O	transporter	nn	8	SENT_34	[p2l302t607r726b676],
8	ABCB1	NN	O	abcb1	nsubjpass	13	SENT_34	[p2l750t602r990b658],
9	and	CC	O	and	_	0	SENT_34	[p2l1021t600r1152b658],
10	ABCG2	NN	O	abcg2	nsubjpass	13	SENT_34	[p2l1176t602r1434b658],
11	has	VBZ	O	have	aux	13	SENT_34	[p2l1460t600r1575b658],
12	been	VBN	O	be	auxpass	13	SENT_34	[p2l1599t600r1770b658],
13	associated	VBN	O	associate	rcmod	4	SENT_34	[p2l1795t600r2152b658],
14	with	IN	O	with	_	0	SENT_34	[p2l6t693r167b750],
15	resistance	NN	O	resistance	prep_with	13	SENT_34	[p2l205t696r548b750],
16	to	TO	O	to	_	0	SENT_34	[p2l587t700r656b750],
17	taXane	NN	O	taxane	nn	18	SENT_34	[p2l695t693r1156b750],
18	—	NN	O	—	prep_to	13	SENT_34	[p2l695t693r1156b750],
19	based	VBN	O	base	_	0	SENT_34	[p2l695t693r1156b750],
20	agents	NNS	O	agent	dobj	19	SENT_34	[p2l1195t700r1418b768],
21	in	IN	O	in	_	0	SENT_34	[p2l1459t693r1519b750],
22	vitr0	NN	O	vitr0	prep_in	19	SENT_34	[p2l1557t685r1792b763],
23	,22	CD	NUMBER	,22	num	22	SENT_34	[p2l1557t685r1792b763],
24	although	IN	O	although	mark	26	SENT_34	[p2l1829t693r2151b768],
25	there	EX	O	there	expl	26	SENT_34	[p2l7t789r188b847],
26	is	VBZ	O	be	advcl	19	SENT_34	[p2l213t792r263b847],
27	minimal	JJ	O	minimal	amod	28	SENT_34	[p2l287t789r590b847],
28	evidence	NN	O	evidence	nsubj	26	SENT_34	[p2l615t789r925b847],
29	to	TO	O	to	aux	30	SENT_34	[p2l949t796r1019b847],
30	suggest	VB	O	suggest	infmod	28	SENT_34	[p2l1046t796r1300b865],
31	a	DT	O	a	det	32	SENT_34	[p2l1324t806r1359b847],
32	role	NN	O	role	dobj	30	SENT_34	[p2l1383t789r1515b847],
33	for	IN	O	for	_	0	SENT_34	[p2l1540t789r1639b847],
34	paclitaxel	NN	O	paclitaxel	prep_for	32	SENT_34	[p2l1661t789r2002b865],
35	as	IN	O	as	_	0	SENT_34	[p2l2027t806r2092b847],
36	a	DT	O	a	det	37	SENT_34	[p2l2117t806r2152b847],
37	substrate	NN	O	substrate	prep_as	30	SENT_34	[p2l9t884r321b942],
38	for	IN	O	for	_	0	SENT_34	[p2l385t884r483b942],
39	ABCG2	NN	O	abcg2	prep_for	37	SENT_34	[p2l543t886r819b942],
40	.	.	O	.	_	0	SENT_34	[p2l543t886r819b942],

1	ABCB1	NN	O	abcb1	nsubj	2	SENT_35	[p2l885t886r1124b942],
2	appears	VBZ	O	appear	_	0	SENT_35	[p2l1193t901r1457b960],
3	to	TO	O	to	aux	8	SENT_35	[p2l1520t891r1590b942],
4	be	VB	O	be	cop	8	SENT_35	[p2l1650t884r1731b942],
5	the	DT	O	the	det	8	SENT_35	[p2l1793t884r1906b942],
6	main	JJ	O	main	amod	8	SENT_35	[p2l1969t887r2152b942],
7	paclitaxel	NN	O	paclitaxel	nn	8	SENT_35	[p2l7t977r348b1053],
8	transporter23	NN	O	transporter23	xcomp	2	SENT_35	[p2l378t969r919b1053],
9	'24	CD	NUMBER	'24	nsubjpass	16	SENT_35	[p2l378t969r919b1053],
10	and	CC	O	and	_	0	SENT_35	[p2l949t977r1080b1035],
11	Variants	NNS	O	variant	nsubjpass	16	SENT_35	[p2l1107t980r1389b1035],
12	in	IN	O	in	_	0	SENT_35	[p2l1419t980r1489b1034],
13	ABCB1	NN	O	abcb1	prep_in	11	SENT_35	[p2l1513t978r1752b1035],
14	have	VBP	O	have	aux	16	SENT_35	[p2l1788t977r1954b1035],
15	been	VBN	O	be	auxpass	16	SENT_35	[p2l1982t977r2152b1035],
16	demonstrated	VBN	O	demonstrate	rcmod	8	SENT_35	[p2l8t1071r499b1129],
17	to	TO	O	to	aux	18	SENT_35	[p2l523t1079r593b1129],
18	alter	VB	O	alter	xcomp	16	SENT_35	[p2l618t1071r774b1129],
19	P-glycoprotein	NN	O	p-glycoprotein	nn	20	SENT_35	[p2l794t1071r1317b1147],
20	eXpression	NN	O	expression	dobj	18	SENT_35	[p2l1342t1064r1886b1147],
21	.25	CD	NUMBER	.25	number	22	SENT_35	[p2l1342t1064r1886b1147],
22	'26	CD	NUMBER	'26	dep	30	SENT_35	[p2l1342t1064r1886b1147],
23	A	DT	O	a	det	25	SENT_35	[p2l1910t1073r1961b1128],
24	nonsynonymous	JJ	O	nonsynonymous	amod	25	SENT_35	[p2l1984t1088r2151b1129, p2l9t1183r461b1242],
25	variant	NN	O	variant	npadvmod	30	SENT_35	[p2l489t1169r741b1224],
26	in	IN	O	in	_	0	SENT_35	[p2l769t1169r840b1223],
27	ABCG2	NN	O	abcg2	nn	29	SENT_35	[p2l863t1168r1120b1224],
28	(	CD	NUMBER	(	num	29	SENT_35	[p2l1152t1167r1508b1238],
29	421C	NN	O	421c	prep_in	25	SENT_35	[p2l1152t1167r1508b1238],
30	>	JJR	O	>	dep	20	SENT_35	[p2l1152t1167r1508b1238],
31	A	DT	O	a	dep	30	SENT_35	[p2l1152t1167r1508b1238],
32	;	:	O	;	_	0	SENT_35	[p2l1152t1167r1508b1238],
33	Q141K	CD	NUMBER	q141k	num	34	SENT_35	[p2l1542t1167r1806b1238],
34	)	NN	O	)	nsubjpass	37	SENT_35	[p2l1542t1167r1806b1238],
35	has	VBZ	O	have	aux	37	SENT_35	[p2l1838t1166r1954b1224],
36	been	VBN	O	be	auxpass	37	SENT_35	[p2l1982t1166r2152b1224],
37	associated	VBN	O	associate	dep	20	SENT_35	[p2l8t1260r365b1318],
38	with	IN	O	with	_	0	SENT_35	[p2l393t1260r555b1318],
39	drug	NN	O	drug	nn	40	SENT_35	[p2l586t1260r747b1336],
40	resistance	NN	O	resistance	prep_with	37	SENT_35	[p2l776t1263r1120b1318],
41	in	FW	O	in	nn	42	SENT_35	[p2l1154t1261r1214b1318],
42	vitro	FW	O	vitro	dep	40	SENT_35	[p2l1244t1261r1391b1318],
43	and	CC	O	and	_	0	SENT_35	[p2l1422t1260r1553b1318],
44	in	IN	O	in	conj_and	42	SENT_35	[p2l1586t1261r1646b1317],
45	viv0	NN	O	viv0	pobj	44	SENT_35	[p2l1676t1253r1988b1330],
46	,	,	O	,	_	0	SENT_35	[p2l1676t1253r1988b1330],
47	Z7	NN	O	z7	dobj	37	SENT_35	[p2l1676t1253r1988b1330],
48	"	''	O	"	punct	37	SENT_35	[p2l1676t1253r1988b1330],
49	29	CD	NUMBER	29	tmod	37	SENT_35	[p2l1676t1253r1988b1330],
50	and	CC	O	and	_	0	SENT_35	[p2l2021t1260r2152b1318],
51	with	IN	O	with	_	0	SENT_35	[p2l6t1355r167b1413],
52	survival	NN	O	survival	prep_with	86	SENT_35	[p2l195t1355r470b1413],
53	in	IN	O	in	_	0	SENT_35	[p2l496t1358r567b1412],
54	prostate	NN	O	prostate	nn	56	SENT_35	[p2l591t1363r875b1431],
55	cancer	NN	O	cancer	nn	56	SENT_35	[p2l903t1372r1132b1413],
56	patients	NNS	O	patient	prep_in	52	SENT_35	[p2l1156t1358r1439b1431],
57	receiving	VBG	O	receive	partmod	56	SENT_35	[p2l1466t1358r1789b1431],
58	docetaxel	NN	O	docetaxel	nn	59	SENT_35	[p2l1814t1355r2151b1413],
59	chemotherapy	NN	O	chemotherapy	dobj	57	SENT_35	[p2l8t1449r526b1524],
60	(	CD	NUMBER	(	num	63	SENT_35	[p2l569t1442r987b1521],
61	P	NN	O	p	nn	63	SENT_35	[p2l569t1442r987b1521],
62	=	JJ	O	=	amod	63	SENT_35	[p2l569t1442r987b1521],
63	O.	NNP	O	O.	dep	59	SENT_35	[p2l569t1442r987b1521],
64	05	CD	NUMBER	05	number	65	SENT_35	[p2l569t1442r987b1521],
65	)	CD	NUMBER	)	dep	63	SENT_35	[p2l569t1442r987b1521],
66	,3	CD	NUMBER	,3	num	67	SENT_35	[p2l569t1442r987b1521],
67	°	NN	O	°	dep	65	SENT_35	[p2l569t1442r987b1521],
68	consequently	RB	O	consequently	advmod	57	SENT_35	[p2l1030t1449r1517b1524],
69	,	,	O	,	_	0	SENT_35	[p2l1030t1449r1517b1524],
70	despite	IN	O	despite	_	0	SENT_35	[p2l1565t1449r1813b1524],
71	the	DT	O	the	det	72	SENT_35	[p2l1857t1449r1969b1506],
72	lack	NN	O	lack	nsubj	75	SENT_35	[p2l2012t1448r2154b1506],
73	of	IN	O	of	_	0	SENT_35	[p2l8t1545r80b1603],
74	evidence	NN	O	evidence	prep_of	72	SENT_35	[p2l117t1545r427b1603],
75	associating	VBG	O	associate	prepc_despite	57	SENT_35	[p2l469t1548r858b1621],
76	taxane	NN	O	taxane	nn	77	SENT_35	[p2l897t1552r1132b1603],
77	transport	NN	O	transport	nsubj	82	SENT_35	[p2l1173t1552r1499b1621],
78	with	IN	O	with	_	0	SENT_35	[p2l1538t1545r1699b1603],
79	ABCG2	NN	O	abcg2	prep_with	77	SENT_35	[p2l1739t1547r1997b1603],
80	the	DT	O	the	det	81	SENT_35	[p2l2038t1545r2151b1603],
81	421C	NN	O	421c	npadvmod	82	SENT_35	[p2l8t1641r322b1697],
82	>	JJR	O	>	xcomp	75	SENT_35	[p2l8t1641r322b1697],
83	A	DT	O	a	det	84	SENT_35	[p2l8t1641r322b1697],
84	variant	NN	O	variant	nsubjpass	86	SENT_35	[p2l348t1643r599b1697],
85	was	VBD	O	be	auxpass	86	SENT_35	[p2l626t1656r755b1697],
86	included	VBN	O	include	conj_and	37	SENT_35	[p2l785t1640r1095b1697],
87	in	IN	O	in	_	0	SENT_35	[p2l1124t1643r1195b1697],
88	this	DT	O	this	det	89	SENT_35	[p2l1224t1640r1354b1697],
89	study	NN	O	study	prep_in	86	SENT_35	[p2l1386t1640r1588b1715],
90	.	.	O	.	_	0	SENT_35	[p2l1386t1640r1588b1715],

1	We	PRP	O	we	nsubj	2	SENT_36	[p2l83t1737r192b1792],
2	assessed	VBD	O	assess	_	0	SENT_36	[p2l261t1735r543b1792],
3	polymorphisms	NNS	O	polymorphism	dobj	2	SENT_36	[p2l609t1735r1166b1810],
4	in	IN	O	in	_	0	SENT_36	[p2l1233t1738r1304b1792],
5	six	CD	NUMBER	six	num	6	SENT_36	[p2l1372t1738r1467b1792],
6	genes	NNS	O	gene	prep_in	3	SENT_36	[p2l1532t1751r1727b1810],
7	associated	VBN	O	associate	partmod	6	SENT_36	[p2l1795t1735r2151b1792],
8	with	IN	O	with	_	0	SENT_36	[p2l6t1830r167b1888],
9	paclitaxel	NN	O	paclitaxel	nn	10	SENT_36	[p2l199t1830r540b1906],
10	metabolism	NN	O	metabolism	prep_with	7	SENT_36	[p2l572t1830r989b1888],
11	and	CC	O	and	_	0	SENT_36	[p2l1022t1830r1153b1888],
12	transport	NN	O	transport	conj_and	10	SENT_36	[p2l1184t1837r1510b1906],
13	to	TO	O	to	aux	14	SENT_36	[p2l1541t1837r1611b1888],
14	determine	VB	O	determine	xcomp	7	SENT_36	[p2l1645t1830r2005b1888],
15	the	DT	O	the	det	16	SENT_36	[p2l2038t1830r2151b1888],
16	contribution	NN	O	contribution	dobj	14	SENT_36	[p2l8t1925r460b1983],
17	of	IN	O	of	_	0	SENT_36	[p2l518t1925r590b1983],
18	inherited	VBN	O	inherit	amod	19	SENT_36	[p2l644t1925r970b1983],
19	differences	NNS	O	difference	prep_of	16	SENT_36	[p2l1029t1925r1410b1983],
20	to	TO	O	to	_	0	SENT_36	[p2l1469t1932r1539b1983],
21	the	DT	O	the	det	22	SENT_36	[p2l1597t1925r1710b1983],
22	pharmacokinetics	NNS	O	pharmacokinetic	prep_to	2	SENT_36	[p2l1769t1925r2150b2001, p2l8t2020r279b2078],
23	and	CC	O	and	_	0	SENT_36	[p2l346t2020r477b2078],
24	progression-free	JJ	O	progression-free	amod	25	SENT_36	[p2l542t2020r1108b2096],
25	survival	NN	O	survival	prep_to	2	SENT_36	[p2l1176t2020r1451b2078],
26	of	IN	O	of	_	0	SENT_36	[p2l1517t2020r1589b2078],
27	breast	NN	O	breast	nn	29	SENT_36	[p2l1648t2020r1858b2078],
28	cancer	NN	O	cancer	nn	29	SENT_36	[p2l1924t2037r2153b2078],
29	patients	NNS	O	patient	prep_of	22	SENT_36	[p2l7t2117r290b2190],
30	receiving	VBG	O	receive	xcomp	2	SENT_36	[p2l320t2117r643b2190],
31	paclitaxel-containing	JJ	O	paclitaxel-containing	amod	32	SENT_36	[p2l670t2114r1430b2190],
32	therapy	NN	O	therapy	dobj	30	SENT_36	[p2l1459t2114r1743b2190],
33	.	.	O	.	_	0	SENT_36	[p2l1459t2114r1743b2190],

1	Results	NNS	O	result	_	0	SENT_37	[p2l10t2345r278b2403],
2	and	CC	O	and	_	0	SENT_37	[p2l308t2345r450b2403],
3	discussion	NN	O	discussion	conj_and	1	SENT_37	[p2l481t2345r870b2403],

1	Genotype	NN	O	genotype	nn	4	SENT_38	[p2l9t2536r353b2611],
2	and	CC	O	and	_	0	SENT_38	[p2l408t2535r539b2593],
3	allele	NN	O	allele	nn	4	SENT_38	[p2l593t2535r775b2593],
4	frequencies	NNS	O	frequency	nsubjpass	6	SENT_38	[p2l829t2535r1231b2611],
5	are	VBP	O	be	auxpass	6	SENT_38	[p2l1286t2552r1387b2593],
6	shown	VBN	O	show	_	0	SENT_38	[p2l1443t2535r1676b2593],
7	in	IN	O	in	_	0	SENT_38	[p2l1728t2538r1799b2592],
8	Table	NNP	O	Table	prep_in	6	SENT_38	[p2l1850t2535r2035b2593],
9	1	CD	NUMBER	1	num	8	SENT_38	[p2l2095t2537r2147b2592],
10	.	.	O	.	_	0	SENT_38	[p2l2095t2537r2147b2592],

1	When	WRB	O	when	advmod	2	SENT_39	[p2l6t2630r224b2687],
2	assessed	VBN	O	assess	advcl	11	SENT_39	[p2l256t2630r538b2687],
3	separately	RB	O	separately	advmod	2	SENT_39	[p2l572t2629r926b2705],
4	by	IN	O	by	_	0	SENT_39	[p2l953t2629r1041b2705],
5	race	NN	O	race	prep_by	2	SENT_39	[p2l1071t2646r1210b2687],
6	the	DT	O	the	det	8	SENT_39	[p2l1243t2629r1355b2687],
7	genotype	NN	O	genotype	nn	8	SENT_39	[p2l1389t2637r1715b2705],
8	frequencies	NNS	O	frequency	nsubj	11	SENT_39	[p2l1748t2629r2151b2705],
9	did	VBD	O	do	aux	11	SENT_39	[p2l8t2725r121b2783],
10	not	RB	O	not	neg	11	SENT_39	[p2l153t2732r274b2783],
11	deviate	VB	O	deviate	_	0	SENT_39	[p2l306t2725r558b2783],
12	from	IN	O	from	_	0	SENT_39	[p2l591t2725r761b2783],
13	Hardy	NNP	PERSON	Hardy	prep_from	11	SENT_39	[p2l794t2725r1390b2801],
14	.	.	O	.	_	0	SENT_39	[p2l794t2725r1390b2801],

1	—	NN	O	—	_	0	SENT_40	[p2l794t2725r1390b2801],
2	.	.	O	.	_	0	SENT_40	[p2l794t2725r1390b2801],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_41	[p2l794t2725r1390b2801],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_41	[p2l1422t2725r1857b2801],
3	.	.	O	.	_	0	SENT_41	[p2l1422t2725r1857b2801],

1	Variant	JJ	O	variant	amod	3	SENT_42	[p2l1892t2727r2152b2783],
2	allele	NN	O	allele	nn	3	SENT_42	[p2l8t2820r190b2878],
3	frequencies	NNS	O	frequency	nsubj	6	SENT_42	[p2l268t2820r671b2896],
4	did	VBD	O	do	aux	6	SENT_42	[p2l749t2820r861b2878],
5	not	RB	O	not	neg	6	SENT_42	[p2l937t2827r1059b2878],
6	deviate	VB	O	deviate	_	0	SENT_42	[p2l1135t2820r1387b2878],
7	significantly	RB	O	significantly	advmod	6	SENT_42	[p2l1467t2820r1907b2896],
8	from	IN	O	from	_	0	SENT_42	[p2l1981t2820r2151b2878],
9	those	DT	O	those	prep_from	6	SENT_42	[p2l7t2914r197b2972],
10	reported	VBN	O	report	partmod	9	SENT_42	[p2l257t2914r556b2990],
11	previously	RB	DATE	previously	advmod	10	SENT_42	[p2l615t2914r985b2990],
12	for	IN	O	for	prep	10	SENT_42	[p2l1041t2914r1140b2972],
13	predominantly	RB	O	predominantly	dep	15	SENT_42	[p2l1197t2914r1734b2990],
14	Caucasian	JJ	LOCATION	caucasian	amod	15	SENT_42	[p2l1793t2916r2151b2972],
15	popu1ations	NNS	O	popu1ation	dep	16	SENT_42	[p2l7t3001r827b3084],
16	.4	CD	NUMBER	.4	dep	17	SENT_42	[p2l7t3001r827b3084],
17	’	NN	O	’	dep	19	SENT_42	[p2l7t3001r827b3084],
18	2	CD	NUMBER	2	num	17	SENT_42	[p2l7t3001r827b3084],
19	°	NN	O	°	dep	24	SENT_42	[p2l7t3001r827b3084],
20	'	''	DATE	'	_	0	SENT_42	[p2l7t3001r827b3084],
21	27	CD	DATE	27	num	22	SENT_42	[p2l7t3001r827b3084],
22	’	CD	NUMBER	’	dep	19	SENT_42	[p2l7t3001r827b3084],
23	31	CD	NUMBER	31	num	24	SENT_42	[p2l7t3001r827b3084],
24	'33	CD	NUMBER	'33	dep	12	SENT_42	[p2l7t3001r827b3084],

1	Paclitaxel	NN	O	paclitaxel	nn	2	SENT_43	[p2l13t3249r244b3294],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_43	[p2l265t3249r706b3308],
3	@	IN	O	@	dep	4	SENT_43	[p2l2026t3237r2152b3361],
4	S	NN	O	s	amod	5	SENT_43	[p2l13t3322r33b3362],
5	Marsh	NNP	PERSON	Marsh	dep	2	SENT_43	[p2l54t3320r176b3362],
6	et	FW	O	et	nn	7	SENT_43	[p2l197t3325r233b3362],
7	al	FW	O	al	dep	5	SENT_43	[p2l250t3320r286b3362],

1	Using	VBG	O	use	_	0	SENT_44	[p3l89t87r293b160],
2	Kruskal	NNP	PERSON	Kruskal	dobj	1	SENT_44	[p3l333t84r846b142],
3	.	.	O	.	_	0	SENT_44	[p3l333t84r846b142],

1	—	NN	O	—	_	0	SENT_45	[p3l333t84r846b142],
2	.	.	O	.	_	0	SENT_45	[p3l333t84r846b142],

1	Wallis	NNP	PERSON	Wallis	ccomp	12	SENT_46	[p3l333t84r846b142],
2	and	CC	O	and	_	0	SENT_46	[p3l889t84r1020b142],
3	analysis	NN	O	analysis	ccomp	12	SENT_46	[p3l1061t84r1336b160],
4	of	IN	O	of	_	0	SENT_46	[p3l1379t84r1450b142],
5	variance	NN	O	variance	prep_of	3	SENT_46	[p3l1485t87r1782b142],
6	(	CD	NUMBER	(	num	9	SENT_46	[p3l1827t84r2146b156],
7	ANOVA	NNP	O	ANOVA	nn	9	SENT_46	[p3l1827t84r2146b156],
8	)	CD	NUMBER	)	num	9	SENT_46	[p3l1827t84r2146b156],
9	tests	NNS	O	test	dep	3	SENT_46	[p3l12t186r183b249],
10	,	,	O	,	_	0	SENT_46	[p3l12t186r183b249],
11	we	PRP	O	we	nsubj	12	SENT_46	[p3l222t196r317b237],
12	found	VBD	O	find	_	0	SENT_46	[p3l353t179r564b237],
13	no	DT	O	no	det	15	SENT_46	[p3l598t196r689b237],
14	significant	JJ	O	significant	amod	15	SENT_46	[p3l726t179r1097b255],
15	association	NN	O	association	dobj	12	SENT_46	[p3l1133t182r1523b237],
16	between	IN	O	between	_	0	SENT_46	[p3l1555t179r1852b237],
17	ABCB1	NN	O	abcb1	nn	28	SENT_46	[p3l1882t180r2145b249],
18	,	,	O	,	_	0	SENT_46	[p3l1882t180r2145b249],
19	ABCG2	NN	O	abcg2	nn	28	SENT_46	[p3l7t275r280b344],
20	,	,	O	,	_	0	SENT_46	[p3l7t275r280b344],
21	CYP1B1	NN	O	cyp1b1	nn	28	SENT_46	[p3l320t275r614b344],
22	,	,	O	,	_	0	SENT_46	[p3l320t275r614b344],
23	CYP3A4	NN	O	cyp3a4	nn	28	SENT_46	[p3l654t275r953b344],
24	,	,	O	,	_	0	SENT_46	[p3l654t275r953b344],
25	CYP3A5	NN	O	cyp3a5	nn	28	SENT_46	[p3l993t275r1275b331],
26	and	CC	O	and	_	0	SENT_46	[p3l1309t274r1440b331],
27	CYPZC8	NN	O	cypzc8	nn	28	SENT_46	[p3l1475t275r1759b331],
28	genotypes	NNS	O	genotype	prep_between	15	SENT_46	[p3l1792t281r2149b349],
29	and	CC	O	and	_	0	SENT_46	[p3l13t366r144b424],
30	paclitaxel	NN	O	paclitaxel	nn	31	SENT_46	[p3l194t367r535b442],
31	clearance	NN	O	clearance	conj_and	15	SENT_46	[p3l587t367r915b424],
32	(	CD	NUMBER	(	num	33	SENT_46	[p3l971t367r1143b438],
33	data	NNS	O	datum	npadvmod	34	SENT_46	[p3l971t367r1143b438],
34	not	RB	O	not	neg	35	SENT_46	[p3l1194t374r1315b424],
35	shown	VBN	O	show	partmod	31	SENT_46	[p3l1368t366r1645b438],
36	)	NN	O	)	dobj	35	SENT_46	[p3l1368t366r1645b438],
37	.	.	O	.	_	0	SENT_46	[p3l1368t366r1645b438],

1	However	RB	O	however	advmod	5	SENT_47	[p3l1701t369r2026b437],
2	,	,	O	,	_	0	SENT_47	[p3l1701t369r2026b437],
3	X2	NN	O	x2	nn	4	SENT_47	[p3l2082t359r2150b439],
4	analysis	NN	O	analysis	nsubj	5	SENT_47	[p3l13t463r288b539],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_47	[p3l348t463r837b521],
6	that	IN	O	that	complm	22	SENT_47	[p3l895t463r1038b521],
7	the	DT	O	the	det	9	SENT_47	[p3l1096t463r1209b521],
8	CYP1B1	NN	O	cyp1b1	nn	9	SENT_47	[p3l1270t465r1622b521],
9	*	NN	O	*	nsubjpass	22	SENT_47	[p3l1270t465r1622b521],
10	3	CD	NUMBER	3	num	15	SENT_47	[p3l1270t465r1622b521],
11	(	CD	NUMBER	(	number	12	SENT_47	[p3l1684t463r1878b535],
12	4326	CD	NUMBER	4326	num	13	SENT_47	[p3l1684t463r1878b535],
13	C	NN	O	c	npadvmod	14	SENT_47	[p3l1939t465r2146b533],
14	>	JJR	O	>	amod	15	SENT_47	[p3l1939t465r2146b533],
15	G	NN	O	g	dep	9	SENT_47	[p3l1939t465r2146b533],
16	;	:	O	;	_	0	SENT_47	[p3l1939t465r2146b533],
17	L432V	NN	O	l432v	dep	9	SENT_47	[p3l13t558r262b630],
18	)	CD	NUMBER	)	num	19	SENT_47	[p3l13t558r262b630],
19	allele	NN	O	allele	dep	17	SENT_47	[p3l297t558r479b615],
20	was	VBD	O	be	auxpass	22	SENT_47	[p3l509t574r637b615],
21	significantly	RB	O	significantly	advmod	22	SENT_47	[p3l671t557r1109b633],
22	associated	VBN	O	associate	ccomp	5	SENT_47	[p3l1139t558r1494b615],
23	with	IN	O	with	_	0	SENT_47	[p3l1524t558r1685b615],
24	progressionfree	NN	O	progressionfree	nn	25	SENT_47	[p3l1716t561r2148b633, p3l12t653r139b711],
25	survival	NN	O	survival	prep_with	22	SENT_47	[p3l208t653r482b711],
26	(	CD	NUMBER	(	num	27	SENT_47	[p3l550t653r941b725],
27	P	NN	O	p	dep	25	SENT_47	[p3l550t653r941b725],
28	=	JJ	O	=	amod	30	SENT_47	[p3l550t653r941b725],
29	0.037	CD	NUMBER	0.037	tmod	28	SENT_47	[p3l550t653r941b725],
30	)	NN	O	)	dep	27	SENT_47	[p3l550t653r941b725],
31	.	.	O	.	_	0	SENT_47	[p3l550t653r941b725],

1	Patients	NNS	O	patient	nsubj	11	SENT_48	[p3l1012t655r1289b711],
2	homozygous	JJ	O	homozygous	amod	1	SENT_48	[p3l1356t653r1807b729],
3	for	IN	O	for	_	0	SENT_48	[p3l1874t653r1972b711],
4	the	DT	O	the	det	6	SENT_48	[p3l2036t653r2148b711],
5	Leucine	NNP	MISC	Leucine	nn	6	SENT_48	[p3l13t751r286b806],
6	allele	NN	O	allele	prep_for	2	SENT_48	[p3l318t748r499b806],
7	(	CD	PERCENT	(	number	8	SENT_48	[p3l534t748r734b820],
8	45	CD	PERCENT	45	dep	9	SENT_48	[p3l534t748r734b820],
9	%	NN	PERCENT	%	dep	6	SENT_48	[p3l534t748r734b820],
10	)	CD	NUMBER	)	tmod	2	SENT_48	[p3l534t748r734b820],
11	had	VBD	O	have	_	0	SENT_48	[p3l767t748r899b806],
12	a	DT	O	a	det	18	SENT_48	[p3l929t765r964b806],
13	significantly	RB	O	significantly	advmod	14	SENT_48	[p3l995t748r1434b824],
14	longer	JJR	O	longer	amod	18	SENT_48	[p3l1462t748r1687b824],
15	progressionfree	NN	O	progressionfree	nn	18	SENT_48	[p3l1716t751r2148b824, p3l12t842r139b900],
16	survival	NN	O	survival	nn	18	SENT_48	[p3l209t843r482b900],
17	(	CD	NUMBER	(	num	18	SENT_48	[p3l553t843r843b915],
18	median	NN	O	median	dobj	11	SENT_48	[p3l553t843r843b915],
19	not	RB	O	not	neg	21	SENT_48	[p3l909t850r1030b900],
20	yet	RB	O	yet	advmod	21	SENT_48	[p3l1094t850r1202b918],
21	reached	VBN	O	reach	partmod	18	SENT_48	[p3l1268t843r1566b915],
22	)	RB	O	)	advmod	21	SENT_48	[p3l1268t843r1566b915],
23	than	IN	O	than	_	0	SENT_48	[p3l1637t843r1801b900],
24	patients	NNS	O	patient	prep_than	21	SENT_48	[p3l1867t846r2149b918],
25	with	IN	O	with	_	0	SENT_48	[p3l11t937r172b995],
26	at	IN	O	at	quantmod	28	SENT_48	[p3l235t944r298b995],
27	least	JJS	O	least	mwe	26	SENT_48	[p3l360t937r517b995],
28	one	CD	NUMBER	one	num	32	SENT_48	[p3l580t954r708b995],
29	Valine	NN	PERSON	valine	nn	32	SENT_48	[p3l771t937r993b995],
30	allele	NN	O	allele	nn	32	SENT_48	[p3l1058t937r1239b995],
31	(	CD	NUMBER	(	num	32	SENT_48	[p3l1306t937r1613b1009],
32	median	NN	O	median	prep_with	24	SENT_48	[p3l1306t937r1613b1009],
33	:	:	O	:	_	0	SENT_48	[p3l1306t937r1613b1009],
34	30	CD	DURATION	30	num	35	SENT_48	[p3l1681t939r1763b995],
35	months	NNS	NUMBER	month	tmod	36	SENT_48	[p3l1826t937r2145b1009],
36	)	RB	O	)	amod	32	SENT_48	[p3l1826t937r2145b1009],
37	.	.	O	.	_	0	SENT_48	[p3l1826t937r2145b1009],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_49	[p3l13t1033r500b1109],
2	.	.	O	.	_	0	SENT_49	[p3l13t1033r500b1109],

1	—	NN	O	—	_	0	SENT_50	[p3l13t1033r500b1109],
2	.	.	O	.	_	0	SENT_50	[p3l13t1033r500b1109],

1	Meier	JJR	PERSON	meier	amod	2	SENT_51	[p3l13t1033r500b1109],
2	analysis	NN	O	analysis	nsubj	6	SENT_51	[p3l532t1033r806b1109],
3	for	IN	O	for	_	0	SENT_51	[p3l840t1033r938b1091],
4	progression-free	JJ	O	progression-free	amod	5	SENT_51	[p3l969t1033r1534b1109],
5	survival	NN	O	survival	prep_for	2	SENT_51	[p3l1569t1033r1843b1091],
6	demonstrated	VBD	O	demonstrate	_	0	SENT_51	[p3l1876t1033r2148b1091, p3l14t1128r250b1186],
7	a	DT	O	a	det	9	SENT_51	[p3l294t1145r329b1186],
8	significant	JJ	O	significant	amod	9	SENT_51	[p3l374t1128r744b1204],
9	association	NN	O	association	dobj	6	SENT_51	[p3l788t1131r1178b1186],
10	with	IN	O	with	_	0	SENT_51	[p3l1220t1128r1382b1186],
11	CYP1B1	NN	O	cyp1b1	prep_with	6	SENT_51	[p3l1427t1129r1778b1186],
12	*	CD	NUMBER	*	number	13	SENT_51	[p3l1427t1129r1778b1186],
13	3	CD	NUMBER	3	num	14	SENT_51	[p3l1427t1129r1778b1186],
14	genotype	NN	O	genotype	dep	11	SENT_51	[p3l1823t1135r2149b1204],
15	(	CD	NUMBER	(	num	16	SENT_51	[p3l16t1223r379b1294],
16	P	NN	O	p	dep	11	SENT_51	[p3l16t1223r379b1294],
17	=	JJ	O	=	amod	16	SENT_51	[p3l16t1223r379b1294],
18	0.037	CD	NUMBER	0.037	tmod	17	SENT_51	[p3l16t1223r379b1294],
19	;	:	O	;	_	0	SENT_51	[p3l16t1223r379b1294],
20	Figure	NNP	O	Figure	dep	11	SENT_51	[p3l454t1225r668b1298],
21	1	CD	NUMBER	1	number	22	SENT_51	[p3l746t1223r825b1294],
22	)	CD	NUMBER	)	dep	20	SENT_51	[p3l746t1223r825b1294],
23	.	.	O	.	_	0	SENT_51	[p3l746t1223r825b1294],

1	This	DT	O	this	det	3	SENT_52	[p3l898t1222r1048b1280],
2	significant	JJ	O	significant	amod	3	SENT_52	[p3l1120t1222r1491b1298],
3	association	NN	O	association	nsubj	5	SENT_52	[p3l1562t1225r1952b1280],
4	was	VBD	O	be	cop	5	SENT_52	[p3l2021t1239r2149b1280],
5	independent	JJ	O	independent	_	0	SENT_52	[p3l12t1317r465b1393],
6	of	IN	O	of	_	0	SENT_52	[p3l500t1317r571b1375],
7	paclitaxel	NN	O	paclitaxel	nn	8	SENT_52	[p3l601t1317r941b1393],
8	clearance	NN	O	clearance	prep_of	5	SENT_52	[p3l977t1317r1322b1388],
9	,	,	O	,	_	0	SENT_52	[p3l977t1317r1322b1388],
10	disease	NN	O	disease	nn	11	SENT_52	[p3l1363t1317r1605b1375],
11	stage	NN	O	stage	prep_of	5	SENT_52	[p3l1642t1325r1814b1393],
12	or	CC	O	or	_	0	SENT_52	[p3l1850t1334r1922b1375],
13	estrogen/progesterone	NN	O	estrogen/progesterone	nn	15	SENT_52	[p3l1956t1325r2148b1375, p3l12t1414r628b1490],
14	receptor	NN	O	receptor	nn	15	SENT_52	[p3l667t1421r957b1490],
15	status	NN	O	status	prep_of	5	SENT_52	[p3l995t1421r1213b1472],
16	.	.	O	.	_	0	SENT_52	[p3l995t1421r1213b1472],

1	No	DT	O	no	det	2	SENT_53	[p3l1253t1416r1356b1472],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	5	SENT_53	[p3l1393t1414r1949b1490],
3	were	VBD	O	be	auxpass	5	SENT_53	[p3l1985t1431r2148b1472],
4	significantly	RB	O	significantly	advmod	5	SENT_53	[p3l14t1508r452b1584],
5	associated	VBN	O	associate	_	0	SENT_53	[p3l513t1509r869b1566],
6	with	IN	O	with	_	0	SENT_53	[p3l929t1509r1090b1566],
7	overall	JJ	O	overall	amod	8	SENT_53	[p3l1153t1509r1390b1566],
8	survival	NN	O	survival	prep_with	5	SENT_53	[p3l1455t1509r1728b1566],
9	(	CD	NUMBER	(	num	10	SENT_53	[p3l1794t1509r1967b1581],
10	data	NNS	O	datum	npadvmod	11	SENT_53	[p3l1794t1509r1967b1581],
11	not	RB	O	not	neg	12	SENT_53	[p3l2029t1516r2150b1566],
12	shown	VBN	O	show	partmod	8	SENT_53	[p3l14t1603r291b1675],
13	)	NN	O	)	dobj	12	SENT_53	[p3l14t1603r291b1675],
14	.	.	O	.	_	0	SENT_53	[p3l14t1603r291b1675],

1	The	DT	O	the	det	2	SENT_54	[p3l87t1699r219b1757],
2	lack	NN	O	lack	nsubj	16	SENT_54	[p3l289t1699r430b1757],
3	of	IN	O	of	_	0	SENT_54	[p3l497t1699r568b1757],
4	association	NN	O	association	prep_of	2	SENT_54	[p3l633t1702r1023b1757],
5	between	IN	O	between	_	0	SENT_54	[p3l1089t1699r1386b1757],
6	polymorphisms	NNS	O	polymorphism	prep_between	4	SENT_54	[p3l1454t1699r2010b1775],
7	in	IN	O	in	_	0	SENT_54	[p3l2079t1702r2149b1756],
8	paclitaxel	NN	O	paclitaxel	nn	9	SENT_54	[p3l12t1794r352b1869],
9	metabolism	NN	O	metabolism	prep_in	6	SENT_54	[p3l396t1794r811b1851],
10	and	CC	O	and	_	0	SENT_54	[p3l855t1794r986b1851],
11	transport	NN	O	transport	nn	12	SENT_54	[p3l1029t1801r1354b1869],
12	genes	NNS	O	gene	prep_in	6	SENT_54	[p3l1397t1810r1591b1869],
13	and	CC	O	and	_	0	SENT_54	[p3l1636t1794r1767b1851],
14	paclitaxel	NN	O	paclitaxel	nn	15	SENT_54	[p3l1809t1794r2149b1869],
15	clearance	NN	O	clearance	prep_in	6	SENT_54	[p3l13t1887r340b1945],
16	supports	VBZ	O	support	_	0	SENT_54	[p3l384t1894r683b1963],
17	recent	JJ	O	recent	amod	18	SENT_54	[p3l724t1894r943b1945],
18	findings	NNS	O	finding	dobj	16	SENT_54	[p3l983t1880r1360b1963],
19	.	.	O	.	_	0	SENT_54	[p3l983t1880r1360b1963],

1	“	NNP	O	“	_	0	SENT_55	[p3l983t1880r1360b1963],
2	One	CD	NUMBER	one	num	1	SENT_55	[p3l1403t1889r1546b1945],
3	recent	JJ	O	recent	amod	4	SENT_55	[p3l1588t1894r1806b1945],
4	study	NN	O	study	nsubj	8	SENT_55	[p3l1849t1887r2041b1963],
5	in	IN	O	in	_	0	SENT_55	[p3l2079t1890r2150b1944],
6	ovarian	JJ	O	ovarian	amod	7	SENT_55	[p3l13t1984r278b2038],
7	cancer	NN	O	cancer	prep_in	4	SENT_55	[p3l327t1998r555b2038],
8	identified	VBD	O	identify	rcmod	1	SENT_55	[p3l602t1981r944b2038],
9	an	DT	O	a	det	10	SENT_55	[p3l993t1998r1078b2038],
10	association	NN	O	association	dobj	8	SENT_55	[p3l1127t1984r1517b2038],
11	between	IN	O	between	_	0	SENT_55	[p3l1563t1981r1861b2038],
12	ABCB1	NN	O	abcb1	prep_between	10	SENT_55	[p3l1904t1983r2143b2038],

1	2677G	CD	NUMBER	2677g	num	3	SENT_56	[p3l13t2077r451b2142],
2	>	JJR	O	>	amod	3	SENT_56	[p3l13t2077r451b2142],
3	A/T	NN	O	a/t	nsubjpass	20	SENT_56	[p3l13t2077r451b2142],
4	and	CC	O	and	_	0	SENT_56	[p3l505t2077r636b2135],
5	response	NN	O	response	nn	7	SENT_56	[p3l696t2094r1001b2153],
6	to	TO	O	to	dep	7	SENT_56	[p3l1061t2084r1131b2135],
7	paclitaxel	NN	O	paclitaxel	nsubjpass	20	SENT_56	[p3l1191t2077r1531b2153],
8	in	IN	O	in	_	0	SENT_56	[p3l1591t2080r1662b2134],
9	53	CD	NUMBER	53	num	13	SENT_56	[p3l1723t2078r1802b2135],
10	Swedish	JJ	MISC	swedish	amod	13	SENT_56	[p3l1866t2077r2149b2135],
11	ovarian	JJ	O	ovarian	amod	13	SENT_56	[p3l13t2172r277b2227],
12	cancer	NN	O	cancer	nn	13	SENT_56	[p3l314t2186r542b2227],
13	patients	NNS	O	patient	prep_in	20	SENT_56	[p3l576t2162r944b2245],
14	,35	CD	NUMBER	,35	nsubjpass	20	SENT_56	[p3l576t2162r944b2245],
15	but	CC	O	but	prep	14	SENT_56	[p3l980t2170r1099b2227],
16	this	DT	O	this	dep	15	SENT_56	[p3l1134t2170r1264b2227],
17	could	MD	O	could	aux	20	SENT_56	[p3l1300t2169r1496b2227],
18	not	RB	O	not	neg	20	SENT_56	[p3l1532t2177r1652b2227],
19	be	VB	O	be	auxpass	20	SENT_56	[p3l1685t2170r1765b2227],
20	replicated	VBN	O	replicate	_	0	SENT_56	[p3l1802t2169r2150b2245],
21	in	IN	O	in	_	0	SENT_56	[p3l12t2266r83b2320],
22	a	DT	O	a	det	26	SENT_56	[p3l115t2280r150b2321],
23	larger	JJR	O	larger	amod	26	SENT_56	[p3l182t2264r380b2339],
24	ovarian	JJ	O	ovarian	amod	26	SENT_56	[p3l412t2266r676b2321],
25	cancer	NN	O	cancer	nn	26	SENT_56	[p3l709t2280r937b2321],
26	study	NN	O	study	prep_in	20	SENT_56	[p3l970t2257r1241b2339],
27	,	,	O	,	_	0	SENT_56	[p3l970t2257r1241b2339],
28	“	NN	O	“	appos	26	SENT_56	[p3l970t2257r1241b2339],
29	and	CC	O	and	_	0	SENT_56	[p3l1275t2263r1406b2321],
30	was	VBD	O	be	auxpass	32	SENT_56	[p3l1435t2280r1563b2321],
31	not	RB	O	not	neg	32	SENT_56	[p3l1596t2271r1717b2321],
32	seen	VBN	O	see	conj_and	20	SENT_56	[p3l1750t2280r1902b2321],
33	in	IN	O	in	_	0	SENT_56	[p3l1934t2266r2005b2320],
34	the	DT	O	the	det	37	SENT_56	[p3l2036t2263r2148b2321],
35	breast	NN	O	breast	nn	37	SENT_56	[p3l10t2360r220b2418],
36	cancer	NN	O	cancer	nn	37	SENT_56	[p3l279t2377r507b2418],
37	patients	NNS	O	patient	prep_in	32	SENT_56	[p3l564t2363r846b2436],
38	in	IN	O	in	_	0	SENT_56	[p3l905t2363r975b2417],
39	this	DT	O	this	det	40	SENT_56	[p3l1034t2360r1163b2418],
40	study	NN	O	study	prep_in	37	SENT_56	[p3l1224t2360r1426b2436],
41	.	.	O	.	_	0	SENT_56	[p3l1224t2360r1426b2436],

1	Although	IN	O	although	mark	5	SENT_57	[p3l1488t2360r1824b2436],
2	in	FW	O	in	nn	4	SENT_57	[p3l1885t2361r1945b2418],
3	vitro	FW	O	vitro	dep	4	SENT_57	[p3l2003t2361r2149b2418],
4	evidence	NN	O	evidence	advmod	5	SENT_57	[p3l13t2455r322b2512],
5	suggests	VBZ	O	suggest	advcl	19	SENT_57	[p3l387t2462r670b2530],
6	a	DT	O	a	det	7	SENT_57	[p3l734t2471r769b2512],
7	role	NN	O	role	dobj	5	SENT_57	[p3l831t2455r962b2512],
8	for	IN	O	for	_	0	SENT_57	[p3l1026t2454r1124b2512],
9	CYP2C8	NN	O	cyp2c8	prep_for	7	SENT_57	[p3l1187t2456r1474b2512],
10	and	CC	O	and	_	0	SENT_57	[p3l1538t2455r1669b2512],
11	CYP3A4	NN	O	cyp3a4	conj_and	9	SENT_57	[p3l1732t2456r2016b2512],
12	in	IN	O	in	_	0	SENT_57	[p3l2079t2458r2149b2512],
13	paclitaxel	NN	O	paclitaxel	nn	14	SENT_57	[p3l12t2548r352b2623],
14	metabolism	NN	O	metabolism	prep_in	5	SENT_57	[p3l390t2541r907b2618],
15	,	,	O	,	_	0	SENT_57	[p3l390t2541r907b2618],
16	“	CD	NUMBER	“	appos	14	SENT_57	[p3l390t2541r907b2618],
17	it	PRP	O	it	nsubj	19	SENT_57	[p3l946t2551r996b2605],
18	is	VBZ	O	be	cop	19	SENT_57	[p3l1032t2551r1082b2605],
19	possible	JJ	O	possible	_	0	SENT_57	[p3l1119t2548r1399b2623],
20	that	IN	O	that	complm	22	SENT_57	[p3l1437t2548r1580b2605],
21	other	JJ	O	other	amod	22	SENT_57	[p3l1617t2548r1806b2605],
22	variables	NNS	O	variable	dep	19	SENT_57	[p3l1840t2548r2148b2605],
23	such	JJ	O	such	_	0	SENT_57	[p3l14t2644r174b2702],
24	as	IN	O	as	_	0	SENT_57	[p3l205t2661r270b2702],
25	epigenetic	JJ	O	epigenetic	amod	27	SENT_57	[p3l302t2647r663b2720],
26	regulation	NN	O	regulation	nn	27	SENT_57	[p3l694t2644r1057b2720],
27	mask	NN	O	mask	prep_such_as	22	SENT_57	[p3l1087t2644r1270b2702],
28	these	DT	O	these	det	29	SENT_57	[p3l1298t2644r1480b2702],
29	effects	NNS	O	effect	dep	27	SENT_57	[p3l1512t2644r1733b2702],
30	in	IN	O	in	dep	22	SENT_57	[p3l1766t2645r1825b2702],
31	viva	FW	O	viva	pobj	30	SENT_57	[p3l1856t2645r2004b2702],
32	.	.	O	.	_	0	SENT_57	[p3l1856t2645r2004b2702],

1	For	IN	O	for	_	0	SENT_58	[p3l2039t2647r2150b2702],
2	example	NN	O	example	prep_for	11	SENT_58	[p3l13t2739r327b2815],
3	,	,	O	,	_	0	SENT_58	[p3l13t2739r327b2815],
4	the	DT	O	the	det	6	SENT_58	[p3l373t2739r486b2797],
5	nuclear	JJ	O	nuclear	amod	6	SENT_58	[p3l527t2739r789b2797],
6	receptor	NN	O	receptor	appos	2	SENT_58	[p3l830t2746r1133b2815],
7	,	,	O	,	_	0	SENT_58	[p3l830t2746r1133b2815],
8	NR1I2	NN	O	nr1i2	nsubjpass	11	SENT_58	[p3l1178t2740r1399b2796],
9	has	VBZ	O	have	aux	11	SENT_58	[p3l1440t2739r1555b2797],
10	been	VBN	O	be	auxpass	11	SENT_58	[p3l1594t2739r1764b2797],
11	shown	VBN	O	show	ccomp	46	SENT_58	[p3l1807t2739r2039b2797],
12	to	TO	O	to	aux	13	SENT_58	[p3l2079t2746r2149b2797],
13	regulate	VB	O	regulate	xcomp	11	SENT_58	[p3l12t2832r293b2908],
14	paclitaxel	NN	O	paclitaxel	nn	15	SENT_58	[p3l332t2832r673b2908],
15	metabolism	NN	O	metabolism	dobj	13	SENT_58	[p3l711t2832r1127b2890],
16	and	CC	O	and	_	0	SENT_58	[p3l1166t2832r1297b2890],
17	efﬂuX	NN	O	efﬂux	conj_and	15	SENT_58	[p3l1336t2825r1624b2903],
18	,37	CD	NUMBER	,37	num	17	SENT_58	[p3l1336t2825r1624b2903],
19	and	CC	O	and	_	0	SENT_58	[p3l1665t2832r1795b2890],
20	methylation	NN	O	methylation	nn	21	SENT_58	[p3l1833t2832r2148b2908, p3l12t2929r157b2983],
21	status	NN	O	status	nsubjpass	27	SENT_58	[p3l213t2934r412b2983],
22	in	IN	O	in	_	0	SENT_58	[p3l467t2929r537b2983],
23	ovarian	JJ	O	ovarian	amod	24	SENT_58	[p3l593t2929r858b2983],
24	tumor	NN	O	tumor	prep_in	21	SENT_58	[p3l912t2934r1133b2983],
25	has	VBZ	O	have	aux	27	SENT_58	[p3l1186t2927r1302b2983],
26	been	VBN	O	be	auxpass	27	SENT_58	[p3l1355t2926r1525b2983],
27	associated	VBN	O	associate	conj_and	11	SENT_58	[p3l1580t2926r1935b2983],
28	with	IN	O	with	_	0	SENT_58	[p3l1988t2926r2150b2983],
29	response	NN	O	response	prep_with	27	SENT_58	[p3l12t3037r317b3096],
30	to	TO	O	to	_	0	SENT_58	[p3l366t3027r435b3078],
31	taxane	NN	O	taxane	nn	32	SENT_58	[p3l484t3027r718b3078],
32	therapy	NN	O	therapy	prep_to	29	SENT_58	[p3l766t3013r1118b3096],
33	.38	CD	NUMBER	.38	num	32	SENT_58	[p3l766t3013r1118b3096],
34	Alternatively	RB	O	alternatively	advmod	27	SENT_58	[p3l1165t3020r1636b3096],
35	,	,	O	,	_	0	SENT_58	[p3l1165t3020r1636b3096],
36	the	DT	O	the	det	38	SENT_58	[p3l1688t3020r1800b3078],
37	multiple	JJ	O	multiple	amod	38	SENT_58	[p3l1849t3020r2148b3096],
38	members	NNS	O	member	nsubj	46	SENT_58	[p3l12t3116r334b3173],
39	of	IN	O	of	_	0	SENT_58	[p3l374t3115r445b3173],
40	the	DT	O	the	det	44	SENT_58	[p3l478t3115r591b3173],
41	paclitaxel	NN	O	paclitaxel	nn	44	SENT_58	[p3l629t3115r969b3191],
42	drug	NN	O	drug	nn	44	SENT_58	[p3l1009t3115r1169b3191],
43	elimination	NN	O	elimination	nn	44	SENT_58	[p3l1207t3116r1622b3173],
44	pathway	NN	O	pathway	prep_of	38	SENT_58	[p3l1659t3115r1964b3191],
45	may	MD	O	may	aux	46	SENT_58	[p3l1999t3132r2152b3191],
46	provide	VB	O	provide	_	0	SENT_58	[p3l12t3211r279b3287],
47	adequate	JJ	O	adequate	amod	48	SENT_58	[p3l305t3212r621b3287],
48	redundancy	NN	O	redundancy	dobj	46	SENT_58	[p3l646t3211r1071b3287],
49	to	TO	O	to	aux	50	SENT_58	[p3l1092t3219r1161b3269],
50	overcome	VB	O	overcome	xcomp	46	SENT_58	[p3l1186t3228r1529b3269],
51	genetic	JJ	O	genetic	amod	52	SENT_58	[p3l1554t3214r1808b3287],
52	variation	NN	O	variation	dobj	50	SENT_58	[p3l1829t3214r2149b3269],
53	in	IN	O	in	_	0	SENT_58	[p3l12t3308r83b3362],
54	any	DT	O	any	det	57	SENT_58	[p3l105t3322r234b3381],
55	one	CD	NUMBER	one	num	57	SENT_58	[p3l254t3322r383b3363],
56	gene	NN	O	gene	nn	57	SENT_58	[p3l405t3298r706b3381],
57	.3	NN	NUMBER	.3	prep_in	50	SENT_58	[p3l405t3298r706b3381],
58	'39	CD	NUMBER	'39	tmod	50	SENT_58	[p3l405t3298r706b3381],
59	The	DT	O	the	det	60	SENT_58	[p3l727t3305r859b3363],
60	pharmacogenetics	NNS	O	pharmacogenetic	nsubj	67	SENT_58	[p3l882t3305r1526b3381],
61	of	IN	O	of	_	0	SENT_58	[p3l1549t3305r1620b3363],
62	paclitaxel	NN	O	paclitaxel	prep_of	60	SENT_58	[p3l1637t3305r1977b3381],
63	may	MD	O	may	aux	67	SENT_58	[p3l1999t3322r2152b3381],
64	also	RB	O	also	advmod	67	SENT_58	[p3l13t3401r147b3458],
65	be	VB	O	be	cop	67	SENT_58	[p3l175t3401r255b3458],
66	tumor-type	JJ	O	tumor-type	amod	67	SENT_58	[p3l285t3408r684b3476],
67	dependent	JJ	O	dependent	rcmod	58	SENT_58	[p3l715t3401r1111b3476],
68	.	.	O	.	_	0	SENT_58	[p3l715t3401r1111b3476],

1	The	DT	O	the	det	3	SENT_59	[p3l87t3496r219b3553],
2	present	JJ	DATE	present	amod	3	SENT_59	[p3l256t3503r516b3571],
3	study	NN	O	study	nsubj	4	SENT_59	[p3l554t3496r746b3571],
4	involved	VBD	O	involve	_	0	SENT_59	[p3l780t3496r1088b3553],
5	patients	NNS	O	patient	dobj	4	SENT_59	[p3l1124t3499r1406b3571],
6	receiving	VBG	O	receive	xcomp	4	SENT_59	[p3l1444t3499r1766b3571],
7	high-dose	JJ	O	high-dose	amod	13	SENT_59	[p3l1801t3496r2148b3571],
8	paclitaxel	NN	O	paclitaxel	nn	13	SENT_59	[p3l12t3589r352b3665],
9	(	NN	O	(	nn	13	SENT_59	[p3l388t3590r448b3661],
10	5	CD	NUMBER	5	num	13	SENT_59	[p3l388t3590r448b3661],
11	75-775	CD	NUMBER	75-775	num	13	SENT_59	[p3l461t3592r705b3647],
12	mg/m2	NN	O	mg/m2	nn	13	SENT_59	[p3l725t3582r1016b3665],
13	)	NN	O	)	dobj	6	SENT_59	[p3l725t3582r1016b3665],
14	.	.	O	.	_	0	SENT_59	[p3l725t3582r1016b3665],

1	It	PRP	O	it	nsubj	15	SENT_60	[p3l1053t3592r1104b3647],
2	has	VBZ	O	have	aux	4	SENT_60	[p3l1137t3589r1252b3647],
3	been	VBN	O	be	auxpass	4	SENT_60	[p3l1283t3589r1452b3647],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_60	[p3l1485t3589r1974b3647],
5	that	IN	O	that	complm	13	SENT_60	[p3l2007t3589r2150b3647],
6	at	IN	O	at	_	0	SENT_60	[p3l13t3692r77b3743],
7	the	DT	O	the	det	9	SENT_60	[p3l120t3685r233b3743],
8	higher	JJR	O	higher	amod	9	SENT_60	[p3l279t3685r509b3761],
9	doses	NNS	O	dose	prep_at	13	SENT_60	[p3l553t3685r740b3743],
10	paclitaxel	NN	O	paclitaxel	nn	11	SENT_60	[p3l785t3685r1125b3761],
11	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	13	SENT_60	[p3l1169t3685r1800b3761],
12	becomes	VBZ	O	become	cop	13	SENT_60	[p3l1844t3685r2149b3743],
13	non-linear	JJ	O	non-linear	ccomp	4	SENT_60	[p4l12t16r385b74],
14	and	CC	O	and	_	0	SENT_60	[p4l410t16r542b74],
15	shows	VBZ	O	show	conj_and	4	SENT_60	[p4l569t16r781b74],
16	high	JJ	O	high	amod	18	SENT_60	[p4l807t16r968b92],
17	inter-patient	JJ	O	inter-patient	amod	18	SENT_60	[p4l994t19r1441b92],
18	Variability	NN	O	variability	dobj	15	SENT_60	[p4l1464t16r1835b92],
19	,	,	O	,	_	0	SENT_60	[p4l1464t16r1835b92],
20	possibly	RB	O	possibly	rcmod	18	SENT_60	[p4l1864t16r2152b92],
21	as	IN	O	as	dep	20	SENT_60	[p4l13t126r78b166],
22	a	DT	O	a	det	23	SENT_60	[p4l115t126r150b166],
23	result	NN	O	result	pobj	21	SENT_60	[p4l185t109r380b166],
24	of	IN	O	of	_	0	SENT_60	[p4l416t109r488b166],
25	differences	NNS	O	difference	prep_of	23	SENT_60	[p4l520t109r900b166],
26	in	IN	O	in	_	0	SENT_60	[p4l936t112r1007b166],
27	elimination	NN	O	elimination	nn	30	SENT_60	[p4l1043t109r1458b166],
28	or	CC	O	or	_	0	SENT_60	[p4l1494t126r1566b166],
29	saturable	JJ	O	saturable	nn	30	SENT_60	[p4l1602t109r1917b166],
30	tissue	NN	O	tissue	prep_in	25	SENT_60	[p4l1953t112r2148b166],

1	Table	NNP	O	Table	nn	3	SENT_61	[p4l9t242r101b270],
2	1	CD	NUMBER	1	num	3	SENT_61	[p4l118t242r129b269],
3	Genotype	NN	O	genotype	dep	15	SENT_61	[p4l173t243r333b278],
4	and	CC	O	and	_	0	SENT_61	[p4l348t242r407b270],
5	allele	NN	O	allele	nn	6	SENT_61	[p4l422t242r506b270],
6	frequencies	NNS	O	frequency	dep	15	SENT_61	[p4l520t242r709b278],
7	for	IN	O	for	_	0	SENT_61	[p4l722t242r771b270],
8	metabolism	NN	O	metabolism	nn	12	SENT_61	[p4l784t242r974b270],
9	and	CC	O	and	_	0	SENT_61	[p4l990t242r1049b270],
10	transporter	NN	O	transporter	nn	12	SENT_61	[p4l1063t246r1251b278],
11	gene	NN	O	gene	nn	12	SENT_61	[p4l1264t250r1344b278],
12	polymorphisms	NNS	O	polymorphism	prep_for	6	SENT_61	[p4l1359t242r1610b278],
13	Polymorphism	NN	O	polymorphism	nn	14	SENT_61	[p4l11t328r218b363],
14	n	NN	O	n	dep	6	SENT_61	[p4l446t336r462b354],
15	Homozygous	JJ	O	homozygous	_	0	SENT_61	[p4l613t329r804b363],
16	wild-type	JJ	O	wild-type	amod	20	SENT_61	[p4l818t328r952b363],
17	Heterozygous	NNP	O	Heterozygous	nn	20	SENT_61	[p4l1090t329r1289b363],
18	Homozygous	NNP	O	Homozygous	nn	20	SENT_61	[p4l1428t329r1618b363],
19	variant	JJ	O	variant	amod	20	SENT_61	[p4l1633t328r1737b354],
20	P	NN	O	p	dep	21	SENT_61	[p4l1901t329r1916b354],
21	q	IN	O	q	dep	15	SENT_61	[p4l2106t336r2123b363],

1	ABCB1	NN	O	abcb1	dep	149	SENT_62	[p4l9t418r103b444],
2	1236C	NN	O	1236c	dep	149	SENT_62	[p4l122t418r280b444],
3	>	JJR	O	>	dep	149	SENT_62	[p4l122t418r280b444],
4	T	NN	O	t	dep	149	SENT_62	[p4l122t418r280b444],
5	87	CD	NUMBER	87	dep	149	SENT_62	[p4l435t418r472b444],
6	24	CD	NUMBER	24	dep	149	SENT_62	[p4l691t418r729b444],
7	(	NN	O	(	dep	149	SENT_62	[p4l744t417r870b451],
8	12.53	CD	NUMBER	12.53	dep	149	SENT_62	[p4l744t417r870b451],
9	)	CD	NUMBER	)	dep	149	SENT_62	[p4l744t417r870b451],
10	"	``	O	"	dep	149	SENT_62	[p4l744t417r870b451],
11	‘	NN	O	‘	dep	149	SENT_62	[p4l744t417r870b451],
12	38	CD	NUMBER	38	dep	149	SENT_62	[p4l1107t418r1143b444],
13	(	CD	NUMBER	(	dep	149	SENT_62	[p4l1158t417r1270b451],
14	14.44	CD	NUMBER	14.44	dep	149	SENT_62	[p4l1158t417r1270b451],
15	)	NN	O	)	dep	149	SENT_62	[p4l1158t417r1270b451],
16	25	CD	NUMBER	25	dep	149	SENT_62	[p4l1497t418r1534b444],
17	(	CD	NUMBER	(	dep	149	SENT_62	[p4l1550t417r1663b451],
18	12.24	CD	NUMBER	12.24	dep	149	SENT_62	[p4l1550t417r1663b451],
19	)	NN	O	)	dep	149	SENT_62	[p4l1550t417r1663b451],
20	0.49	CD	NUMBER	0.49	dep	149	SENT_62	[p4l1873t418r1941b444],
21	0.51	CD	NUMBER	0.51	dep	149	SENT_62	[p4l2081t418r2143b444],
22	ABCB7	NN	O	abcb7	dep	149	SENT_62	[p4l9t460r103b486],
23	2677G	NN	O	2677g	dep	149	SENT_62	[p4l121t456r296b486],
24	>	JJR	O	>	dep	149	SENT_62	[p4l121t456r296b486],
25	Tb	NN	O	tb	dep	149	SENT_62	[p4l121t456r296b486],
26	89	CD	NUMBER	89	dep	149	SENT_62	[p4l435t460r472b486],
27	24	CD	NUMBER	24	dep	149	SENT_62	[p4l691t460r729b486],
28	(	NN	O	(	dep	149	SENT_62	[p4l744t460r857b493],
29	13.53	CD	NUMBER	13.53	dep	149	SENT_62	[p4l744t460r857b493],
30	)	CD	NUMBER	)	dep	149	SENT_62	[p4l744t460r857b493],
31	35	CD	NUMBER	35	dep	149	SENT_62	[p4l1107t460r1142b486],
32	(	NN	O	(	dep	149	SENT_62	[p4l1158t460r1270b493],
33	12.71	CD	NUMBER	12.71	dep	149	SENT_62	[p4l1158t460r1270b493],
34	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1158t460r1270b493],
35	23	CD	NUMBER	23	dep	149	SENT_62	[p4l1497t460r1534b486],
36	(	NN	O	(	dep	149	SENT_62	[p4l1550t460r1642b493],
37	12.3	CD	NUMBER	12.3	dep	149	SENT_62	[p4l1550t460r1642b493],
38	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1550t460r1642b493],
39	0.48	CD	NUMBER	0.48	dep	149	SENT_62	[p4l1873t460r1941b486],
40	0.48	CD	NUMBER	0.48	dep	149	SENT_62	[p4l2081t460r2149b486],
41	ABCG2	NN	O	abcg2	dep	149	SENT_62	[p4l9t503r114b529],
42	421C	NN	O	421c	dep	149	SENT_62	[p4l126t503r268b529],
43	>	JJR	O	>	dep	149	SENT_62	[p4l126t503r268b529],
44	A	DT	O	a	dep	149	SENT_62	[p4l126t503r268b529],
45	84	CD	NUMBER	84	dep	149	SENT_62	[p4l435t503r472b529],
46	60	CD	NUMBER	60	dep	149	SENT_62	[p4l692t503r729b529],
47	(	NN	O	(	dep	149	SENT_62	[p4l744t502r857b536],
48	13.68	CD	NUMBER	13.68	dep	149	SENT_62	[p4l744t502r857b536],
49	)	CD	NUMBER	)	dep	149	SENT_62	[p4l744t502r857b536],
50	21	CD	NUMBER	21	dep	149	SENT_62	[p4l1105t503r1136b529],
51	(	NN	O	(	dep	149	SENT_62	[p4l1158t502r1270b536],
52	13.36	CD	NUMBER	13.36	dep	149	SENT_62	[p4l1158t502r1270b536],
53	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1158t502r1270b536],
54	3	CD	NUMBER	3	dep	149	SENT_62	[p4l1519t503r1534b529],
55	(	NN	O	(	dep	149	SENT_62	[p4l1550t502r1663b536],
56	10.38	CD	NUMBER	10.38	dep	149	SENT_62	[p4l1550t502r1663b536],
57	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1550t502r1663b536],
58	0.84	CD	NUMBER	0.84	dep	149	SENT_62	[p4l1873t503r1941b529],
59	0.16	CD	NUMBER	0.16	dep	149	SENT_62	[p4l2081t503r2149b529],
60	CYP1Bl	NN	O	cyp1bl	dep	149	SENT_62	[p4l12t545r160b571],
61	*	NN	O	*	dep	149	SENT_62	[p4l12t545r160b571],
62	3	CD	NUMBER	3	dep	149	SENT_62	[p4l12t545r160b571],
63	84	CD	NUMBER	84	dep	149	SENT_62	[p4l435t545r472b571],
64	38	CD	NUMBER	38	dep	149	SENT_62	[p4l693t545r729b571],
65	(	NN	O	(	dep	149	SENT_62	[p4l744t544r857b578],
66	13.49	CD	NUMBER	13.49	dep	149	SENT_62	[p4l744t544r857b578],
67	)	CD	NUMBER	)	dep	149	SENT_62	[p4l744t544r857b578],
68	31	CD	NUMBER	31	dep	149	SENT_62	[p4l1107t545r1136b571],
69	(	NN	O	(	dep	149	SENT_62	[p4l1158t544r1270b578],
70	13.06	CD	NUMBER	13.06	dep	149	SENT_62	[p4l1158t544r1270b578],
71	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1158t544r1270b578],
72	15	CD	NUMBER	15	dep	149	SENT_62	[p4l1499t545r1534b571],
73	(	NN	O	(	dep	149	SENT_62	[p4l1550t544r1663b578],
74	13.67	CD	NUMBER	13.67	dep	149	SENT_62	[p4l1550t544r1663b578],
75	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1550t544r1663b578],
76	0.64	CD	NUMBER	0.64	dep	149	SENT_62	[p4l1873t545r1941b571],
77	0.36	CD	NUMBER	0.36	dep	149	SENT_62	[p4l2081t545r2149b571],
78	CYP2C8	NN	O	cyp2c8	dep	149	SENT_62	[p4l12t587r163b613],
79	*	NN	O	*	dep	149	SENT_62	[p4l12t587r163b613],
80	3	CD	NUMBER	3	dep	149	SENT_62	[p4l12t587r163b613],
81	84	CD	NUMBER	84	dep	149	SENT_62	[p4l435t587r472b613],
82	72	CD	NUMBER	72	dep	149	SENT_62	[p4l693t587r729b613],
83	(	CD	NUMBER	(	dep	149	SENT_62	[p4l744t586r857b620],
84	11.19	CD	NUMBER	11.19	dep	149	SENT_62	[p4l744t586r857b620],
85	)	NN	O	)	dep	149	SENT_62	[p4l744t586r857b620],
86	11	CD	NUMBER	11	dep	149	SENT_62	[p4l1107t587r1136b613],
87	(	CD	NUMBER	(	dep	149	SENT_62	[p4l1158t586r1270b620],
88	12.33	CD	NUMBER	12.33	dep	149	SENT_62	[p4l1158t586r1270b620],
89	)	NN	O	)	dep	149	SENT_62	[p4l1158t586r1270b620],
90	1	CD	NUMBER	1	dep	149	SENT_62	[p4l1519t587r1529b613],
91	(	CD	NUMBER	(	dep	149	SENT_62	[p4l1550t586r1663b620],
92	13.66	CD	NUMBER	13.66	dep	149	SENT_62	[p4l1550t586r1663b620],
93	)	NN	O	)	dep	149	SENT_62	[p4l1550t586r1663b620],
94	0.92	CD	NUMBER	0.92	dep	149	SENT_62	[p4l1873t587r1941b613],
95	0.08	CD	NUMBER	0.08	dep	149	SENT_62	[p4l2081t587r2149b613],
96	CYP2C8	NN	O	cyp2c8	dep	149	SENT_62	[p4l12t629r163b655],
97	*	NN	O	*	dep	149	SENT_62	[p4l12t629r163b655],
98	4	CD	NUMBER	4	dep	149	SENT_62	[p4l12t629r163b655],
99	87	CD	NUMBER	87	dep	149	SENT_62	[p4l435t629r472b655],
100	80	CD	NUMBER	80	dep	149	SENT_62	[p4l692t629r729b655],
101	(	CD	NUMBER	(	dep	149	SENT_62	[p4l744t628r857b662],
102	11.76	CD	NUMBER	11.76	dep	149	SENT_62	[p4l744t628r857b662],
103	)	NN	O	)	dep	149	SENT_62	[p4l744t628r857b662],
104	6	CD	NUMBER	6	dep	149	SENT_62	[p4l1126t629r1143b655],
105	(	NN	O	(	dep	149	SENT_62	[p4l1158t628r1270b662],
106	13.32	CD	NUMBER	13.32	dep	149	SENT_62	[p4l1158t628r1270b662],
107	)	NN	O	)	dep	149	SENT_62	[p4l1158t628r1270b662],
108	1	CD	NUMBER	1	dep	149	SENT_62	[p4l1519t629r1529b655],
109	(	CD	NUMBER	(	dep	149	SENT_62	[p4l1550t628r1623b662],
110	n/a	NN	O	n/a	dep	149	SENT_62	[p4l1550t628r1623b662],
111	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1550t628r1623b662],
112	0.95	CD	NUMBER	0.95	dep	149	SENT_62	[p4l1873t629r1940b655],
113	0.05	CD	NUMBER	0.05	dep	149	SENT_62	[p4l2081t629r2148b655],
114	CYP3A4	NN	O	cyp3a4	dep	149	SENT_62	[p4l12t671r182b697],
115	*	CD	NUMBER	*	dep	149	SENT_62	[p4l12t671r182b697],
116	1B	NN	O	1b	dep	149	SENT_62	[p4l12t671r182b697],
117	90	CD	NUMBER	90	dep	149	SENT_62	[p4l435t671r473b697],
118	81	CD	NUMBER	81	dep	149	SENT_62	[p4l692t671r723b697],
119	(	NN	O	(	dep	149	SENT_62	[p4l744t670r857b704],
120	13.30	CD	NUMBER	13.30	dep	149	SENT_62	[p4l744t670r857b704],
121	)	NN	O	)	dep	149	SENT_62	[p4l744t670r857b704],
122	7	CD	NUMBER	7	dep	149	SENT_62	[p4l1127t671r1143b697],
123	(	CD	NUMBER	(	dep	149	SENT_62	[p4l1158t670r1270b704],
124	12.68	CD	NUMBER	12.68	dep	149	SENT_62	[p4l1158t670r1270b704],
125	)	NN	O	)	dep	149	SENT_62	[p4l1158t670r1270b704],
126	2	CD	NUMBER	2	dep	149	SENT_62	[p4l1518t671r1535b697],
127	(	CD	NUMBER	(	dep	149	SENT_62	[p4l1550t670r1663b704],
128	10.51	CD	NUMBER	10.51	dep	149	SENT_62	[p4l1550t670r1663b704],
129	)	NN	O	)	dep	149	SENT_62	[p4l1550t670r1663b704],
130	0.94	CD	NUMBER	0.94	dep	149	SENT_62	[p4l1873t671r1941b697],
131	0.06	CD	NUMBER	0.06	dep	149	SENT_62	[p4l2081t671r2149b697],
132	CYP3A5	NN	O	cyp3a5	dep	149	SENT_62	[p4l12t713r187b739],
133	*	CD	NUMBER	*	dep	149	SENT_62	[p4l12t713r187b739],
134	3C	NN	O	3c	dep	149	SENT_62	[p4l12t713r187b739],
135	86	CD	NUMBER	86	dep	149	SENT_62	[p4l435t713r472b739],
136	3	CD	NUMBER	3	dep	149	SENT_62	[p4l713t713r728b739],
137	(	NN	O	(	dep	149	SENT_62	[p4l744t712r857b746],
138	13.14	CD	NUMBER	13.14	dep	149	SENT_62	[p4l744t712r857b746],
139	)	CD	NUMBER	)	dep	149	SENT_62	[p4l744t712r857b746],
140	17	CD	NUMBER	17	dep	149	SENT_62	[p4l1107t713r1143b739],
141	(	NN	O	(	dep	149	SENT_62	[p4l1158t712r1270b746],
142	13.25	CD	NUMBER	13.25	dep	149	SENT_62	[p4l1158t712r1270b746],
143	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1158t712r1270b746],
144	66	CD	NUMBER	66	dep	149	SENT_62	[p4l1498t713r1535b739],
145	(	NN	O	(	dep	149	SENT_62	[p4l1550t712r1663b746],
146	13.34	CD	NUMBER	13.34	dep	149	SENT_62	[p4l1550t712r1663b746],
147	)	CD	NUMBER	)	dep	149	SENT_62	[p4l1550t712r1663b746],
148	0.13	CD	NUMBER	0.13	dep	149	SENT_62	[p4l1873t713r1941b739],
149	0.87	CD	NUMBER	0.87	_	0	SENT_62	[p4l2081t713r2149b739],

1	aMean	JJ	O	amean	amod	6	SENT_63	[p4l10t812r94b840],
2	paclitaxel	NN	O	paclitaxel	nn	6	SENT_63	[p4l108t817r225b847],
3	clearance	NN	O	clearance	nn	6	SENT_63	[p4l238t817r357b840],
4	(	CD	NUMBER	(	num	6	SENT_63	[p4l369t815r472b846],
5	I/h/m2	NN	O	i/h/m2	nn	6	SENT_63	[p4l369t815r472b846],
6	)	NN	O	)	_	0	SENT_63	[p4l369t815r472b846],
7	in	IN	O	in	_	0	SENT_63	[p4l484t818r505b840],
8	parentheses	NNS	O	parenthesis	prep_in	6	SENT_63	[p4l518t817r675b847],
9	.	.	O	.	_	0	SENT_63	[p4l518t817r675b847],

1	bABCBi	NNP	O	bABCBi	nsubj	6	SENT_64	[p4l10t851r99b876],
2	2677	CD	DATE	2677	num	1	SENT_64	[p4l113t855r178b876],
3	is	VBZ	O	be	cop	6	SENT_64	[p4l189t855r205b876],
4	a	DT	O	a	det	6	SENT_64	[p4l216t861r228b876],
5	tri-allelic	JJ	O	tri-allelic	amod	6	SENT_64	[p4l239t854r346b876],
6	polymorphism	NN	O	polymorphism	ccomp	25	SENT_64	[p4l358t854r548b883],
7	:	:	O	:	_	0	SENT_64	[p4l358t854r548b883],
8	in	IN	O	in	_	0	SENT_64	[p4l562t855r582b876],
9	addition	NN	O	addition	_	0	SENT_64	[p4l594t854r697b876],
10	to	TO	O	to	_	0	SENT_64	[p4l709t857r734b876],
11	the	DT	O	the	det	15	SENT_64	[p4l745t854r785b876],
12	G	NN	O	g	nn	15	SENT_64	[p4l797t855r815b876],
13	and	CC	O	and	_	0	SENT_64	[p4l827t854r873b876],
14	T	NN	O	t	nn	15	SENT_64	[p4l884t855r900b876],
15	alleles	NNS	O	allele	prep_in_addition_to	6	SENT_64	[p4l910t854r984b876],
16	listed	VBN	O	list	partmod	15	SENT_64	[p4l996t854r1060b876],
17	in	IN	O	in	_	0	SENT_64	[p4l1072t855r1093b876],
18	the	DT	O	the	det	19	SENT_64	[p4l1104t854r1144b876],
19	table	NN	O	table	prep_in	16	SENT_64	[p4l1155t854r1224b881],
20	,	,	O	,	_	0	SENT_64	[p4l1155t854r1224b881],
21	3	CD	NUMBER	3	num	22	SENT_64	[p4l1238t855r1250b876],
22	patients	NNS	O	patient	nsubj	25	SENT_64	[p4l1263t855r1362b883],
23	were	VBD	O	be	cop	25	SENT_64	[p4l1372t861r1434b876],
24	heterozygous	JJ	O	heterozygous	amod	25	SENT_64	[p4l1446t854r1616b883],
25	G/A	NN	O	g/a	_	0	SENT_64	[p4l1627t854r1682b881],
26	,	,	O	,	_	0	SENT_64	[p4l1627t854r1682b881],
27	and	CC	O	and	_	0	SENT_64	[p4l1695t854r1741b876],
28	4	CD	NUMBER	4	num	29	SENT_64	[p4l1752t855r1767b876],
29	patients	NNS	O	patient	npadvmod	30	SENT_64	[p4l1779t855r1878b883],
30	heterozygous	JJ	O	heterozygous	amod	31	SENT_64	[p4l1890t854r2060b883],
31	T/A	NN	O	t/a	conj_and	25	SENT_64	[p4l2070t854r2121b879],
32	.	.	O	.	_	0	SENT_64	[p4l2070t854r2121b879],

1	A	DT	O	a	_	0	SENT_65	[p4l2133t855r2151b876],

1	2	CD	NUMBER	2	num	3	SENT_66	[p4l1264t888r1275b901],
2	allele	NN	O	allele	nn	3	SENT_66	[p4l10t891r73b913],
3	frequency	NN	O	frequency	nsubj	4	SENT_66	[p4l83t891r308b920],
4	=	JJ	O	=	_	0	SENT_66	[p4l83t891r308b920],
5	0.04	CD	NUMBER	0.04	dobj	4	SENT_66	[p4l83t891r308b920],
6	.	.	O	.	_	0	SENT_66	[p4l83t891r308b920],

1	Mean	NN	O	mean	nn	3	SENT_67	[p4l322t892r392b913],
2	paclitaxel	NN	O	paclitaxel	nn	3	SENT_67	[p4l405t890r522b920],
3	clearance	NN	O	clearance	_	0	SENT_67	[p4l535t891r654b913],
4	for	IN	O	for	_	0	SENT_67	[p4l664t891r700b913],
5	G/A	NNP	O	G/A	prep_for	3	SENT_67	[p4l710t891r766b916],
6	:	:	O	:	_	0	SENT_67	[p4l710t891r766b916],
7	11.77	CD	NUMBER	11.77	number	8	SENT_67	[p4l780t888r949b918],
8	|	CD	NUMBER	|	dep	3	SENT_67	[p4l780t888r949b918],
9	/	:	O	/	punct	17	SENT_67	[p4l780t888r949b918],
10	h/m2	CD	NUMBER	h/m2	dep	17	SENT_67	[p4l780t888r949b918],
11	,	,	O	,	_	0	SENT_67	[p4l780t888r949b918],
12	and	CC	O	and	dep	10	SENT_67	[p4l962t891r1008b913],
13	for	IN	O	for	dep	12	SENT_67	[p4l1019t891r1055b913],
14	T/A	NN	O	t/a	pobj	13	SENT_67	[p4l1064t891r1116b916],
15	:	:	O	:	_	0	SENT_67	[p4l1064t891r1116b916],
16	9.24	CD	NUMBER	9.24	num	17	SENT_67	[p4l1129t890r1261b916],
17	|	CD	NUMBER	|	dep	8	SENT_67	[p4l1129t890r1261b916],
18	/	:	O	/	punct	17	SENT_67	[p4l1129t890r1261b916],
19	h/m	NN	O	h/m	dep	8	SENT_67	[p4l1129t890r1261b916],
20	.	.	O	.	_	0	SENT_67	[p4l1278t909r1282b913],

1	mg	NN	O	mg	nn	4	SENT_68	[p4l8t1203r135b1327],
2	Paclitaxel	NN	O	paclitaxel	nn	4	SENT_68	[p4l1455t1215r1685b1260],
3	pharmacogenetics	NNS	O	pharmacogenetic	nn	4	SENT_68	[p4l1707t1215r2149b1274],
4	S	NN	O	s	_	0	SENT_68	[p4l1879t1288r1899b1328],
5	Marsh	NNP	PERSON	Marsh	dep	4	SENT_68	[p4l1921t1286r2043b1328],
6	et	FW	O	et	nn	7	SENT_68	[p4l2065t1291r2101b1328],
7	al	FW	O	al	dep	4	SENT_68	[p4l2117t1286r2153b1328],

1	.	.	O	.	_	0	SENT_69	[p4l896t2459r1605b2478],

1	----	CD	NUMBER	----	_	0	SENT_70	[p4l896t2459r1605b2478],
2	4	CD	NUMBER	4	number	3	SENT_70	[p4l896t2459r1605b2478],
3	---	CD	NUMBER	---	num	1	SENT_70	[p4l896t2459r1605b2478],
4	.	.	O	.	_	0	SENT_70	[p4l896t2459r1605b2478],

1	|	NN	O	|	_	0	SENT_71	[p4l896t2459r1605b2478],
2	.	.	O	.	_	0	SENT_71	[p4l896t2459r1605b2478],

1	_	NN	O	_	_	0	SENT_72	[p4l896t2459r1605b2478],
2	|	NN	O	|	dep	1	SENT_72	[p4l896t2459r1605b2478],
3	.	.	O	.	_	0	SENT_72	[p4l896t2459r1605b2478],

1	i.	NNP	O	i.	nn	2	SENT_73	[p4l896t2459r1605b2478],
2	|	NNP	O	|	_	0	SENT_73	[p4l896t2459r1605b2478],
3	.	.	O	.	_	0	SENT_73	[p4l896t2459r1605b2478],

1	I.	NN	O	i.	_	0	SENT_74	[p4l896t2459r1605b2478],
2	.	.	O	.	_	0	SENT_74	[p4l896t2459r1605b2478],

1	--	:	O	--	_	0	SENT_75	[p4l896t2459r1605b2478],
2	4	CD	NUMBER	4	_	0	SENT_75	[p4l896t2459r1605b2478],
3	.	.	O	.	_	0	SENT_75	[p4l896t2459r1605b2478],

1	|	NN	O	|	_	0	SENT_76	[p4l896t2459r1605b2478],
2	.	.	O	.	_	0	SENT_76	[p4l896t2459r1605b2478],

1	----	CD	NUMBER	----	_	0	SENT_77	[p4l896t2459r1605b2478],
2	_	CD	NUMBER	_	num	4	SENT_77	[p4l896t2459r1605b2478],
3	|	CD	NUMBER	|	num	4	SENT_77	[p4l896t2459r1605b2478],
4	Ma	NNP	O	Ma	dep	1	SENT_77	[p4l1639t2453r1882b2511],
5	"	``	O	"	punct	4	SENT_77	[p4l1639t2453r1882b2511],
6	*	SYM	O	*	dep	4	SENT_77	[p4l1639t2453r1882b2511],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_78	[p4l25t2342r79b2703],
2	survival	NN	O	survival	_	0	SENT_78	[p4l25t2070r79b2320],

1	o	NN	O	o	_	0	SENT_79	[p4l230t3244r257b3283],
2	20	CD	NUMBER	20	num	3	SENT_79	[p4l572t3244r626b3283],
3	40	CD	NUMBER	40	dep	1	SENT_79	[p4l933t3244r983b3283],
4	so	IN	O	so	advmod	6	SENT_79	[p4l1289t3244r1343b3283],
5	30	CD	NUMBER	30	number	6	SENT_79	[p4l1650t3244r1703b3283],
6	100	CD	NUMBER	100	rcmod	3	SENT_79	[p4l1996t3244r2076b3283],

1	months	NNS	DURATION	month	dep	3	SENT_80	[p4l788t3338r1024b3390],
2	progression	NN	O	progression	dep	1	SENT_80	[p4l1050t3338r1441b3404],
3	free	JJ	O	free	_	0	SENT_80	[p4l1463t3338r1587b3390],

1	Figure	NNP	O	Figure	nn	3	SENT_81	[p4l12t3472r204b3539],
2	1	CD	NUMBER	1	num	3	SENT_81	[p4l252t3473r273b3522],
3	Patients	NNS	O	patient	nsubj	14	SENT_81	[p4l354t3473r581b3523],
4	with	IN	O	with	_	0	SENT_81	[p4l623t3471r750b3523],
5	two	CD	NUMBER	two	num	7	SENT_81	[p4l795t3477r907b3523],
6	Leucine	NN	O	leucine	nn	7	SENT_81	[p4l953t3473r1175b3523],
7	alleles	NNS	O	allele	prep_with	3	SENT_81	[p4l1218t3471r1392b3523],
8	at	IN	O	at	_	0	SENT_81	[p4l1435t3477r1490b3523],
9	the	DT	O	the	det	13	SENT_81	[p4l1530t3471r1624b3523],
10	CYP1B1	NN	O	cyp1b1	nn	13	SENT_81	[p4l1672t3473r1956b3523],
11	*	NN	O	*	nn	13	SENT_81	[p4l1672t3473r1956b3523],
12	3	CD	NUMBER	3	num	13	SENT_81	[p4l1672t3473r1956b3523],
13	locus	NN	O	locus	prep_at	7	SENT_81	[p4l2003t3471r2149b3523],
14	experienced	VBD	O	experience	_	0	SENT_81	[p4l9t3555r368b3623],
15	longer	JJR	O	longer	amod	17	SENT_81	[p4l398t3555r588b3623],
16	progression-free	JJ	O	progression-free	amod	17	SENT_81	[p4l612t3555r1087b3623],
17	survival	NN	O	survival	dobj	14	SENT_81	[p4l1112t3555r1327b3607],
18	compared	VBN	O	compare	_	0	SENT_81	[p4l1355t3555r1653b3623],
19	to	TO	O	to	prepc_compared_to	14	SENT_81	[p4l1679t3561r1737b3607],
20	patients	NNS	O	patient	pobj	14	SENT_81	[p4l1765t3556r1996b3623],
21	with	IN	O	with	_	0	SENT_81	[p4l2019t3555r2146b3607],
22	at	IN	O	at	quantmod	24	SENT_81	[p4l9t3645r64b3691],
23	least	JJS	O	least	mwe	22	SENT_81	[p4l91t3639r221b3691],
24	one	CD	NUMBER	one	num	28	SENT_81	[p4l246t3654r355b3691],
25	Valine	NN	PERSON	valine	nn	28	SENT_81	[p4l379t3639r559b3691],
26	allele	NN	O	allele	nn	28	SENT_81	[p4l585t3639r733b3691],
27	(	CD	NUMBER	(	num	28	SENT_81	[p4l761t3639r877b3704],
28	P	NN	O	p	prep_with	20	SENT_81	[p4l761t3639r877b3704],
29	:	:	O	:	_	0	SENT_81	[p4l761t3639r877b3704],
30	0.037	CD	NUMBER	0.037	num	31	SENT_81	[p4l895t3639r1106b3704],
31	)	NN	O	)	dep	28	SENT_81	[p4l895t3639r1106b3704],
32	.	.	O	.	_	0	SENT_81	[p4l895t3639r1106b3704],

1	distribution	NN	O	distribution	_	0	SENT_82	[p5l9t96r484b161],
2	?	.	O	?	_	0	SENT_82	[p5l9t96r484b161],

1	Consequently	RB	O	consequently	advmod	5	SENT_83	[p5l520t104r1025b179],
2	,	,	O	,	_	0	SENT_83	[p5l520t104r1025b179],
3	it	PRP	O	it	nsubj	5	SENT_83	[p5l1065t107r1114b161],
4	is	VBZ	O	be	cop	5	SENT_83	[p5l1150t107r1200b161],
5	possible	JJ	O	possible	_	0	SENT_83	[p5l1235t104r1516b179],
6	that	IN	O	that	complm	12	SENT_83	[p5l1552t104r1695b161],
7	novel	JJ	O	novel	amod	9	SENT_83	[p5l1730t104r1926b161],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_83	[p5l1961t104r2147b179, p5l9t202r458b274],
9	associations	NNS	O	association	nsubj	12	SENT_83	[p5l504t202r925b256],
10	previously	RB	DATE	previously	advmod	12	SENT_83	[p5l971t199r1341b274],
11	not	RB	O	not	neg	12	SENT_83	[p5l1384t206r1505b256],
12	seen	VBN	O	see	ccomp	5	SENT_83	[p5l1552t215r1704b256],
13	in	IN	O	in	_	0	SENT_83	[p5l1750t202r1820b256],
14	patients	NNS	O	patient	prep_in	12	SENT_83	[p5l1866t202r2148b274],
15	receiving	VBG	O	receive	partmod	14	SENT_83	[p5l9t297r331b370],
16	lower	JJR	O	lower	amod	18	SENT_83	[p5l362t294r557b352],
17	paclitaxel	NN	O	paclitaxel	nn	18	SENT_83	[p5l587t294r928b370],
18	doses	NNS	O	dose	dobj	15	SENT_83	[p5l961t294r1148b352],
19	could	MD	O	could	aux	22	SENT_83	[p5l1181t294r1377b352],
20	have	VB	O	have	aux	22	SENT_83	[p5l1409t294r1574b352],
21	been	VBN	O	be	auxpass	22	SENT_83	[p5l1605t294r1774b352],
22	identified	VBN	O	identify	rcmod	18	SENT_83	[p5l1806t294r2149b352],
23	here	RB	O	here	advmod	22	SENT_83	[p5l9t389r178b459],
24	,	,	O	,	_	0	SENT_83	[p5l9t389r178b459],
25	and	CC	O	and	_	0	SENT_83	[p5l219t389r350b447],
26	existing	VBG	O	exist	amod	27	SENT_83	[p5l386t392r664b465],
27	associations	NNS	O	association	conj_and	14	SENT_83	[p5l699t392r1120b447],
28	not	RB	O	not	neg	29	SENT_83	[p5l1157t396r1277b447],
29	replicated	VBN	O	replicate	partmod	27	SENT_83	[p5l1312t389r1678b465],
30	.	.	O	.	_	0	SENT_83	[p5l1312t389r1678b465],

1	In	IN	O	in	_	0	SENT_84	[p5l1718t391r1791b446],
2	addition	NN	O	addition	prep_in	9	SENT_84	[p5l1827t389r2143b459],
3	,	,	O	,	_	0	SENT_84	[p5l1827t389r2143b459],
4	cyclophosphamide	NN	O	cyclophosphamide	conj_and	2	SENT_84	[p5l9t484r680b560],
5	and	CC	O	and	_	0	SENT_84	[p5l728t484r859b542],
6	doxorubicin	NN	O	doxorubicin	conj_and	2	SENT_84	[p5l906t484r1338b542],
7	are	VBP	O	be	auxpass	9	SENT_84	[p5l1385t501r1486b542],
8	also	RB	O	also	advmod	9	SENT_84	[p5l1535t484r1668b542],
9	metabolized	VBN	O	metabolize	_	0	SENT_84	[p5l1715t484r2149b542],
10	by	IN	O	by	_	0	SENT_84	[p5l7t577r94b652],
11	CYP3A4	NN	O	cyp3a4	agent	9	SENT_84	[p5l119t578r403b634],
12	and	CC	O	and	_	0	SENT_84	[p5l431t576r562b634],
13	CYP3A54	NN	O	cyp3a54	agent	9	SENT_84	[p5l590t569r1035b634],
14	°	CD	NUMBER	°	number	15	SENT_84	[p5l590t569r1035b634],
15	‘	CD	NUMBER	‘	nsubjpass	9	SENT_84	[p5l590t569r1035b634],
16	42	CD	NUMBER	42	nsubj	19	SENT_84	[p5l590t569r1035b634],
17	and	CC	O	and	_	0	SENT_84	[p5l1061t577r1193b634],
18	this	DT	DATE	this	nsubj	19	SENT_84	[p5l1218t577r1348b634],
19	may	MD	DATE	may	rcmod	15	SENT_84	[p5l1375t593r1528b652],
20	in	IN	O	in	_	0	SENT_84	[p5l1551t579r1621b633],
21	part	NN	O	part	nn	22	SENT_84	[p5l1647t584r1787b652],
22	mask	NN	O	mask	prep_in	19	SENT_84	[p5l1814t577r1997b634],
23	any	DT	O	any	det	24	SENT_84	[p5l2022t593r2151b652],
24	associations	NNS	O	association	dep	22	SENT_84	[p5l9t676r430b731],
25	between	IN	O	between	_	0	SENT_84	[p5l476t673r774b731],
26	polymorphisms	NNS	O	polymorphism	prep_between	24	SENT_84	[p5l821t673r1377b749],
27	in	IN	O	in	_	0	SENT_84	[p5l1426t676r1496b730],
28	these	DT	O	these	det	29	SENT_84	[p5l1543t673r1725b731],
29	genes	NNS	O	gene	prep_in	26	SENT_84	[p5l1774t690r1969b749],
30	and	CC	O	and	_	0	SENT_84	[p5l2018t673r2149b731],
31	paclitaxel	NN	O	paclitaxel	nn	32	SENT_84	[p5l8t767r349b843],
32	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	22	SENT_84	[p5l378t767r1010b843],
33	in	IN	O	in	_	0	SENT_84	[p5l1041t770r1112b824],
34	the	DT	O	the	det	35	SENT_84	[p5l1141t768r1254b825],
35	patients	NNS	O	patient	prep_in	32	SENT_84	[p5l1284t770r1567b843],
36	in	IN	O	in	_	0	SENT_84	[p5l1598t770r1668b824],
37	this	DT	O	this	det	38	SENT_84	[p5l1698t767r1827b825],
38	study	NN	O	study	prep_in	35	SENT_84	[p5l1860t768r2062b843],
39	.	.	O	.	_	0	SENT_84	[p5l1860t768r2062b843],

1	It	PRP	O	it	nsubj	3	SENT_85	[p5l2097t770r2149b825],
2	is	VBZ	O	be	cop	3	SENT_85	[p5l9t865r59b920],
3	possible	JJ	O	possible	_	0	SENT_85	[p5l107t862r387b938],
4	that	IN	O	that	complm	13	SENT_85	[p5l435t863r579b920],
5	paclitaxel	NN	O	paclitaxel	nsubj	13	SENT_85	[p5l625t862r966b938],
6	in	IN	O	in	_	0	SENT_85	[p5l1014t865r1084b919],
7	combination	NN	O	combination	prep_in	5	SENT_85	[p5l1133t862r1590b920],
8	with	IN	O	with	_	0	SENT_85	[p5l1635t862r1797b920],
9	different	JJ	O	different	amod	11	SENT_85	[p5l1845t862r2149b920],
10	chemotherapy	NN	O	chemotherapy	nn	11	SENT_85	[p5l9t958r526b1034],
11	agents	NNS	O	agent	prep_with	7	SENT_85	[p5l549t965r773b1034],
12	will	MD	O	will	aux	13	SENT_85	[p5l797t958r927b1015],
13	have	VB	O	have	ccomp	3	SENT_85	[p5l953t958r1118b1016],
14	a	DT	O	a	det	17	SENT_85	[p5l1145t975r1180b1016],
15	different	JJ	O	different	amod	17	SENT_85	[p5l1206t958r1509b1016],
16	pharmacogenetic	JJ	O	pharmacogenetic	amod	17	SENT_85	[p5l1534t958r2149b1034],
17	profile	NN	O	profile	dobj	13	SENT_85	[p5l8t1052r256b1128],
18	.	.	O	.	_	0	SENT_85	[p5l8t1052r256b1128],

1	The	DT	O	the	det	3	SENT_86	[p5l83t1148r216b1205],
2	significant	JJ	O	significant	amod	3	SENT_86	[p5l259t1147r629b1223],
3	association	NN	O	association	nsubj	12	SENT_86	[p5l671t1151r1062b1205],
4	between	IN	O	between	_	0	SENT_86	[p5l1100t1148r1398b1205],
5	CYP1B1	NN	O	cyp1b1	prep_between	3	SENT_86	[p5l1440t1149r1792b1205],
6	*	CD	NUMBER	*	number	7	SENT_86	[p5l1440t1149r1792b1205],
7	3	CD	NUMBER	3	dep	5	SENT_86	[p5l1440t1149r1792b1205],
8	and	CC	O	and	_	0	SENT_86	[p5l1834t1148r1966b1205],
9	progression-free	JJ	O	progression-free	amod	10	SENT_86	[p5l2005t1164r2148b1223, p5l9t1243r452b1319],
10	survival	NN	O	survival	prep_between	3	SENT_86	[p5l493t1243r767b1301],
11	could	MD	O	could	aux	12	SENT_86	[p5l805t1243r1000b1301],
12	reﬂect	VB	O	reﬂect	_	0	SENT_86	[p5l1038t1243r1256b1301],
13	altered	JJ	O	altered	amod	15	SENT_86	[p5l1294t1243r1534b1301],
14	paclitaxel	NN	O	paclitaxel	nn	15	SENT_86	[p5l1570t1243r1911b1319],
15	metabolism	NN	O	metabolism	dobj	12	SENT_86	[p5l1948t1250r2147b1301, p5l6t1338r264b1396],
16	.	.	O	.	_	0	SENT_86	[p5l1948t1250r2147b1301, p5l6t1338r264b1396],

1	CYP1B1	NN	O	cyp1b1	nsubjpass	5	SENT_87	[p5l325t1339r678b1396],
2	*	CD	NUMBER	*	num	3	SENT_87	[p5l325t1339r678b1396],
3	3	CD	NUMBER	3	dep	1	SENT_87	[p5l325t1339r678b1396],
4	is	VBZ	O	be	auxpass	5	SENT_87	[p5l733t1341r783b1396],
5	associated	VBN	O	associate	_	0	SENT_87	[p5l840t1338r1196b1396],
6	with	IN	O	with	_	0	SENT_87	[p5l1248t1338r1410b1396],
7	increased	VBN	O	increase	amod	10	SENT_87	[p5l1464t1338r1795b1396],
8	estrogen	NN	O	estrogen	nn	10	SENT_87	[p5l1850t1345r2148b1414],
9	hydroxylation	NN	O	hydroxylation	nn	10	SENT_87	[p5l9t1431r516b1507],
10	activity	NN	O	activity	prep_with	5	SENT_87	[p5l571t1424r914b1507],
11	,	,	O	,	_	0	SENT_87	[p5l571t1424r914b1507],
12	”	NN	O	”	appos	10	SENT_87	[p5l571t1424r914b1507],
13	consequently	RB	O	consequently	advmod	5	SENT_87	[p5l970t1431r1457b1507],
14	,	,	O	,	_	0	SENT_87	[p5l970t1431r1457b1507],
15	as	IN	O	as	mark	26	SENT_87	[p5l1517t1448r1582b1489],
16	a	DT	O	a	det	18	SENT_87	[p5l1637t1448r1672b1489],
17	competitive	JJ	O	competitive	amod	18	SENT_87	[p5l1727t1434r2147b1507],
18	substrate	NN	O	substrate	nsubjpass	26	SENT_87	[p5l10t1525r322b1582],
19	for	IN	O	for	_	0	SENT_87	[p5l378t1524r476b1582],
20	CYP1B1	NN	O	cyp1b1	nn	23	SENT_87	[p5l531t1517r897b1595],
21	,13	CD	NUMBER	,13	num	23	SENT_87	[p5l531t1517r897b1595],
22	paclitaxel	NN	O	paclitaxel	nn	23	SENT_87	[p5l952t1525r1293b1600],
23	metabolism	NN	O	metabolism	prep_for	18	SENT_87	[p5l1348t1525r1764b1582],
24	could	MD	O	could	aux	26	SENT_87	[p5l1820t1525r2016b1582],
25	be	VB	O	be	auxpass	26	SENT_87	[p5l2068t1525r2148b1582],
26	increased	VBN	O	increase	advcl	5	SENT_87	[p5l9t1621r339b1679],
27	by	IN	O	by	_	0	SENT_87	[p5l370t1621r458b1697],
28	the	DT	O	the	det	29	SENT_87	[p5l488t1621r601b1679],
29	presence	NN	O	presence	agent	26	SENT_87	[p5l634t1638r940b1697],
30	of	IN	O	of	_	0	SENT_87	[p5l974t1621r1046b1679],
31	the	DT	O	the	det	33	SENT_87	[p5l1075t1621r1188b1679],
32	CYP1B1	NN	O	cyp1b1	nn	33	SENT_87	[p5l1224t1622r1493b1679],
33	*	NN	O	*	prep_of	29	SENT_87	[p5l1505t1622r1576b1679],
34	3	CD	NUMBER	3	num	35	SENT_87	[p5l1505t1622r1576b1679],
35	alleles	NNS	O	allele	dep	33	SENT_87	[p5l1611t1621r1842b1691],
36	,	,	O	,	_	0	SENT_87	[p5l1611t1621r1842b1691],
37	thereby	RB	O	thereby	advmod	33	SENT_87	[p5l1880t1621r2151b1697],
38	reducing	VBG	O	reduce	partmod	33	SENT_87	[p5l9t1715r320b1791],
39	the	DT	O	the	det	40	SENT_87	[p5l360t1716r472b1773],
40	concentration	NN	O	concentration	dobj	38	SENT_87	[p5l515t1718r1015b1773],
41	of	IN	O	of	_	0	SENT_87	[p5l1057t1715r1129b1773],
42	active	JJ	O	active	amod	43	SENT_87	[p5l1167t1718r1371b1773],
43	paclitaxel	NN	O	paclitaxel	prep_of	40	SENT_87	[p5l1413t1715r1772b1791],
44	.	.	O	.	_	0	SENT_87	[p5l1413t1715r1772b1791],

1	However	RB	O	however	advmod	28	SENT_88	[p5l1818t1718r2144b1786],
2	,	,	O	,	_	0	SENT_88	[p5l1818t1718r2144b1786],
3	the	DT	O	the	det	4	SENT_88	[p5l8t1811r121b1868],
4	suggestion	NN	O	suggestion	nsubj	28	SENT_88	[p5l151t1814r524b1886],
5	that	WDT	O	that	rel	9	SENT_88	[p5l551t1811r695b1868],
6	docetaxel	NN	O	docetaxel	nsubjpass	9	SENT_88	[p5l722t1811r1059b1868],
7	is	VBZ	O	be	auxpass	9	SENT_88	[p5l1087t1814r1137b1868],
8	not	RB	O	not	neg	9	SENT_88	[p5l1165t1818r1286b1868],
9	metabolized	VBN	O	metabolize	rcmod	4	SENT_88	[p5l1313t1811r1746b1868],
10	by	IN	O	by	prep	9	SENT_88	[p5l1772t1811r1859b1886],
11	and	CC	O	and	_	0	SENT_88	[p5l1885t1811r2016b1868],
12	yet	RB	O	yet	advmod	13	SENT_88	[p5l2041t1818r2149b1886],
13	binds	VBZ	O	bind	conj_and	9	SENT_88	[p5l7t1904r200b1962],
14	to	TO	O	to	_	0	SENT_88	[p5l231t1911r301b1962],
15	CYP1B1	NN	O	cyp1b1	prep_to	13	SENT_88	[p5l333t1897r700b1974],
16	,14	CD	NUMBER	,14	num	15	SENT_88	[p5l333t1897r700b1974],
17	thereby	RB	O	thereby	advmod	18	SENT_88	[p5l731t1904r1001b1980],
18	reducing	VBG	O	reduce	partmod	15	SENT_88	[p5l1029t1904r1341b1980],
19	available	JJ	O	available	amod	20	SENT_88	[p5l1371t1904r1679b1962],
20	docetaxel	NN	O	docetaxel	dobj	18	SENT_88	[p5l1711t1904r2048b1962],
21	in	IN	O	in	_	0	SENT_88	[p5l2078t1907r2149b1961],
22	the	DT	O	the	det	23	SENT_88	[p5l8t2000r121b2057],
23	cell	NN	O	cell	prep_in	20	SENT_88	[p5l153t2000r290b2070],
24	,	,	O	,	_	0	SENT_88	[p5l153t2000r290b2070],
25	would	MD	O	would	aux	28	SENT_88	[p5l325t2000r546b2057],
26	be	VB	O	be	cop	28	SENT_88	[p5l575t2000r655b2057],
27	more	RBR	O	more	advmod	28	SENT_88	[p5l687t2016r868b2057],
28	supportive	JJ	O	supportive	_	0	SENT_88	[p5l903t2003r1275b2075],
29	of	IN	O	of	_	0	SENT_88	[p5l1308t1999r1379b2057],
30	a	DT	O	a	det	31	SENT_88	[p5l1407t2016r1442b2057],
31	role	NN	O	role	prep_of	28	SENT_88	[p5l1473t2000r1605b2057],
32	for	IN	O	for	_	0	SENT_88	[p5l1637t1999r1736b2057],
33	CYP1B1	NN	O	cyp1b1	prep_for	31	SENT_88	[p5l1768t2001r2041b2057],
34	in	IN	O	in	_	0	SENT_88	[p5l2078t2003r2149b2057],
35	taxane	NN	O	taxane	nn	36	SENT_88	[p5l8t2102r243b2152],
36	efficacy	NN	O	efficacy	prep_in	33	SENT_88	[p5l283t2094r552b2170],
37	without	IN	O	without	_	0	SENT_88	[p5l587t2095r870b2152],
38	a	DT	O	a	det	40	SENT_88	[p5l910t2111r945b2152],
39	direct	JJ	O	direct	amod	40	SENT_88	[p5l984t2095r1184b2152],
40	effect	NN	O	effect	prep_without	28	SENT_88	[p5l1223t2094r1414b2152],
41	on	IN	O	on	_	0	SENT_88	[p5l1454t2111r1544b2152],
42	taxane	NN	O	taxane	nn	43	SENT_88	[p5l1584t2102r1818b2152],
43	metabolism	NN	O	metabolism	prep_on	40	SENT_88	[p5l1858t2095r2147b2152, p5l9t2190r174b2248],
44	.	.	O	.	_	0	SENT_88	[p5l1858t2095r2147b2152, p5l9t2190r174b2248],

1	Alternatively	RB	O	alternatively	advmod	8	SENT_89	[p5l203t2190r673b2266],
2	,	,	O	,	_	0	SENT_89	[p5l203t2190r673b2266],
3	the	DT	O	the	det	4	SENT_89	[p5l704t2190r816b2248],
4	alterations	NNS	O	alteration	nsubj	8	SENT_89	[p5l843t2190r1216b2248],
5	in	IN	O	in	_	0	SENT_89	[p5l1242t2193r1312b2247],
6	CYP1B1	NN	O	cyp1b1	prep_in	4	SENT_89	[p5l1340t2192r1609b2248],
7	may	MD	O	may	aux	8	SENT_89	[p5l1641t2207r1794b2266],
8	inﬂuence	VB	O	inﬂuence	_	0	SENT_89	[p5l1817t2190r2148b2248],
9	tumor	NN	O	tumor	nn	10	SENT_89	[p5l8t2292r229b2343],
10	biology	NN	O	biology	dobj	8	SENT_89	[p5l301t2285r579b2361],
11	.	.	O	.	_	0	SENT_89	[p5l301t2285r579b2361],

1	CYP1B1	NN	O	cyp1b1	_	0	SENT_90	[p5l660t2286r1013b2343],
2	*	CD	NUMBER	*	number	3	SENT_90	[p5l660t2286r1013b2343],
3	3	CD	NUMBER	3	num	4	SENT_90	[p5l660t2286r1013b2343],
4	alleles	NNS	O	allele	nsubjpass	6	SENT_90	[p5l1089t2285r1303b2343],
5	are	VBP	O	be	auxpass	6	SENT_90	[p5l1379t2302r1481b2343],
6	associated	VBN	O	associate	rcmod	1	SENT_90	[p5l1558t2285r1914b2343],
7	with	IN	O	with	_	0	SENT_90	[p5l1987t2285r2148b2343],
8	biased	VBN	O	bias	amod	9	SENT_90	[p5l6t2380r228b2438],
9	formation	NN	O	formation	prep_with	6	SENT_90	[p5l252t2380r610b2438],
10	of	IN	O	of	_	0	SENT_90	[p5l634t2380r706b2438],
11	4	CD	NUMBER	4	number	12	SENT_90	[p5l726t2380r1414b2456],
12	—	CD	NUMBER	—	num	13	SENT_90	[p5l726t2380r1414b2456],
13	hydroXyestradiol	NN	O	hydroxyestradiol	prep_of	9	SENT_90	[p5l726t2380r1414b2456],
14	,	,	O	,	_	0	SENT_90	[p5l726t2380r1414b2456],
15	which	WDT	O	which	nsubj	18	SENT_90	[p5l1442t2380r1662b2438],
16	is	VBZ	O	be	cop	18	SENT_90	[p5l1686t2383r1737b2438],
17	potentially	RB	O	potentially	advmod	18	SENT_90	[p5l1761t2380r2151b2456],
18	carcinogenic	JJ	O	carcinogenic	rcmod	13	SENT_90	[p5l9t2465r626b2548],
19	,18	CD	NUMBER	,18	number	20	SENT_90	[p5l9t2465r626b2548],
20	’43	CD	NUMBER	’43	dep	1	SENT_90	[p5l9t2465r626b2548],
21	compared	VBN	O	compare	_	0	SENT_90	[p5l664t2473r1015b2548],
22	to	TO	O	to	prepc_compared_to	20	SENT_90	[p5l1049t2480r1119b2530],
23	formation	NN	O	formation	pobj	20	SENT_90	[p5l1154t2472r1511b2530],
24	of	IN	O	of	_	0	SENT_90	[p5l1547t2472r1618b2530],
25	the	DT	O	the	det	27	SENT_90	[p5l1649t2473r1762b2530],
26	lower	JJR	O	lower	amod	27	SENT_90	[p5l1797t2473r1992b2530],
27	risk	NN	O	risk	prep_of	23	SENT_90	[p5l2026t2472r2151b2530],
28	2-hydroxyestradiol	JJ	O	2-hydroxyestradiol	amod	29	SENT_90	[p5l10t2567r680b2643],
29	metabolite	NN	O	metabolite	dep	27	SENT_90	[p5l715t2559r1181b2625],
30	.	.	O	.	_	0	SENT_90	[p5l715t2559r1181b2625],

1	“	NN	O	“	ccomp	17	SENT_91	[p5l715t2559r1181b2625],
2	Consequently	RB	O	consequently	advmod	1	SENT_91	[p5l1219t2567r1724b2643],
3	,	,	O	,	_	0	SENT_91	[p5l1219t2567r1724b2643],
4	the	DT	O	the	det	5	SENT_91	[p5l1764t2567r1877b2625],
5	role	NN	O	role	nsubj	17	SENT_91	[p5l1912t2567r2045b2625],
6	of	IN	O	of	_	0	SENT_91	[p5l2081t2567r2153b2625],
7	CYP1B1	NN	O	cyp1b1	prep_of	5	SENT_91	[p5l10t2662r284b2718],
8	in	IN	O	in	_	0	SENT_91	[p5l361t2663r432b2717],
9	estrogen	NN	O	estrogen	nn	10	SENT_91	[p5l505t2668r803b2736],
10	metabo1ism17	NN	O	metabo1ism17	prep_in	7	SENT_91	[p5l875t2653r1522b2718],
11	'	''	DATE	'	_	0	SENT_91	[p5l875t2653r1522b2718],
12	19	CD	DATE	19	nn	15	SENT_91	[p5l875t2653r1522b2718],
13	'	''	O	'	_	0	SENT_91	[p5l875t2653r1522b2718],
14	Z	NN	O	z	nn	15	SENT_91	[p5l875t2653r1522b2718],
15	°	NN	O	°	nsubj	17	SENT_91	[p5l875t2653r1522b2718],
16	may	MD	O	may	aux	17	SENT_91	[p5l1594t2677r1747b2736],
17	inﬂuence	VB	O	inﬂuence	_	0	SENT_91	[p5l1817t2660r2147b2718],
18	the	DT	O	the	det	19	SENT_91	[p5l8t2757r121b2814],
19	risk	NN	O	risk	dobj	17	SENT_91	[p5l172t2757r297b2814],
20	of	IN	O	of	_	0	SENT_91	[p5l347t2756r418b2814],
21	invasive	JJ	O	invasive	amod	26	SENT_91	[p5l464t2760r750b2814],
22	or	CC	O	or	_	0	SENT_91	[p5l803t2773r874b2814],
23	paclitaxel	NN	O	paclitaxel	npadvmod	24	SENT_91	[p5l923t2757r1264b2832],
24	resistant	JJ	O	resistant	conj_or	21	SENT_91	[p5l1315t2760r1612b2814],
25	breast	NN	O	breast	nn	26	SENT_91	[p5l1660t2757r1870b2814],
26	cancer	NN	O	cancer	prep_of	19	SENT_91	[p5l1921t2773r2150b2814],
27	in	IN	O	in	_	0	SENT_91	[p5l9t2855r79b2909],
28	patients	NNS	O	patient	prep_in	17	SENT_91	[p5l147t2855r429b2928],
29	carrying	VBG	O	carry	partmod	28	SENT_91	[p5l500t2855r791b2928],
30	the	DT	O	the	det	34	SENT_91	[p5l858t2852r971b2910],
31	CYP1B1	NN	O	cyp1b1	nn	34	SENT_91	[p5l1043t2854r1395b2910],
32	*	NN	O	*	nn	34	SENT_91	[p5l1043t2854r1395b2910],
33	3	CD	NUMBER	3	num	34	SENT_91	[p5l1043t2854r1395b2910],
34	allele	NN	O	allele	dobj	29	SENT_91	[p5l1466t2852r1666b2910],
35	.	.	O	.	_	0	SENT_91	[p5l1466t2852r1666b2910],

1	This	DT	O	this	det	2	SENT_92	[p5l1738t2852r1887b2910],
2	study	NN	O	study	nsubjpass	4	SENT_92	[p5l1959t2852r2151b2928],
3	was	VBD	O	be	auxpass	4	SENT_92	[p5l7t2963r135b3004],
4	performed	VBN	O	perform	_	0	SENT_92	[p5l169t2946r538b3022],
5	in	IN	O	in	_	0	SENT_92	[p5l573t2950r644b3004],
6	a	DT	O	a	det	9	SENT_92	[p5l679t2963r713b3004],
7	small	JJ	O	small	amod	9	SENT_92	[p5l749t2947r934b3004],
8	sample	NN	O	sample	nn	9	SENT_92	[p5l970t2947r1215b3022],
9	size	NN	O	size	prep_in	4	SENT_92	[p5l1252t2950r1375b3004],
10	and	CC	O	and	_	0	SENT_92	[p5l1412t2947r1543b3004],
11	the	DT	O	the	det	12	SENT_92	[p5l1577t2947r1689b3004],
12	data	NNS	O	datum	nsubjpass	15	SENT_92	[p5l1725t2947r1874b3004],
13	should	MD	O	should	aux	15	SENT_92	[p5l1910t2947r2149b3004],
14	be	VB	O	be	auxpass	15	SENT_92	[p5l7t3042r87b3099],
15	considered	VBN	O	consider	conj_and	4	SENT_92	[p5l155t3042r538b3099],
16	preliminary	JJ	O	preliminary	dobj	15	SENT_92	[p5l604t3042r1024b3117],
17	until	IN	O	until	mark	18	SENT_92	[p5l1087t3042r1258b3099],
18	validated	VBN	O	validate	advcl	15	SENT_92	[p5l1324t3042r1651b3099],
19	in	IN	O	in	_	0	SENT_92	[p5l1718t3045r1788b3099],
20	a	DT	O	a	det	24	SENT_92	[p5l1856t3058r1891b3099],
21	large	JJ	O	large	amod	24	SENT_92	[p5l1958t3042r2144b3117],
22	,	,	O	,	_	0	SENT_92	[p5l1958t3042r2144b3117],
23	prospective	JJ	O	prospective	amod	24	SENT_92	[p5l8t3140r411b3213],
24	study	NN	O	study	prep_in	18	SENT_92	[p5l443t3137r645b3213],
25	.	.	O	.	_	0	SENT_92	[p5l443t3137r645b3213],

1	Patients	NNS	O	patient	_	0	SENT_93	[p5l12t3617r325b3674],
2	and	CC	O	and	_	0	SENT_93	[p5l355t3617r496b3674],
3	methods	NNS	O	method	conj_and	1	SENT_93	[p5l530t3617r864b3674],

1	Patients	NNS	O	patient	nn	3	SENT_94	[p6l13t72r265b128],
2	Genomic	JJ	O	genomic	amod	3	SENT_94	[p6l11t168r330b224],
3	DNA	NN	O	dna	nsubjpass	5	SENT_94	[p6l370t168r537b223],
4	was	VBD	O	be	auxpass	5	SENT_94	[p6l573t183r700b224],
5	isolated	VBN	O	isolate	_	0	SENT_94	[p6l740t166r1007b224],
6	from	IN	O	from	_	0	SENT_94	[p6l1047t166r1214b224],
7	the	DT	O	the	det	8	SENT_94	[p6l1254t166r1365b224],
8	plasma	NN	O	plasma	prep_from	5	SENT_94	[p6l1405t166r1650b242],
9	of	IN	O	of	_	0	SENT_94	[p6l1690t166r1762b224],
10	93	CD	NUMBER	93	num	12	SENT_94	[p6l1797t168r1876b224],
11	female	JJ	O	female	amod	12	SENT_94	[p6l1919t166r2148b224],
12	patients	NNS	O	patient	prep_of	8	SENT_94	[p6l9t264r286b337],
13	(	IN	O	(	_	0	SENT_94	[p6l331t261r505b333],
14	89	CD	PERCENT	89	num	15	SENT_94	[p6l331t261r505b333],
15	%	NN	PERCENT	%	prep_(	12	SENT_94	[p6l331t261r505b333],
16	Caucasian	JJ	MISC	caucasian	amod	12	SENT_94	[p6l548t262r918b330],
17	;	:	O	;	_	0	SENT_94	[p6l548t262r918b330],
18	8	CD	PERCENT	8	num	19	SENT_94	[p6l964t262r1072b319],
19	%	NN	PERCENT	%	npadvmod	20	SENT_94	[p6l964t262r1072b319],
20	Asian	JJ	MISC	asian	amod	12	SENT_94	[p6l1112t262r1321b330],
21	;	:	O	;	_	0	SENT_94	[p6l1112t262r1321b330],
22	3	CD	PERCENT	3	num	23	SENT_94	[p6l1367t262r1474b319],
23	%	NN	PERCENT	%	dep	24	SENT_94	[p6l1367t262r1474b319],
24	African	JJ	MISC	african	parataxis	5	SENT_94	[p6l1514t261r2145b331],
25	.	.	O	.	_	0	SENT_94	[p6l1514t261r2145b331],

1	—	NN	O	—	_	0	SENT_95	[p6l1514t261r2145b331],
2	.	.	O	.	_	0	SENT_95	[p6l1514t261r2145b331],

1	American	NNP	MISC	American	_	0	SENT_96	[p6l1514t261r2145b331],
2	,	,	O	,	_	0	SENT_96	[p6l1514t261r2145b331],
3	age	NN	O	age	nn	4	SENT_96	[p6l10t372r122b431],
4	range	NN	O	range	appos	1	SENT_96	[p6l163t372r354b431],
5	30-63	CD	NUMBER	30-63	dep	4	SENT_96	[p6l396t357r620b425],
6	;	:	O	;	_	0	SENT_96	[p6l396t357r620b425],
7	median	NN	O	median	dep	1	SENT_96	[p6l663t355r926b413],
8	48	CD	DURATION	48	num	9	SENT_96	[p6l966t357r1048b413],
9	years	NNS	NUMBER	year	dep	7	SENT_96	[p6l1086t356r1285b431],
10	)	RB	O	)	advmod	9	SENT_96	[p6l1086t356r1285b431],
11	with	IN	O	with	_	0	SENT_96	[p6l1326t355r1487b413],
12	high-risk	JJ	O	high-risk	amod	14	SENT_96	[p6l1526t355r1836b431],
13	primary	JJ	O	primary	amod	14	SENT_96	[p6l1873t358r2153b431],
14	(	NN	O	(	prep_with	9	SENT_96	[p6l13t451r187b522],
15	84	CD	PERCENT	84	num	18	SENT_96	[p6l13t451r187b522],
16	%	NN	PERCENT	%	nn	18	SENT_96	[p6l13t451r187b522],
17	stage	NN	O	stage	nn	18	SENT_96	[p6l214t458r384b526],
18	IIIA	NN	O	iium	dep	27	SENT_96	[p6l411t452r539b507],
19	through	IN	O	through	_	0	SENT_96	[p6l562t450r847b526],
20	111C	NN	O	111c	prep_through	18	SENT_96	[p6l873t451r1027b523],
21	)	CD	NUMBER	)	num	20	SENT_96	[p6l873t451r1027b523],
22	or	CC	O	or	_	0	SENT_96	[p6l1056t467r1127b508],
23	stage	NN	O	stage	prep_through	18	SENT_96	[p6l1152t458r1322b526],
24	IV	CD	NUMBER	iv	num	25	SENT_96	[p6l1348t453r1426b507],
25	(	NN	O	(	dep	27	SENT_96	[p6l1454t451r1652b522],
26	16	CD	PERCENT	16	num	27	SENT_96	[p6l1454t451r1652b522],
27	%	NN	PERCENT	%	dep	9	SENT_96	[p6l1454t451r1652b522],
28	)	CD	NUMBER	)	num	30	SENT_96	[p6l1454t451r1652b522],
29	breast	NN	O	breast	nn	30	SENT_96	[p6l1678t450r1885b508],
30	cancer	NN	O	cancer	dep	27	SENT_96	[p6l1910t467r2145b508],
31	.	.	O	.	_	0	SENT_96	[p6l1910t467r2145b508],

1	74	CD	PERCENT	74	num	2	SENT_97	[p6l15t548r161b603],
2	%	NN	PERCENT	%	nsubjpass	6	SENT_97	[p6l15t548r161b603],
3	of	IN	O	of	_	0	SENT_97	[p6l183t546r255b604],
4	patients	NNS	O	patient	prep_of	2	SENT_97	[p6l271t549r548b622],
5	were	VBD	O	be	auxpass	6	SENT_97	[p6l569t563r730b604],
6	estrogen/progesterone	VBN	O	estrogen/progesterone	_	0	SENT_97	[p6l754t546r1529b622],
7	receptor	NN	O	receptor	nsubj	8	SENT_97	[p6l1551t553r1837b622],
8	positive	JJ	O	positive	xcomp	6	SENT_97	[p6l1857t549r2145b622],
9	.	.	O	.	_	0	SENT_97	[p6l1857t549r2145b622],

1	Patients	NNS	O	patient	nsubj	2	SENT_98	[p6l10t641r283b696],
2	received	VBD	O	receive	_	0	SENT_98	[p6l342t639r627b696],
3	paclitaxel	NN	O	paclitaxel	nn	5	SENT_98	[p6l685t639r1019b714],
4	575	CD	NUMBER	575	num	5	SENT_98	[p6l1080t641r1367b696],
5	—	NN	O	—	dobj	2	SENT_98	[p6l1080t641r1367b696],
6	775	CD	NUMBER	775	num	7	SENT_98	[p6l1080t641r1367b696],
7	mg/m2	NN	O	mg/m2	nsubj	8	SENT_98	[p6l1387t631r1629b714],
8	infused	VBD	O	infuse	rcmod	5	SENT_98	[p6l1687t638r1943b696],
9	over	IN	O	over	_	0	SENT_98	[p6l2001t656r2150b696],
10	24	CD	NUMBER	24	num	11	SENT_98	[p6l10t734r92b790],
11	h	NN	O	h	prep_over	8	SENT_98	[p6l108t733r172b803],
12	,	,	O	,	_	0	SENT_98	[p6l108t733r172b803],
13	doxorubicin	NN	O	doxorubicin	nn	15	SENT_98	[p6l210t733r635b790],
14	165	CD	NUMBER	165	num	15	SENT_98	[p6l674t734r790b790],
15	mg/m2	NN	O	mg/m2	prep_over	8	SENT_98	[p6l809t726r1052b808],
16	as	IN	O	as	_	0	SENT_98	[p6l1085t750r1150b790],
17	a	DT	O	a	det	19	SENT_98	[p6l1183t750r1218b790],
18	continuous	JJ	O	continuous	amod	19	SENT_98	[p6l1251t736r1645b790],
19	infusion	NN	O	infusion	prep_as	15	SENT_98	[p6l1679t732r1968b790],
20	over	IN	O	over	_	0	SENT_98	[p6l2001t750r2150b790],
21	96	CD	NUMBER	96	num	22	SENT_98	[p6l10t831r92b887],
22	h	NN	O	h	prep_over	19	SENT_98	[p6l108t829r172b899],
23	,	,	O	,	_	0	SENT_98	[p6l108t829r172b899],
24	and	CC	O	and	_	0	SENT_98	[p6l228t829r358b887],
25	cyclophosphamide	NN	O	cyclophosphamide	nn	27	SENT_98	[p6l409t829r1068b905],
26	100	CD	NUMBER	100	num	27	SENT_98	[p6l1126t831r1246b887],
27	mg/kg	NN	O	mg/kg	prep_over	8	SENT_98	[p6l1262t829r1500b905],
28	,	,	O	,	_	0	SENT_98	[p6l1262t829r1500b905],
29	as	IN	O	as	_	0	SENT_98	[p6l1555t846r1620b887],
30	consolidation	NN	O	consolidation	nn	31	SENT_98	[p6l1672t829r2150b887],
31	therapy	NN	O	therapy	prep_as	8	SENT_98	[p6l9t924r278b1000],
32	following	VBG	O	follow	partmod	31	SENT_98	[p6l304t924r636b1000],
33	either	CC	O	either	prep	32	SENT_98	[p6l665t924r866b982],
34	adjuvant	JJ	O	adjuvant	amod	38	SENT_98	[p6l894t924r1202b1000],
35	chemotherapy	NN	O	chemotherapy	nn	38	SENT_98	[p6l1231t924r1739b1000],
36	(	NN	O	(	nn	38	SENT_98	[p6l1768t924r1992b1000],
37	stages	NNS	O	stage	nn	38	SENT_98	[p6l1768t924r1992b1000],
38	IIIA	NN	O	iium	dep	33	SENT_98	[p6l2022t925r2151b981],
39	through	IN	O	through	_	0	SENT_98	[p6l9t1019r294b1095],
40	111C	NN	O	111c	prep_through	32	SENT_98	[p6l332t1019r486b1091],
41	)	CD	NUMBER	)	num	40	SENT_98	[p6l332t1019r486b1091],
42	or	CC	O	or	_	0	SENT_98	[p6l527t1036r599b1077],
43	after	IN	O	after	_	0	SENT_98	[p6l635t1019r791b1077],
44	induction	NN	O	induction	nn	45	SENT_98	[p6l827t1019r1171b1077],
45	therapy	NN	O	therapy	prep_after	32	SENT_98	[p6l1208t1019r1477b1095],
46	(	CD	NUMBER	(	num	45	SENT_98	[p6l1515t1019r1709b1095],
47	stage	NN	O	stage	nn	50	SENT_98	[p6l1515t1019r1709b1095],
48	IV	CD	NUMBER	iv	num	50	SENT_98	[p6l1748t1022r1826b1076],
49	disease	NN	O	disease	nn	50	SENT_98	[p6l1863t1019r2145b1091],
50	)	NN	O	)	dep	32	SENT_98	[p6l1863t1019r2145b1091],
51	.	.	O	.	_	0	SENT_98	[p6l1863t1019r2145b1091],

1	Paclitaxel	NN	O	paclitaxel	nn	2	SENT_99	[p6l10t1111r341b1169],
2	clearance	NN	O	clearance	nsubjpass	4	SENT_99	[p6l379t1112r702b1169],
3	was	VBD	O	be	auxpass	4	SENT_99	[p6l738t1128r866b1169],
4	measured	VBN	O	measure	_	0	SENT_99	[p6l904t1112r1237b1169],
5	as	IN	O	as	mark	6	SENT_99	[p6l1275t1128r1340b1169],
6	described	VBN	O	describe	advcl	4	SENT_99	[p6l1379t1111r1705b1169],
7	previously	RB	DATE	previously	advmod	6	SENT_99	[p6l1742t1104r2150b1187],
8	?	.	O	?	_	0	SENT_99	[p6l1742t1104r2150b1187],

1	Median	JJ	O	median	amod	2	SENT_100	[p6l8t1208r274b1266],
2	overall	JJ	O	overall	nsubj	11	SENT_100	[p6l311t1208r544b1266],
3	follow	VB	O	follow	rcmod	2	SENT_100	[p6l583t1208r916b1284],
4	—	CD	NUMBER	—	npadvmod	5	SENT_100	[p6l583t1208r916b1284],
5	up	IN	O	up	advmod	3	SENT_100	[p6l583t1208r916b1284],
6	of	IN	O	of	_	0	SENT_100	[p6l956t1208r1027b1266],
7	alive	JJ	O	alive	amod	8	SENT_100	[p6l1061t1208r1220b1266],
8	patients	NNS	O	patient	prep_of	2	SENT_100	[p6l1257t1211r1534b1284],
9	was	VBD	O	be	cop	11	SENT_100	[p6l1571t1225r1698b1266],
10	55	CD	DURATION	55	num	11	SENT_100	[p6l1738t1210r1816b1266],
11	months	NNS	NUMBER	month	_	0	SENT_100	[p6l1857t1208r2145b1266],
12	.	.	O	.	_	0	SENT_100	[p6l1857t1208r2145b1266],

1	Appropriate	JJ	O	appropriate	amod	3	SENT_101	[p6l8t1304r423b1378],
2	written	VBN	O	write	amod	3	SENT_101	[p6l444t1305r699b1360],
3	consent	NN	O	consent	nsubjpass	13	SENT_101	[p6l722t1310r995b1360],
4	was	VBD	O	be	auxpass	5	SENT_101	[p6l1015t1319r1143b1360],
5	obtained	VBN	O	obtain	rcmod	3	SENT_101	[p6l1166t1302r1473b1360],
6	for	IN	O	for	_	0	SENT_101	[p6l1496t1302r1593b1360],
7	all	DT	O	all	det	8	SENT_101	[p6l1616t1302r1696b1360],
8	patients	NNS	O	patient	prep_for	5	SENT_101	[p6l1719t1305r1996b1378],
9	and	CC	O	and	_	0	SENT_101	[p6l2020t1302r2150b1360],
10	this	DT	O	this	det	11	SENT_101	[p6l9t1397r137b1455],
11	study	NN	O	study	prep_for	5	SENT_101	[p6l168t1397r357b1473],
12	was	VBD	O	be	auxpass	13	SENT_101	[p6l381t1414r507b1455],
13	approved	VBN	O	approve	_	0	SENT_101	[p6l538t1397r861b1473],
14	by	IN	O	by	_	0	SENT_101	[p6l887t1397r975b1473],
15	the	DT	O	the	det	18	SENT_101	[p6l1000t1397r1111b1455],
16	Institutional	JJ	ORGANIZATION	institutional	amod	18	SENT_101	[p6l1141t1397r1576b1455],
17	Review	NNP	ORGANIZATION	Review	nn	18	SENT_101	[p6l1605t1400r1851b1455],
18	Board	NNP	ORGANIZATION	Board	agent	13	SENT_101	[p6l1878t1397r2095b1455],
19	.	.	O	.	_	0	SENT_101	[p6l1878t1397r2095b1455],

1	Genotyping	VBG	O	genotype	_	0	SENT_102	[p6l15t1585r382b1660],
2	Eight	CD	NUMBER	eight	num	3	SENT_102	[p6l10t1678r194b1754],
3	polymorphisms	NNS	O	polymorphism	dobj	1	SENT_102	[p6l239t1678r795b1754],
4	in	IN	O	in	_	0	SENT_102	[p6l842t1681r913b1735],
5	six	CD	NUMBER	six	num	6	SENT_102	[p6l961t1681r1055b1736],
6	genes	NNS	O	gene	prep_in	3	SENT_102	[p6l1099t1695r1294b1754],
7	associated	VBN	O	associate	partmod	6	SENT_102	[p6l1342t1678r1698b1736],
8	with	IN	O	with	_	0	SENT_102	[p6l1742t1678r1903b1736],
9	metabolism	NN	O	metabolism	prep_with	7	SENT_102	[p6l1949t1686r2149b1736, p6l7t1772r247b1830],
10	(	CD	NUMBER	(	num	11	SENT_102	[p6l346t1773r731b1845],
11	CYP2C8	NN	O	cyp2c8	dep	37	SENT_102	[p6l346t1773r731b1845],
12	*	CD	NUMBER	*	number	13	SENT_102	[p6l346t1773r731b1845],
13	3	CD	NUMBER	3	dep	11	SENT_102	[p6l346t1773r731b1845],
14	and	CC	O	and	_	0	SENT_102	[p6l829t1772r960b1830],
15	*	CD	NUMBER	*	number	16	SENT_102	[p6l1056t1775r1147b1842],
16	4	CD	NUMBER	4	dep	11	SENT_102	[p6l1056t1775r1147b1842],
17	;	:	O	;	_	0	SENT_102	[p6l1056t1775r1147b1842],
18	CYP1B1	NN	O	cyp1b1	dep	13	SENT_102	[p6l1248t1774r1620b1842],
19	*	CD	NUMBER	*	number	20	SENT_102	[p6l1248t1774r1620b1842],
20	3	CD	NUMBER	3	dep	18	SENT_102	[p6l1248t1774r1620b1842],
21	;	:	O	;	_	0	SENT_102	[p6l1248t1774r1620b1842],
22	CYP3A4	NN	O	cyp3a4	dep	13	SENT_102	[p6l1721t1774r2146b1842],
23	*	CD	NUMBER	*	num	24	SENT_102	[p6l1721t1774r2146b1842],
24	1B	NN	O	1b	dep	22	SENT_102	[p6l1721t1774r2146b1842],
25	;	:	O	;	_	0	SENT_102	[p6l1721t1774r2146b1842],
26	CYP3A5	NN	O	cyp3a5	nn	29	SENT_102	[p6l11t1869r448b1941],
27	*	CD	NUMBER	*	num	29	SENT_102	[p6l11t1869r448b1941],
28	3C	NN	O	3c	nn	29	SENT_102	[p6l11t1869r448b1941],
29	)	NN	O	)	dep	13	SENT_102	[p6l11t1869r448b1941],
30	and	CC	O	and	_	0	SENT_102	[p6l485t1869r617b1927],
31	transport	NN	O	transport	nn	33	SENT_102	[p6l650t1876r975b1945],
32	(	CD	NUMBER	(	num	33	SENT_102	[p6l1013t1869r1270b1941],
33	ABCB1	NN	O	abcb1	conj_and	29	SENT_102	[p6l1013t1869r1270b1941],
34	2677	CD	DATE	2677	num	35	SENT_102	[p6l1312t1871r1480b1927],
35	G	NN	O	g	dep	37	SENT_102	[p6l1517t1869r1780b1934],
36	>	JJR	O	>	amod	37	SENT_102	[p6l1517t1869r1780b1934],
37	T/A	NN	O	t/a	dep	42	SENT_102	[p6l1517t1869r1780b1934],
38	and	CC	O	and	_	0	SENT_102	[p6l1813t1869r1944b1927],
39	1236	CD	DATE	1236	num	40	SENT_102	[p6l1984t1871r2148b1927],
40	C	NN	O	c	conj_and	37	SENT_102	[p6l11t1965r199b2033],
41	>	JJR	O	>	amod	42	SENT_102	[p6l11t1965r199b2033],
42	T	NN	O	t	dep	9	SENT_102	[p6l11t1965r199b2033],
43	;	:	O	;	_	0	SENT_102	[p6l11t1965r199b2033],
44	ABCG2	NN	O	abcg2	nsubj	58	SENT_102	[p6l234t1965r490b2021],
45	421	CD	NUMBER	421	num	46	SENT_102	[p6l526t1965r648b2021],
46	C	NN	O	c	npadvmod	47	SENT_102	[p6l690t1964r894b2036],
47	>	JJR	O	>	dep	53	SENT_102	[p6l690t1964r894b2036],
48	A	DT	O	a	det	49	SENT_102	[p6l690t1964r894b2036],
49	)	NN	O	)	nsubj	53	SENT_102	[p6l690t1964r894b2036],
50	of	IN	O	of	_	0	SENT_102	[p6l934t1963r1006b2021],
51	paclitaxel	NN	O	paclitaxel	prep_of	49	SENT_102	[p6l1037t1964r1378b2039],
52	were	VBD	O	be	aux	53	SENT_102	[p6l1412t1980r1575b2021],
53	analyzed	VBN	O	analyze	parataxis	7	SENT_102	[p6l1613t1964r1924b2039],
54	using	VBG	O	use	xcomp	53	SENT_102	[p6l1958t1967r2151b2039],
55	Pyrosequencing	VBG	O	pyrosequence	xcomp	54	SENT_102	[p6l10t2062r572b2136],
56	technology	NN	O	technology	dobj	55	SENT_102	[p6l612t2060r1015b2136],
57	as	IN	O	as	_	0	SENT_102	[p6l1055t2077r1120b2118],
58	described	VBN	O	describe	parataxis	7	SENT_102	[p6l1163t2060r1494b2118],
59	previously	RB	DATE	previously	advmod	58	SENT_102	[p6l1535t2060r1904b2136],
60	(	CD	NUMBER	(	num	62	SENT_102	[p6l1947t2060r2152b2136],
61	assay	NN	O	assay	nn	62	SENT_102	[p6l1947t2060r2152b2136],
62	information	NN	O	information	dobj	58	SENT_102	[p6l9t2153r441b2211],
63	available	JJ	O	available	amod	62	SENT_102	[p6l471t2153r779b2211],
64	on	IN	O	on	_	0	SENT_102	[p6l811t2170r902b2211],
65	request	NN	O	request	prep_on	58	SENT_102	[p6l931t2146r1466b2229],
66	)	CD	NUMBER	)	number	67	SENT_102	[p6l931t2146r1466b2229],
67	.28	CD	NUMBER	.28	num	65	SENT_102	[p6l931t2146r1466b2229],
68	'	''	DATE	'	_	0	SENT_102	[p6l931t2146r1466b2229],
69	33	CD	DATE	33	num	70	SENT_102	[p6l931t2146r1466b2229],
70	'44	CD	DATE	'44	dobj	53	SENT_102	[p6l931t2146r1466b2229],

1	Statistics	NNPS	O	Statistics	nn	2	SENT_103	[p6l12t2341r291b2397],
2	Associations	NNS	O	association	nsubjpass	9	SENT_103	[p6l8t2437r445b2493],
3	between	IN	O	between	_	0	SENT_103	[p6l500t2435r797b2493],
4	genotype	NN	O	genotype	nn	7	SENT_103	[p6l853t2442r1179b2511],
5	and	CC	O	and	_	0	SENT_103	[p6l1237t2435r1368b2493],
6	paclitaxel	NN	O	paclitaxel	conj_and	4	SENT_103	[p6l1423t2435r1764b2511],
7	clearance	NN	O	clearance	prep_between	2	SENT_103	[p6l1821t2435r2148b2493],
8	were	VBD	O	be	auxpass	9	SENT_103	[p6l8t2547r171b2588],
9	performed	VBN	O	perform	_	0	SENT_103	[p6l225t2530r595b2606],
10	using	VBG	O	use	xcomp	9	SENT_103	[p6l647t2533r839b2606],
11	Kruskal	NNP	PERSON	Kruskal	dobj	10	SENT_103	[p6l893t2530r1407b2588],
12	.	.	O	.	_	0	SENT_103	[p6l893t2530r1407b2588],

1	—	NN	O	—	_	0	SENT_104	[p6l893t2530r1407b2588],
2	.	.	O	.	_	0	SENT_104	[p6l893t2530r1407b2588],

1	Wallis	NNP	PERSON	Wallis	_	0	SENT_105	[p6l893t2530r1407b2588],
2	and	CC	O	and	_	0	SENT_105	[p6l1462t2530r1593b2588],
3	ANOVA	NNP	O	ANOVA	conj_and	1	SENT_105	[p6l1646t2532r1920b2588],
4	tests	NNS	O	test	dep	1	SENT_105	[p6l1973t2537r2145b2588],
5	.	.	O	.	_	0	SENT_105	[p6l1973t2537r2145b2588],

1	Genotype	NN	O	genotype	nsubjpass	6	SENT_106	[p6l11t2627r695b2701],
2	—	CD	NUMBER	—	num	4	SENT_106	[p6l11t2627r695b2701],
3	outcome	NN	O	outcome	nn	4	SENT_106	[p6l11t2627r695b2701],
4	associations	NNS	O	association	dep	1	SENT_106	[p6l745t2629r1166b2683],
5	were	VBD	O	be	auxpass	6	SENT_106	[p6l1214t2643r1377b2683],
6	performed	VBN	O	perform	_	0	SENT_106	[p6l1426t2625r1796b2701],
7	using	VBG	O	use	xcomp	6	SENT_106	[p6l1842t2629r2035b2701],
8	X2	NN	O	x2	dobj	7	SENT_106	[p6l2082t2619r2150b2698],
9	and	CC	O	and	_	0	SENT_106	[p6l10t2722r141b2780],
10	Kaplan	NNP	PERSON	Kaplan	dobj	7	SENT_106	[p6l171t2722r659b2798],
11	.	.	O	.	_	0	SENT_106	[p6l171t2722r659b2798],

1	—	NN	O	—	_	0	SENT_107	[p6l171t2722r659b2798],
2	.	.	O	.	_	0	SENT_107	[p6l171t2722r659b2798],

1	Meier	JJR	PERSON	meier	_	0	SENT_108	[p6l171t2722r659b2798],
2	analysis	NN	O	analysis	dep	1	SENT_108	[p6l688t2722r982b2798],
3	.	.	O	.	_	0	SENT_108	[p6l688t2722r982b2798],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_109	[p6l8t2911r729b2987],

1	We	PRP	O	we	nsubj	2	SENT_110	[p6l8t3098r105b3148],
2	thank	VBP	O	thank	_	0	SENT_110	[p6l140t3096r325b3147],
3	A	DT	O	a	det	4	SENT_110	[p6l355t3097r400b3147],
4	Garsa	NN	O	garsa	dobj	2	SENT_110	[p6l434t3097r607b3147],
5	for	IN	O	for	_	0	SENT_110	[p6l640t3096r727b3147],
6	technical	JJ	O	technical	amod	7	SENT_110	[p6l760t3096r1049b3148],
7	assistance	NN	O	assistance	prep_for	4	SENT_110	[p6l1083t3099r1388b3148],
8	with	IN	O	with	_	0	SENT_110	[p6l1421t3096r1565b3147],
9	this	DT	O	this	det	10	SENT_110	[p6l1598t3096r1713b3147],
10	project	NN	O	project	prep_with	2	SENT_110	[p6l1746t3099r1981b3164],
11	.	.	O	.	_	0	SENT_110	[p6l1746t3099r1981b3164],

1	This	DT	O	this	det	2	SENT_111	[p6l2016t3096r2149b3147],
2	work	NN	O	work	nsubjpass	4	SENT_111	[p6l8t3181r165b3232],
3	was	VBD	O	be	auxpass	4	SENT_111	[p6l204t3196r317b3232],
4	supported	VBN	O	support	_	0	SENT_111	[p6l361t3181r675b3249],
5	by	IN	O	by	_	0	SENT_111	[p6l714t3181r792b3249],
6	CA	NNP	O	CA	agent	4	SENT_111	[p6l833t3182r927b3232],
7	33572	CD	NUMBER	33572	num	6	SENT_111	[p6l969t3182r1174b3244],
8	,	,	O	,	_	0	SENT_111	[p6l969t3182r1174b3244],
9	CA	NNP	O	CA	dep	13	SENT_111	[p6l1222t3182r1315b3232],
10	62505	CD	NUMBER	62505	num	9	SENT_111	[p6l1358t3182r1544b3232],
11	(	CD	NUMBER	(	num	13	SENT_111	[p6l1592t3181r1846b3245],
12	Duarte	NNP	PERSON	Duarte	nn	13	SENT_111	[p6l1592t3181r1846b3245],
13	)	NN	O	)	conj_and	4	SENT_111	[p6l1592t3181r1846b3245],
14	and	CC	O	and	_	0	SENT_111	[p6l1891t3181r2008b3232],
15	the	DT	O	the	det	20	SENT_111	[p6l2049t3181r2149b3233],
16	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	nn	20	SENT_111	[p6l10t3266r579b3334],
17	Research	NNP	ORGANIZATION	Research	nn	20	SENT_111	[p6l605t3266r878b3318],
18	Network	NNP	ORGANIZATION	Network	nn	20	SENT_111	[p6l903t3266r1174b3318],
19	U01	NN	O	u01	nn	20	SENT_111	[p6l1198t3268r1321b3318],
20	GM63340	NN	O	gm63340	dep	24	SENT_111	[p6l1352t3268r1661b3318],
21	(	CD	NUMBER	(	num	24	SENT_111	[p6l1690t3266r1768b3330],
22	St	NNP	LOCATION	St	nn	24	SENT_111	[p6l1690t3266r1768b3330],
23	Louis	NNP	LOCATION	Louis	nn	24	SENT_111	[p6l1794t3266r2000b3330],
24	)	NN	O	)	conj_and	4	SENT_111	[p6l1794t3266r2000b3330],
25	.	.	O	.	_	0	SENT_111	[p6l1794t3266r2000b3330],

1	Duality	NN	O	duality	_	0	SENT_112	[p6l12t3480r287b3556],
2	of	IN	O	of	_	0	SENT_112	[p6l315t3480r396b3538],
3	interest	NN	O	interest	prep_of	1	SENT_112	[p6l424t3480r722b3538],

1	None	NN	O	none	nsubj	2	SENT_113	[p6l13t3661r192b3716],
2	declared	VBD	O	declare	_	0	SENT_113	[p6l223t3659r525b3716],
3	.	.	O	.	_	0	SENT_113	[p6l223t3659r525b3716],

1	References	NNS	O	reference	_	0	SENT_114	[p7l12t80r425b137],

1	U	NNP	O	U	nn	2	SENT_115	[p7l45t942r72b989],
2	)	NNP	O	)	_	0	SENT_115	[p7l45t942r72b989],

1	Crown	NNP	O	Crown	nn	2	SENT_116	[p7l142t259r325b306],
2	J	NNP	O	J	_	0	SENT_116	[p7l348t260r377b318],
3	,	,	O	,	_	0	SENT_116	[p7l348t260r377b318],
4	O’Leary	NNP	O	O’Leary	nn	5	SENT_116	[p7l404t258r618b322],
5	M	NNP	O	M	appos	2	SENT_116	[p7l642t260r709b317],
6	,	,	O	,	_	0	SENT_116	[p7l642t260r709b317],
7	Ooi	NNP	O	Ooi	nn	8	SENT_116	[p7l735t259r831b306],
8	WS	NNP	O	WS	appos	5	SENT_116	[p7l853t259r959b306],
9	.	.	O	.	_	0	SENT_116	[p7l853t259r959b306],

1	Docetaxel	NNP	O	Docetaxel	_	0	SENT_117	[p7l988t258r1260b306],
2	and	CC	O	and	_	0	SENT_117	[p7l1284t258r1385b306],
3	paclitaxel	NN	O	paclitaxel	conj_and	1	SENT_117	[p7l1412t258r1669b322],
4	in	IN	O	in	_	0	SENT_117	[p7l1695t259r1740b306],
5	the	DT	O	the	det	6	SENT_117	[p7l1763t258r1851b306],
6	treatment	NN	O	treatment	prep_in	3	SENT_117	[p7l1873t263r2151b306],
7	of	IN	O	of	_	0	SENT_117	[p7l142t334r196b383],
8	breast	NN	O	breast	nn	9	SENT_117	[p7l228t334r395b383],
9	cancer	NN	O	cancer	prep_of	6	SENT_117	[p7l426t348r622b383],
10	:	:	O	:	_	0	SENT_117	[p7l426t348r622b383],
11	a	DT	O	a	det	12	SENT_117	[p7l658t348r684b383],
12	review	NN	O	review	dep	1	SENT_117	[p7l721t335r900b383],
13	of	IN	O	of	_	0	SENT_117	[p7l931t334r985b383],
14	clinical	JJ	O	clinical	amod	15	SENT_117	[p7l1015t334r1200b383],
15	experience	NN	O	experience	prep_of	12	SENT_117	[p7l1235t335r1554b398],
16	.	.	O	.	_	0	SENT_117	[p7l1235t335r1554b398],

1	Oncologist	NN	O	oncologist	_	0	SENT_118	[p7l1593t334r1875b398],
2	2004	CD	DATE	2004	num	1	SENT_118	[p7l1905t335r2062b393],
3	;	:	O	;	_	0	SENT_118	[p7l1905t335r2062b393],
4	9	CD	NUMBER	9	num	6	SENT_118	[p7l2097t335r2146b383],
5	:	:	O	:	_	0	SENT_118	[p7l2097t335r2146b383],
6	24-32	CD	NUMBER	24-32	dep	1	SENT_118	[p7l142t411r332b457],
7	.	.	O	.	_	0	SENT_118	[p7l142t411r332b457],

1	Somlo	NNP	O	Somlo	nn	2	SENT_119	[p7l143t486r317b535],
2	G	NNP	O	G	_	0	SENT_119	[p7l349t488r406b545],
3	,	,	O	,	_	0	SENT_119	[p7l349t488r406b545],
4	Doroshow	NNP	PERSON	Doroshow	nn	5	SENT_119	[p7l444t486r729b535],
5	JH	NNP	O	JH	appos	2	SENT_119	[p7l758t488r833b546],
6	,	,	O	,	_	0	SENT_119	[p7l758t488r833b546],
7	Synold	JJ	ORGANIZATION	synold	amod	8	SENT_119	[p7l869t486r1054b550],
8	T	NN	ORGANIZATION	t	appos	2	SENT_119	[p7l1085t488r1133b545],
9	,	,	O	,	_	0	SENT_119	[p7l1085t488r1133b545],
10	Longmate	NNP	PERSON	Longmate	nn	11	SENT_119	[p7l1171t488r1450b550],
11	J	NNP	PERSON	J	appos	2	SENT_119	[p7l1481t488r1510b546],
12	,	,	O	,	_	0	SENT_119	[p7l1481t488r1510b546],
13	Reardon	NNP	PERSON	Reardon	nn	14	SENT_119	[p7l1548t486r1772b535],
14	D	NNP	O	D	appos	2	SENT_119	[p7l1809t488r1864b545],
15	,	,	O	,	_	0	SENT_119	[p7l1809t488r1864b545],
16	Chow	NNP	O	Chow	nn	17	SENT_119	[p7l1900t486r2065b535],
17	W	NNP	O	W	appos	2	SENT_119	[p7l2092t488r2152b534],
18	et	FW	O	et	nn	19	SENT_119	[p7l143t567r192b610],
19	al.	FW	O	al.	dep	17	SENT_119	[p7l212t562r270b610],
20	.	.	O	.	_	0	SENT_119	[p7l212t562r270b610],

1	High-dose	JJ	O	high-dose	amod	2	SENT_120	[p7l299t562r579b625],
2	paclitaxel	NN	O	paclitaxel	_	0	SENT_120	[p7l604t562r861b626],
3	in	IN	O	in	_	0	SENT_120	[p7l888t563r932b610],
4	combination	NN	O	combination	prep_in	2	SENT_120	[p7l957t562r1308b610],
5	with	IN	O	with	_	0	SENT_120	[p7l1331t562r1450b610],
6	doxorubicin	NN	O	doxorubicin	prep_with	4	SENT_120	[p7l1475t562r1824b621],
7	,	,	O	,	_	0	SENT_120	[p7l1475t562r1824b621],
8	cyc	NN	O	cyc	nn	10	SENT_120	[p7l1851t562r2149b626, p7l144t638r387b701],
9	|	NN	O	|	nn	10	SENT_120	[p7l1851t562r2149b626, p7l144t638r387b701],
10	ophosphamide	NN	O	ophosphamide	prep_with	4	SENT_120	[p7l1851t562r2149b626, p7l144t638r387b701],
11	and	CC	O	and	_	0	SENT_120	[p7l418t638r518b686],
12	peripheral	JJ	O	peripheral	amod	16	SENT_120	[p7l553t638r828b701],
13	blood	NN	O	blood	nn	16	SENT_120	[p7l863t638r1019b686],
14	progenitor	NN	O	progenitor	nn	16	SENT_120	[p7l1053t639r1349b701],
15	cell	NN	O	cell	nn	16	SENT_120	[p7l1377t638r1464b686],
16	rescue	NN	O	rescue	conj_and	6	SENT_120	[p7l1499t652r1671b686],
17	in	IN	O	in	_	0	SENT_120	[p7l1703t639r1747b686],
18	patients	NNS	O	patient	prep_in	16	SENT_120	[p7l1782t639r1999b701],
19	with	IN	O	with	_	0	SENT_120	[p7l2027t638r2147b686],
20	high	JJ	O	high	amod	22	SENT_120	[p7l144t714r381b778],
21	—	NN	O	—	nn	22	SENT_120	[p7l144t714r381b778],
22	risk	NN	O	risk	prep_with	18	SENT_120	[p7l144t714r381b778],
23	primary	JJ	O	primary	amod	2	SENT_120	[p7l406t715r619b778],
24	and	CC	O	and	_	0	SENT_120	[p7l643t714r744b763],
25	responding	VBG	O	respond	conj_and	23	SENT_120	[p7l773t714r1083b778],
26	metastatic	JJ	O	metastatic	amod	28	SENT_120	[p7l1113t715r1398b763],
27	breast	NN	O	breast	nn	28	SENT_120	[p7l1424t714r1591b763],
28	carcinoma	NN	O	carcinoma	dobj	25	SENT_120	[p7l1614t715r1918b763],
29	:	:	O	:	_	0	SENT_120	[p7l1614t715r1918b763],
30	toxicity	NN	O	toxicity	nn	31	SENT_120	[p7l1946t715r2150b778],
31	profile	NN	O	profile	dep	2	SENT_120	[p7l144t790r331b854],
32	,	,	O	,	_	0	SENT_120	[p7l144t790r331b854],
33	relationship	NN	O	relationship	conj_and	31	SENT_120	[p7l385t790r707b854],
34	to	TO	O	to	_	0	SENT_120	[p7l754t796r809b839],
35	paclitaxel	NN	O	paclitaxel	nn	36	SENT_120	[p7l859t790r1116b854],
36	pharmacokinetics	NNS	O	pharmacokinetic	prep_to	33	SENT_120	[p7l1169t790r1657b854],
37	and	CC	O	and	_	0	SENT_120	[p7l1705t790r1806b839],
38	short	JJ	O	short	amod	41	SENT_120	[p7l1855t790r2146b839],
39	—	NN	O	—	nn	41	SENT_120	[p7l1855t790r2146b839],
40	term	NN	O	term	nn	41	SENT_120	[p7l1855t790r2146b839],
41	outcome	NN	O	outcome	dep	2	SENT_120	[p7l142t871r405b913],
42	.	.	O	.	_	0	SENT_120	[p7l142t871r405b913],

1	Br	NN	O	br	_	0	SENT_121	[p7l436t867r526b924],
2	]	CD	NUMBER	]	num	1	SENT_121	[p7l436t867r526b924],
3	Cancer	NN	O	cancer	dep	1	SENT_121	[p7l552t867r738b913],
4	2001	CD	DATE	2001	num	3	SENT_121	[p7l757t866r914b923],
5	;	:	O	;	_	0	SENT_121	[p7l757t866r914b923],
6	84	CD	NUMBER	84	num	8	SENT_121	[p7l942t866r1028b913],
7	:	:	O	:	_	0	SENT_121	[p7l942t866r1028b913],
8	1591-1598	CD	DATE	1591-1598	dep	1	SENT_121	[p7l1059t866r1392b913],
9	.	.	O	.	_	0	SENT_121	[p7l1059t866r1392b913],

1	Marsh	NNP	PERSON	Marsh	nn	3	SENT_122	[p7l144t941r310b989],
2	S.	NNP	PERSON	S.	nn	3	SENT_122	[p7l340t942r382b989],
3	Taxane	NNP	PERSON	Taxane	_	0	SENT_122	[p7l409t943r609b989],
4	pharmacogenetics	NNS	O	pharmacogenetic	dep	3	SENT_122	[p7l637t941r1163b1004],
5	.	.	O	.	_	0	SENT_122	[p7l637t941r1163b1004],

1	Personalized	VBN	O	personalize	_	0	SENT_123	[p7l1196t941r1529b989],
2	Med	JJ	O	med	amod	3	SENT_123	[p7l1552t941r1671b989],
3	2006	CD	DATE	2006	dobj	1	SENT_123	[p7l1691t942r1848b999],
4	;	:	O	;	_	0	SENT_123	[p7l1691t942r1848b999],
5	3	CD	NUMBER	3	num	7	SENT_123	[p7l1878t942r1925b989],
6	:	:	O	:	_	0	SENT_123	[p7l1878t942r1925b989],
7	33-43	CD	NUMBER	33-43	dep	3	SENT_123	[p7l1957t942r2143b989],
8	.	.	O	.	_	0	SENT_123	[p7l1957t942r2143b989],

1	Bahadur	NNP	PERSON	Bahadur	nn	2	SENT_124	[p7l144t1017r375b1066],
2	N	NNP	PERSON	N	_	0	SENT_124	[p7l397t1019r455b1076],
3	,	,	O	,	_	0	SENT_124	[p7l397t1019r455b1076],
4	Leathart	NNP	O	Leathart	nn	5	SENT_124	[p7l484t1017r709b1066],
5	JB	NNP	O	JB	appos	2	SENT_124	[p7l728t1019r794b1077],
6	,	,	O	,	_	0	SENT_124	[p7l728t1019r794b1077],
7	Mutch	NNP	PERSON	Mutch	nn	8	SENT_124	[p7l823t1017r999b1066],
8	E	NNP	O	E	appos	2	SENT_124	[p7l1027t1019r1067b1076],
9	,	,	O	,	_	0	SENT_124	[p7l1027t1019r1067b1076],
10	Steime	NNP	O	Steime	nn	11	SENT_124	[p7l1095t1017r1492b1081],
11	|	NNP	O	|	appos	2	SENT_124	[p7l1095t1017r1492b1081],
12	.	.	O	.	_	0	SENT_124	[p7l1095t1017r1492b1081],

1	—	NN	O	—	_	0	SENT_125	[p7l1095t1017r1492b1081],
2	.	.	O	.	_	0	SENT_125	[p7l1095t1017r1492b1081],

1	Crespi	NNP	ORGANIZATION	Crespi	nn	2	SENT_126	[p7l1095t1017r1492b1081],
2	D	NNP	ORGANIZATION	D	_	0	SENT_126	[p7l1520t1019r1576b1076],
3	,	,	O	,	_	0	SENT_126	[p7l1520t1019r1576b1076],
4	Dunn	NNP	ORGANIZATION	Dunn	nn	5	SENT_126	[p7l1604t1019r1754b1066],
5	SA	NNP	ORGANIZATION	SA	appos	2	SENT_126	[p7l1779t1019r1861b1076],
6	,	,	O	,	_	0	SENT_126	[p7l1779t1019r1861b1076],
7	Gilissen	NNP	O	Gilissen	nn	8	SENT_126	[p7l1888t1017r2094b1066],
8	R	NNP	O	R	appos	2	SENT_126	[p7l2121t1019r2151b1066],
9	et	FW	O	et	nn	10	SENT_126	[p7l143t1098r192b1141],
10	al.	FW	O	al.	dep	8	SENT_126	[p7l214t1093r272b1141],
11	.	.	O	.	_	0	SENT_126	[p7l214t1093r272b1141],

1	CYP2C8	NN	O	cyp2c8	nn	2	SENT_127	[p7l300t1094r524b1141],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_127	[p7l552t1093r980b1157],
3	in	IN	O	in	_	0	SENT_127	[p7l1005t1094r1050b1141],
4	Caucasians	NNPS	MISC	Caucasians	prep_in	2	SENT_127	[p7l1077t1094r1381b1141],
5	and	CC	O	and	_	0	SENT_127	[p7l1405t1093r1506b1141],
6	their	PRP$	O	they	poss	7	SENT_127	[p7l1531t1093r1659b1141],
7	relationship	NN	O	relationship	prep_in	2	SENT_127	[p7l1683t1093r2004b1157],
8	with	IN	O	with	_	0	SENT_127	[p7l2027t1093r2147b1141],
9	paclitaxel	NN	O	paclitaxel	nn	11	SENT_127	[p7l144t1169r401b1232],
10	6alpha-hydroxylase	JJ	O	6alpha-hydroxylase	amod	11	SENT_127	[p7l455t1169r996b1232],
11	activity	NN	O	activity	prep_with	2	SENT_127	[p7l1047t1170r1244b1232],
12	in	IN	O	in	_	0	SENT_127	[p7l1294t1170r1338b1217],
13	human	JJ	O	human	amod	15	SENT_127	[p7l1392t1169r1583b1217],
14	liver	NN	O	liver	nn	15	SENT_127	[p7l1638t1169r1750b1217],
15	microsomes	NNS	O	microsome	prep_in	11	SENT_127	[p7l1800t1170r2145b1217],
16	.	.	O	.	_	0	SENT_127	[p7l1800t1170r2145b1217],

1	Biochem	NNP	O	Biochem	nn	2	SENT_128	[p7l144t1244r365b1292],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_128	[p7l391t1244r677b1292],
3	2002	CD	DATE	2002	num	2	SENT_128	[p7l697t1246r854b1302],
4	;	:	O	;	_	0	SENT_128	[p7l697t1246r854b1302],
5	64	CD	NUMBER	64	num	7	SENT_128	[p7l882t1246r967b1292],
6	:	:	O	:	_	0	SENT_128	[p7l882t1246r967b1292],
7	1579-1589	CD	DATE	1579-1589	dep	2	SENT_128	[p7l999t1246r1331b1292],
8	.	.	O	.	_	0	SENT_128	[p7l999t1246r1331b1292],

1	Taniguchi	NNP	PERSON	Taniguchi	nn	2	SENT_129	[p7l139t1320r413b1384],
2	R	NNP	PERSON	R	_	0	SENT_129	[p7l444t1322r488b1379],
3	,	,	O	,	_	0	SENT_129	[p7l444t1322r488b1379],
4	Kumai	NNP	PERSON	Kumai	nn	5	SENT_129	[p7l520t1321r690b1369],
5	T	NN	O	t	appos	2	SENT_129	[p7l716t1322r764b1379],
6	,	,	O	,	_	0	SENT_129	[p7l716t1322r764b1379],
7	Matsumoto	NNP	ORGANIZATION	Matsumoto	nn	8	SENT_129	[p7l796t1322r1115b1369],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_129	[p7l1145t1322r1203b1379],
9	,	,	O	,	_	0	SENT_129	[p7l1145t1322r1203b1379],
10	Watanabe	NNP	PERSON	Watanabe	nn	11	SENT_129	[p7l1229t1320r1512b1369],
11	M	NNP	O	M	appos	2	SENT_129	[p7l1541t1322r1609b1379],
12	,	,	O	,	_	0	SENT_129	[p7l1541t1322r1609b1379],
13	Kamio	NNP	LOCATION	Kamio	nn	14	SENT_129	[p7l1641t1321r1813b1369],
14	K	NNP	LOCATION	K	appos	2	SENT_129	[p7l1842t1322r1888b1379],
15	,	,	O	,	_	0	SENT_129	[p7l1842t1322r1888b1379],
16	Suzuki	NNP	PERSON	Suzuki	nn	17	SENT_129	[p7l1919t1320r2092b1369],
17	S	NNP	O	S	appos	2	SENT_129	[p7l2122t1322r2148b1369],
18	et	FW	O	et	nn	19	SENT_129	[p7l143t1402r192b1445],
19	al.	FW	O	al.	dep	17	SENT_129	[p7l235t1396r292b1445],
20	.	.	O	.	_	0	SENT_129	[p7l235t1396r292b1445],

1	Utilization	NN	O	utilization	_	0	SENT_130	[p7l343t1396r618b1445],
2	of	IN	O	of	_	0	SENT_130	[p7l665t1396r718b1445],
3	human	JJ	O	human	amod	5	SENT_130	[p7l762t1396r954b1445],
4	liver	NN	O	liver	nn	5	SENT_130	[p7l1003t1396r1116b1445],
5	microsomes	NNS	O	microsome	prep_of	1	SENT_130	[p7l1161t1397r1491b1445],
6	to	TO	O	to	aux	7	SENT_130	[p7l1535t1402r1590b1445],
7	explain	VB	O	explain	infmod	1	SENT_130	[p7l1635t1396r1832b1460],
8	individual	JJ	O	individual	amod	9	SENT_130	[p7l1881t1396r2146b1445],
9	differences	NNS	O	difference	dobj	7	SENT_130	[p7l142t1472r441b1520],
10	in	IN	O	in	_	0	SENT_130	[p7l505t1473r549b1520],
11	paclitaxel	NN	O	paclitaxel	nn	12	SENT_130	[p7l616t1472r873b1535],
12	metabolism	NN	O	metabolism	prep_in	9	SENT_130	[p7l940t1472r1262b1520],
13	by	IN	O	by	_	0	SENT_130	[p7l1329t1472r1394b1535],
14	CYP2C8	NN	O	cyp2c8	prep_by	7	SENT_130	[p7l1456t1473r1680b1520],
15	and	CC	O	and	_	0	SENT_130	[p7l1744t1472r1845b1520],
16	CYP3A4	NN	O	cyp3a4	prep_by	7	SENT_130	[p7l1910t1473r2146b1520],
17	.	.	O	.	_	0	SENT_130	[p7l1910t1473r2146b1520],

1	/	:	O	/	punct	3	SENT_131	[p7l137t1549r158b1606],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_131	[p7l183t1547r468b1595],
3	Sci	NNP	O	Sci	_	0	SENT_131	[p7l490t1548r563b1595],
4	2005	CD	DATE	2005	dep	3	SENT_131	[p7l584t1549r741b1605],
5	;	:	O	;	_	0	SENT_131	[p7l584t1549r741b1605],
6	97	CD	NUMBER	97	dep	3	SENT_131	[p7l769t1549r855b1595],
7	:	:	O	:	_	0	SENT_131	[p7l769t1549r855b1595],
8	83-90	CD	NUMBER	83-90	dep	6	SENT_131	[p7l884t1549r1072b1595],
9	.	.	O	.	_	0	SENT_131	[p7l884t1549r1072b1595],

1	Soyama	NN	MISC	soyama	nn	2	SENT_132	[p7l139t1624r355b1686],
2	A	NN	MISC	a	_	0	SENT_132	[p7l374t1625r427b1681],
3	,	,	O	,	_	0	SENT_132	[p7l374t1625r427b1681],
4	Saito	NNP	PERSON	Saito	nn	5	SENT_132	[p7l452t1624r585b1671],
5	Y	NN	PERSON	y	appos	2	SENT_132	[p7l602t1624r650b1681],
6	,	,	O	,	_	0	SENT_132	[p7l602t1624r650b1681],
7	Hanioka	FW	ORGANIZATION	hanioka	appos	2	SENT_132	[p7l676t1622r897b1671],
8	N	NN	ORGANIZATION	n	dep	7	SENT_132	[p7l921t1625r979b1681],
9	,	,	O	,	_	0	SENT_132	[p7l921t1625r979b1681],
10	Murayama	NN	PERSON	murayama	nn	11	SENT_132	[p7l1005t1625r1299b1686],
11	N	NN	O	n	appos	2	SENT_132	[p7l1324t1625r1381b1681],
12	,	,	O	,	_	0	SENT_132	[p7l1324t1625r1381b1681],
13	Nakajima	NNP	PERSON	Nakajima	nn	14	SENT_132	[p7l1408t1622r1663b1686],
14	O	NNP	PERSON	O	appos	2	SENT_132	[p7l1685t1624r1746b1681],
15	,	,	O	,	_	0	SENT_132	[p7l1685t1624r1746b1681],
16	Katori	NNP	PERSON	Katori	nn	17	SENT_132	[p7l1772t1624r1929b1671],
17	N	NNP	O	N	appos	2	SENT_132	[p7l1953t1625r1993b1670],
18	et	FW	O	et	nn	19	SENT_132	[p7l2019t1628r2067b1671],
19	al.	FW	O	al.	dep	17	SENT_132	[p7l2084t1622r2142b1671],
20	.	.	O	.	_	0	SENT_132	[p7l2084t1622r2142b1671],

1	Non-synonymous	JJ	O	non-synonymous	amod	4	SENT_133	[p7l141t1701r633b1763],
2	single	JJ	O	single	amod	4	SENT_133	[p7l669t1699r827b1763],
3	nucleotide	NN	O	nucleotide	nn	4	SENT_133	[p7l866t1699r1156b1748],
4	alterations	NNS	O	alteration	nsubj	12	SENT_133	[p7l1192t1699r1478b1748],
5	found	VBN	O	find	partmod	4	SENT_133	[p7l1511t1699r1674b1748],
6	in	IN	O	in	_	0	SENT_133	[p7l1714t1700r1759b1747],
7	the	DT	O	the	det	10	SENT_133	[p7l1795t1699r1883b1748],
8	CYP2C8	NN	O	cyp2c8	nn	10	SENT_133	[p7l1920t1700r2144b1748],
9	gene	NN	O	gene	nn	10	SENT_133	[p7l138t1789r274b1838],
10	result	NN	O	result	prep_in	5	SENT_133	[p7l309t1775r457b1823],
11	in	IN	O	in	prep	5	SENT_133	[p7l489t1776r534b1823],
12	reduced	VBN	O	reduce	_	0	SENT_133	[p7l570t1775r792b1823],
13	in	FW	O	in	nn	14	SENT_133	[p7l828t1776r874b1823],
14	vitro	FW	O	vitro	advmod	12	SENT_133	[p7l908t1776r1022b1823],
15	paclitaxel	NN	O	paclitaxel	nn	16	SENT_133	[p7l1054t1775r1311b1838],
16	metabolism	NN	O	metabolism	dobj	12	SENT_133	[p7l1348t1775r1688b1823],
17	.	.	O	.	_	0	SENT_133	[p7l1348t1775r1688b1823],

1	Biol	NNP	O	Biol	nn	3	SENT_134	[p7l1726t1775r1820b1823],
2	Pharm	NNP	O	Pharm	nn	3	SENT_134	[p7l1850t1775r2022b1823],
3	Bull	NNP	O	Bull	_	0	SENT_134	[p7l2055t1775r2151b1823],
4	2001	CD	DATE	2001	num	3	SENT_134	[p7l138t1851r295b1907],
5	;	:	O	;	_	0	SENT_134	[p7l138t1851r295b1907],
6	24	CD	NUMBER	24	num	8	SENT_134	[p7l325t1851r409b1897],
7	:	:	O	:	_	0	SENT_134	[p7l325t1851r409b1897],
8	1427-1430	CD	DATE	1427-1430	dep	3	SENT_134	[p7l440t1851r773b1897],
9	.	.	O	.	_	0	SENT_134	[p7l440t1851r773b1897],

1	Amirimani	JJ	PERSON	amirimani	amod	2	SENT_135	[p7l136t1927r422b1974],
2	B	NN	PERSON	b	_	0	SENT_135	[p7l459t1928r503b1984],
3	,	,	O	,	_	0	SENT_135	[p7l459t1928r503b1984],
4	Ning	NN	O	ning	nn	5	SENT_135	[p7l540t1927r671b1989],
5	B	NN	O	b	appos	2	SENT_135	[p7l708t1928r752b1984],
6	,	,	O	,	_	0	SENT_135	[p7l708t1928r752b1984],
7	Deitz	NNP	ORGANIZATION	Deitz	nn	8	SENT_135	[p7l790t1927r929b1974],
8	AC	NN	ORGANIZATION	ac	appos	5	SENT_135	[p7l957t1927r1053b1984],
9	,	,	O	,	_	0	SENT_135	[p7l957t1927r1053b1984],
10	Weber	NNP	ORGANIZATION	Weber	nn	11	SENT_135	[p7l1086t1925r1270b1974],
11	BL	NN	ORGANIZATION	bl	appos	5	SENT_135	[p7l1302t1928r1377b1984],
12	,	,	O	,	_	0	SENT_135	[p7l1302t1928r1377b1984],
13	Kadlubar	NNP	O	Kadlubar	nn	14	SENT_135	[p7l1414t1925r1661b1974],
14	FF	NNP	O	FF	appos	5	SENT_135	[p7l1693t1928r1762b1984],
15	,	,	O	,	_	0	SENT_135	[p7l1693t1928r1762b1984],
16	Rebbeck	NNP	O	Rebbeck	nn	17	SENT_135	[p7l1799t1925r2031b1974],
17	TR	NN	O	tr	appos	5	SENT_135	[p7l2058t1928r2142b1974],
18	.	.	O	.	_	0	SENT_135	[p7l2058t1928r2142b1974],

1	Increased	VBN	O	increase	amod	3	SENT_136	[p7l141t2002r398b2051],
2	transcriptional	JJ	O	transcriptional	amod	3	SENT_136	[p7l431t2002r826b2066],
3	activity	NN	O	activity	_	0	SENT_136	[p7l861t2003r1058b2066],
4	of	IN	O	of	_	0	SENT_136	[p7l1089t2002r1143b2051],
5	the	DT	O	the	det	6	SENT_136	[p7l1171t2002r1259b2051],
6	CYP3A4	NN	O	cyp3a4	prep_of	3	SENT_136	[p7l1292t2003r1612b2051],
7	*	CD	NUMBER	*	num	10	SENT_136	[p7l1292t2003r1612b2051],
8	1B	NN	O	1b	nn	10	SENT_136	[p7l1292t2003r1612b2051],
9	promoter	NN	O	promoter	nn	10	SENT_136	[p7l1647t2008r1910b2066],
10	variant	NN	O	variant	dep	6	SENT_136	[p7l1938t2003r2142b2051],
11	.	.	O	.	_	0	SENT_136	[p7l1938t2003r2142b2051],

1	Environ	NNP	O	Environ	nn	3	SENT_137	[p7l140t2079r333b2126],
2	Mol	NNP	O	Mol	nn	3	SENT_137	[p7l360t2078r463b2126],
3	Mutagen	NNP	O	Mutagen	_	0	SENT_137	[p7l485t2080r725b2141],
4	2003	CD	DATE	2003	num	3	SENT_137	[p7l750t2079r907b2137],
5	;	:	O	;	_	0	SENT_137	[p7l750t2079r907b2137],
6	42	CD	NUMBER	42	num	8	SENT_137	[p7l935t2079r1020b2126],
7	:	:	O	:	_	0	SENT_137	[p7l935t2079r1020b2126],
8	299-305	CD	NUMBER	299-305	dep	3	SENT_137	[p7l1049t2079r1312b2126],
9	.	.	O	.	_	0	SENT_137	[p7l1049t2079r1312b2126],

1	Hustert	NNP	PERSON	Hustert	nn	2	SENT_138	[p7l141t2155r340b2200],
2	E	NNP	PERSON	E	_	0	SENT_138	[p7l376t2155r416b2210],
3	,	,	O	,	_	0	SENT_138	[p7l376t2155r416b2210],
4	Haberl	NNP	PERSON	Haberl	nn	5	SENT_138	[p7l457t2152r632b2200],
5	M	NNP	O	M	appos	2	SENT_138	[p7l672t2155r740b2210],
6	,	,	O	,	_	0	SENT_138	[p7l672t2155r740b2210],
7	Burk	NNP	PERSON	Burk	nn	8	SENT_138	[p7l780t2152r900b2200],
8	O	NNP	PERSON	O	appos	2	SENT_138	[p7l934t2154r995b2210],
9	,	,	O	,	_	0	SENT_138	[p7l934t2154r995b2210],
10	Wolbold	JJ	O	wolbold	amod	11	SENT_138	[p7l1031t2152r1265b2200],
11	R	NN	O	r	appos	2	SENT_138	[p7l1305t2155r1349b2210],
12	,	,	O	,	_	0	SENT_138	[p7l1305t2155r1349b2210],
13	He	PRP	O	he	nsubj	14	SENT_138	[p7l1389t2155r1460b2200],
14	YQ	VBZ	O	yq	dep	2	SENT_138	[p7l1493t2154r1591b2210],
15	,	,	O	,	_	0	SENT_138	[p7l1493t2154r1591b2210],
16	Klein	NNP	PERSON	Klein	nn	17	SENT_138	[p7l1632t2152r1761b2200],
17	K	NNP	O	K	appos	2	SENT_138	[p7l1800t2154r1833b2200],
18	et	FW	O	et	nn	19	SENT_138	[p7l1868t2158r1916b2200],
19	al.	FW	O	al.	dep	17	SENT_138	[p7l1948t2152r2006b2200],
20	.	.	O	.	_	0	SENT_138	[p7l1948t2152r2006b2200],

1	The	DT	O	the	det	3	SENT_139	[p7l2042t2152r2145b2200],
2	genetic	JJ	O	genetic	amod	3	SENT_139	[p7l138t2230r342b2293],
3	determinants	NNS	O	determinant	_	0	SENT_139	[p7l370t2229r738b2278],
4	of	IN	O	of	_	0	SENT_139	[p7l766t2229r820b2278],
5	the	DT	O	the	det	7	SENT_139	[p7l844t2229r932b2278],
6	CYP3A5	NN	O	cyp3a5	nn	7	SENT_139	[p7l961t2230r1179b2278],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_139	[p7l1212t2229r1630b2293],
8	.	.	O	.	_	0	SENT_139	[p7l1212t2229r1630b2293],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_140	[p7l1664t2229r2148b2293],
2	2001	CD	DATE	2001	num	1	SENT_140	[p7l138t2306r295b2362],
3	;	:	O	;	_	0	SENT_140	[p7l138t2306r295b2362],
4	11	CD	NUMBER	11	num	6	SENT_140	[p7l328t2306r409b2352],
5	:	:	O	:	_	0	SENT_140	[p7l328t2306r409b2352],
6	773-779	CD	NUMBER	773-779	dep	1	SENT_140	[p7l440t2306r700b2352],
7	.	.	O	.	_	0	SENT_140	[p7l440t2306r700b2352],

1	Iscan	NNP	MISC	Iscan	nn	2	SENT_141	[p7l141t2382r272b2428],
2	M	NNP	O	M	_	0	SENT_141	[p7l297t2382r364b2439],
3	,	,	O	,	_	0	SENT_141	[p7l297t2382r364b2439],
4	Klaavuniemi	NNP	ORGANIZATION	Klaavuniemi	nn	5	SENT_141	[p7l390t2380r723b2428],
5	T	NN	ORGANIZATION	t	appos	2	SENT_141	[p7l743t2382r791b2439],
6	,	,	O	,	_	0	SENT_141	[p7l743t2382r791b2439],
7	Coban	NNP	ORGANIZATION	Coban	nn	8	SENT_141	[p7l814t2380r994b2428],
8	T	NN	ORGANIZATION	t	appos	2	SENT_141	[p7l1014t2382r1062b2439],
9	,	,	O	,	_	0	SENT_141	[p7l1014t2382r1062b2439],
10	Kapucuoglu	NNP	ORGANIZATION	Kapucuoglu	nn	11	SENT_141	[p7l1088t2380r1416b2444],
11	N	NNP	ORGANIZATION	N	appos	2	SENT_141	[p7l1441t2382r1499b2439],
12	,	,	O	,	_	0	SENT_141	[p7l1441t2382r1499b2439],
13	Pelkonen	NNP	PERSON	Pelkonen	nn	14	SENT_141	[p7l1525t2380r1772b2428],
14	O	NNP	PERSON	O	appos	2	SENT_141	[p7l1794t2381r1855b2439],
15	,	,	O	,	_	0	SENT_141	[p7l1794t2381r1855b2439],
16	Raunio	NNP	O	Raunio	nn	19	SENT_141	[p7l1881t2381r2066b2428],
17	H.	NNP	O	H.	nn	19	SENT_141	[p7l2088t2382r2142b2428],
18	The	NNP	O	The	nn	19	SENT_141	[p7l136t2455r239b2504],
19	expression	NN	O	expression	appos	2	SENT_141	[p7l262t2457r551b2519],
20	of	IN	O	of	_	0	SENT_141	[p7l578t2455r631b2504],
21	cytochrome	NN	O	cytochrome	nn	23	SENT_141	[p7l651t2455r984b2519],
22	P450	NN	O	p450	nn	23	SENT_141	[p7l1010t2457r1147b2504],
23	enzymes	NNS	O	enzyme	prep_of	19	SENT_141	[p7l1171t2470r1411b2519],
24	in	IN	O	in	_	0	SENT_141	[p7l1435t2457r1480b2503],
25	human	JJ	O	human	amod	27	SENT_141	[p7l1507t2455r1699b2504],
26	breast	NN	O	breast	nn	27	SENT_141	[p7l1727t2455r1893b2504],
27	tumours	NNS	O	tumour	prep_in	23	SENT_141	[p7l1913t2461r2145b2504],
28	and	CC	O	and	_	0	SENT_141	[p7l138t2531r239b2579],
29	normal	JJ	O	normal	amod	31	SENT_141	[p7l268t2531r459b2579],
30	breast	NN	O	breast	nn	31	SENT_141	[p7l490t2531r657b2579],
31	tissue	NN	O	tissue	appos	2	SENT_141	[p7l679t2532r847b2579],
32	.	.	O	.	_	0	SENT_141	[p7l679t2532r847b2579],

1	Breast	NN	O	breast	nn	4	SENT_142	[p7l878t2533r1040b2579],
2	Cancer	NN	O	cancer	nn	4	SENT_142	[p7l1065t2532r1252b2579],
3	Res	NNP	O	Res	nn	4	SENT_142	[p7l1272t2533r1356b2579],
4	Treat	NNP	O	Treat	_	0	SENT_142	[p7l1385t2533r1520b2579],
5	2001	CD	DATE	2001	num	4	SENT_142	[p7l1542t2532r1699b2589],
6	;	:	O	;	_	0	SENT_142	[p7l1542t2532r1699b2589],
7	70	CD	NUMBER	70	num	9	SENT_142	[p7l1731t2532r1812b2579],
8	:	:	O	:	_	0	SENT_142	[p7l1731t2532r1812b2579],
9	47-54	CD	NUMBER	47-54	dep	4	SENT_142	[p7l1840t2533r2030b2579],
10	.	.	O	.	_	0	SENT_142	[p7l1840t2533r2030b2579],

1	McFadyen	NNP	PERSON	McFadyen	nn	2	SENT_143	[p7l146t2607r428b2671],
2	MC	NNP	O	MC	nsubj	20	SENT_143	[p7l468t2608r579b2666],
3	,	,	O	,	_	0	SENT_143	[p7l468t2608r579b2666],
4	Cruickshank	NNP	PERSON	Cruickshank	nn	5	SENT_143	[p7l618t2607r955b2655],
5	ME	NNP	O	ME	appos	2	SENT_143	[p7l992t2609r1090b2666],
6	,	,	O	,	_	0	SENT_143	[p7l992t2609r1090b2666],
7	Miller	NNP	PERSON	Miller	nn	8	SENT_143	[p7l1132t2607r1287b2655],
8	ID	NNP	O	ID	appos	5	SENT_143	[p7l1322t2609r1394b2666],
9	,	,	O	,	_	0	SENT_143	[p7l1322t2609r1394b2666],
10	McLeod	NNP	PERSON	McLeod	nn	11	SENT_143	[p7l1435t2607r1653b2655],
11	HL	NNS	O	hl	nsubj	15	SENT_143	[p7l1693t2609r1777b2666],
12	,	,	O	,	_	0	SENT_143	[p7l1693t2609r1777b2666],
13	Melvin	NNP	PERSON	Melvin	nn	14	SENT_143	[p7l1818t2607r1999b2655],
14	V	NNP	PERSON	V	nsubj	15	SENT_143	[p7l2034t2609r2142b2666],
15	\	VBD	O	\	parataxis	20	SENT_143	[p7l2034t2609r2142b2666],
16	f	FW	O	f	nn	17	SENT_143	[p7l2034t2609r2142b2666],
17	|	FW	O	|	dobj	15	SENT_143	[p7l2034t2609r2142b2666],
18	'	''	O	'	_	0	SENT_143	[p7l2034t2609r2142b2666],
19	,	,	O	,	_	0	SENT_143	[p7l2034t2609r2142b2666],
20	Haites	VBZ	O	haite	_	0	SENT_143	[p7l146t2684r310b2731],
21	NE	NN	O	ne	dobj	20	SENT_143	[p7l340t2685r416b2730],
22	et	FW	O	et	nn	21	SENT_143	[p7l444t2688r493b2731],
23	al.	FW	O	al.	dep	21	SENT_143	[p7l517t2682r575b2731],
24	.	.	O	.	_	0	SENT_143	[p7l517t2682r575b2731],

1	Cytochrome	NN	O	cytochrome	nn	5	SENT_144	[p7l606t2682r951b2746],
2	P450	NN	O	p450	nn	5	SENT_144	[p7l982t2684r1119b2731],
3	CYP1	NN	O	cyp1	nn	5	SENT_144	[p7l1147t2684r1280b2731],
4	B1	NN	O	b1	nn	5	SENT_144	[p7l1299t2684r1353b2730],
5	over-expression	NN	O	over-expression	_	0	SENT_144	[p7l1392t2684r1826b2746],
6	in	IN	O	in	_	0	SENT_144	[p7l1857t2684r1902b2730],
7	primary	JJ	O	primary	amod	11	SENT_144	[p7l1933t2684r2146b2746],
8	and	CC	O	and	_	0	SENT_144	[p7l143t2758r243b2806],
9	metastatic	JJ	O	metastatic	amod	11	SENT_144	[p7l273t2759r557b2806],
10	ovarian	JJ	O	ovarian	amod	11	SENT_144	[p7l583t2759r782b2806],
11	cancer	NN	O	cancer	prep_in	5	SENT_144	[p7l810t2772r1006b2806],
12	.	.	O	.	_	0	SENT_144	[p7l810t2772r1006b2806],

1	Br	NN	O	br	_	0	SENT_145	[p7l1037t2760r1127b2817],
2	]	CD	NUMBER	]	num	1	SENT_145	[p7l1037t2760r1127b2817],
3	Cancer	NN	O	cancer	dep	1	SENT_145	[p7l1153t2760r1339b2806],
4	2001	CD	DATE	2001	num	3	SENT_145	[p7l1358t2759r1515b2816],
5	;	:	O	;	_	0	SENT_145	[p7l1358t2759r1515b2816],
6	85	CD	NUMBER	85	num	8	SENT_145	[p7l1543t2759r1628b2806],
7	:	:	O	:	_	0	SENT_145	[p7l1543t2759r1628b2806],
8	242-246	CD	NUMBER	242-246	dep	1	SENT_145	[p7l1657t2759r1920b2806],
9	.	.	O	.	_	0	SENT_145	[p7l1657t2759r1920b2806],

1	McKay	NN	PERSON	mckay	nn	2	SENT_146	[p7l146t2835r331b2897],
2	JA	NN	O	ja	_	0	SENT_146	[p7l354t2836r423b2893],
3	,	,	O	,	_	0	SENT_146	[p7l354t2836r423b2893],
4	Melvin	NNP	PERSON	Melvin	nn	5	SENT_146	[p7l455t2834r636b2882],
5	WT	NNP	O	WT	appos	2	SENT_146	[p7l662t2835r770b2892],
6	,	,	O	,	_	0	SENT_146	[p7l662t2835r770b2892],
7	Ah-See	NNP	O	Ah-See	nn	8	SENT_146	[p7l796t2834r991b2882],
8	AK	NNP	O	AK	appos	2	SENT_146	[p7l1014t2835r1105b2892],
9	,	,	O	,	_	0	SENT_146	[p7l1014t2835r1105b2892],
10	Ewen	NNP	PERSON	Ewen	nn	11	SENT_146	[p7l1137t2836r1279b2882],
11	SW	NNP	PERSON	SW	appos	2	SENT_146	[p7l1308t2835r1410b2892],
12	,	,	O	,	_	0	SENT_146	[p7l1308t2835r1410b2892],
13	Greenlee	NNP	ORGANIZATION	Greenlee	nn	14	SENT_146	[p7l1440t2834r1687b2882],
14	WF	NNP	ORGANIZATION	WF	appos	2	SENT_146	[p7l1710t2835r1814b2892],
15	,	,	O	,	_	0	SENT_146	[p7l1710t2835r1814b2892],
16	Marcus	NNP	PERSON	Marcus	nn	17	SENT_146	[p7l1845t2836r2043b2882],
17	CB	NNP	O	CB	appos	2	SENT_146	[p7l2070t2835r2145b2882],
18	et	FW	O	et	nn	19	SENT_146	[p7l144t2916r194b2958],
19	al.	FW	O	al.	dep	17	SENT_146	[p7l212t2910r269b2958],
20	.	.	O	.	_	0	SENT_146	[p7l212t2910r269b2958],

1	Expression	NN	O	expression	_	0	SENT_147	[p7l297t2911r583b2974],
2	of	IN	O	of	_	0	SENT_147	[p7l607t2910r661b2958],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_147	[p7l679t2910r1011b2974],
4	P450	NN	O	p450	nn	6	SENT_147	[p7l1036t2911r1172b2958],
5	CYP1	NN	O	cyp1	nn	6	SENT_147	[p7l1195t2911r1327b2958],
6	B1	NN	O	b1	prep_of	1	SENT_147	[p7l1346t2911r1400b2958],
7	in	IN	O	in	_	0	SENT_147	[p7l1435t2911r1480b2958],
8	breast	NN	O	breast	nn	9	SENT_147	[p7l1505t2910r1671b2958],
9	cancer	NN	O	cancer	prep_in	1	SENT_147	[p7l1691t2924r1887b2958],
10	.	.	O	.	_	0	SENT_147	[p7l1691t2924r1887b2958],

1	FEBS	NNP	O	FEBS	nn	2	SENT_148	[p7l1913t2911r2031b2958],
2	Lett	NNP	PERSON	Lett	_	0	SENT_148	[p7l2052t2912r2150b2958],
3	1995	CD	DATE	1995	num	2	SENT_148	[p7l146t2986r300b3042],
4	;	:	O	;	_	0	SENT_148	[p7l146t2986r300b3042],
5	374	CD	NUMBER	374	num	7	SENT_148	[p7l330t2986r450b3032],
6	:	:	O	:	_	0	SENT_148	[p7l330t2986r450b3032],
7	270-272	CD	NUMBER	270-272	dep	2	SENT_148	[p7l479t2986r741b3032],
8	.	.	O	.	_	0	SENT_148	[p7l479t2986r741b3032],

1	Murray	NNP	ORGANIZATION	Murray	nn	2	SENT_149	[p7l146t3063r343b3125],
2	GI	NNP	ORGANIZATION	GI	_	0	SENT_149	[p7l370t3063r444b3120],
3	,	,	O	,	_	0	SENT_149	[p7l370t3063r444b3120],
4	Taylor	NNP	PERSON	Taylor	nn	5	SENT_149	[p7l472t3061r645b3125],
5	MC	NNP	O	MC	appos	2	SENT_149	[p7l672t3062r783b3120],
6	,	,	O	,	_	0	SENT_149	[p7l672t3062r783b3120],
7	McFadyen	NNP	PERSON	McFadyen	nn	8	SENT_149	[p7l817t3061r1100b3125],
8	MC	NNP	O	MC	appos	2	SENT_149	[p7l1132t3062r1243b3120],
9	,	,	O	,	_	0	SENT_149	[p7l1132t3062r1243b3120],
10	McKay	NNP	PERSON	McKay	nn	11	SENT_149	[p7l1276t3063r1462b3125],
11	JA	NNP	O	JA	appos	2	SENT_149	[p7l1487t3063r1555b3121],
12	,	,	O	,	_	0	SENT_149	[p7l1487t3063r1555b3121],
13	Greenlee	NNP	ORGANIZATION	Greenlee	nn	14	SENT_149	[p7l1586t3061r1833b3110],
14	WF	NNP	ORGANIZATION	WF	appos	2	SENT_149	[p7l1858t3063r1961b3120],
15	,	,	O	,	_	0	SENT_149	[p7l1858t3063r1961b3120],
16	Burke	NNP	PERSON	Burke	nn	17	SENT_149	[p7l1994t3061r2145b3110],
17	MD	NNP	O	MD	appos	2	SENT_149	[p7l146t3139r244b3185],
18	et	FW	O	et	nn	19	SENT_149	[p7l288t3142r336b3185],
19	al.	FW	O	al.	dep	17	SENT_149	[p7l375t3137r432b3185],
20	.	.	O	.	_	0	SENT_149	[p7l375t3137r432b3185],

1	Tumor-specific	JJ	O	tumor-specific	amod	2	SENT_150	[p7l475t3137r887b3200],
2	expression	NN	O	expression	_	0	SENT_150	[p7l928t3138r1218b3200],
3	of	IN	O	of	_	0	SENT_150	[p7l1261t3137r1315b3185],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_150	[p7l1353t3137r1686b3200],
5	P450	NN	O	p450	nn	6	SENT_150	[p7l1730t3138r1866b3185],
6	CYP1B1	NN	O	cyp1b1	prep_of	2	SENT_150	[p7l1909t3138r2143b3185],
7	.	.	O	.	_	0	SENT_150	[p7l1909t3138r2143b3185],

1	Cancer	NNP	O	Cancer	nn	2	SENT_151	[p7l146t3213r333b3259],
2	Res	NNP	O	Res	_	0	SENT_151	[p7l353t3214r438b3259],
3	1997	CD	DATE	1997	num	2	SENT_151	[p7l464t3213r618b3269],
4	;	:	O	;	_	0	SENT_151	[p7l464t3213r618b3269],
5	57	CD	NUMBER	57	num	7	SENT_151	[p7l646t3214r731b3259],
6	:	:	O	:	_	0	SENT_151	[p7l646t3214r731b3259],
7	3026-3031	CD	DURATION	3026-3031	dep	2	SENT_151	[p7l763t3213r1096b3259],
8	.	.	O	.	_	0	SENT_151	[p7l763t3213r1096b3259],

1	Rochat	NNP	PERSON	Rochat	nn	2	SENT_152	[p7l146t3288r334b3337],
2	B	NNP	PERSON	B	_	0	SENT_152	[p7l373t3290r417b3347],
3	,	,	O	,	_	0	SENT_152	[p7l373t3290r417b3347],
4	Morsman	NNP	O	Morsman	nn	5	SENT_152	[p7l460t3290r720b3337],
5	JM	NN	O	jm	appos	2	SENT_152	[p7l758t3290r847b3348],
6	,	,	O	,	_	0	SENT_152	[p7l758t3290r847b3348],
7	Murray	NNP	ORGANIZATION	Murray	nn	8	SENT_152	[p7l891t3290r1088b3352],
8	GI	NNP	ORGANIZATION	GI	appos	2	SENT_152	[p7l1125t3289r1199b3347],
9	,	,	O	,	_	0	SENT_152	[p7l1125t3289r1199b3347],
10	Figg	NNP	PERSON	Figg	nn	11	SENT_152	[p7l1243t3289r1356b3352],
11	WD	NNP	O	WD	appos	2	SENT_152	[p7l1392t3290r1512b3347],
12	,	,	O	,	_	0	SENT_152	[p7l1392t3290r1512b3347],
13	McLeod	NNP	PERSON	McLeod	nn	14	SENT_152	[p7l1556t3288r1774b3337],
14	HL	NNS	O	hl	appos	2	SENT_152	[p7l1817t3290r1901b3337],
15	.	.	O	.	_	0	SENT_152	[p7l1817t3290r1901b3337],

1	Human	JJ	O	human	amod	2	SENT_153	[p7l1945t3290r2143b3337],
2	CYP1B1	NN	O	cyp1b1	_	0	SENT_153	[p7l143t3365r349b3413],
3	and	CC	O	and	_	0	SENT_153	[p7l405t3364r506b3413],
4	anticancer	JJ	O	anticancer	amod	6	SENT_153	[p7l552t3365r842b3413],
5	agent	NN	O	agent	nn	6	SENT_153	[p7l883t3370r1042b3428],
6	metabolism	NN	O	metabolism	conj_and	2	SENT_153	[p7l1087t3364r1426b3413],
7	:	:	O	:	_	0	SENT_153	[p7l1087t3364r1426b3413],
8	mechanism	NN	O	mechanism	dep	2	SENT_153	[p7l1476t3364r1791b3413],
9	for	IN	O	for	prep	8	SENT_153	[p7l1835t3364r1913b3413],
10	tumorspecific	JJ	O	tumorspecific	amod	12	SENT_153	[p7l1953t3370r2145b3413, p7l142t3440r344b3504],
11	drug	NN	O	drug	nn	12	SENT_153	[p7l370t3440r497b3503],
12	inactivation	NN	O	inactivation	dep	9	SENT_153	[p7l527t3440r876b3488],
13	?	.	O	?	_	0	SENT_153	[p7l527t3440r876b3488],
14	]	SYM	O	]	dep	2	SENT_153	[p7l898t3442r919b3500],

1	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_154	[p7l944t3440r1229b3488],
2	Exp	NNP	O	Exp	nn	3	SENT_154	[p7l1251t3442r1340b3504],
3	Ther	NNP	O	Ther	_	0	SENT_154	[p7l1370t3440r1487b3488],
4	2001	CD	DATE	2001	num	3	SENT_154	[p7l1505t3441r1662b3499],
5	;	:	O	;	_	0	SENT_154	[p7l1505t3441r1662b3499],
6	296	CD	NUMBER	296	num	8	SENT_154	[p7l1692t3441r1812b3488],
7	:	:	O	:	_	0	SENT_154	[p7l1692t3441r1812b3488],
8	537-541	CD	NUMBER	537-541	dep	3	SENT_154	[p7l1841t3441r2104b3488],
9	.	.	O	.	_	0	SENT_154	[p7l1841t3441r2104b3488],

1	Bournique	JJ	PERSON	bournique	amod	2	SENT_155	[p7l146t3517r429b3579],
2	B	NN	O	b	nsubj	22	SENT_155	[p7l465t3518r510b3574],
3	,	,	O	,	_	0	SENT_155	[p7l465t3518r510b3574],
4	Lemarie	NNP	PERSON	Lemarie	nn	8	SENT_155	[p7l548t3517r763b3564],
5	A.	NNP	PERSON	A.	nn	8	SENT_155	[p7l794t3518r846b3564],
6	Docetaxel	NNP	PERSON	Docetaxel	nn	8	SENT_155	[p7l885t3515r1157b3564],
7	(	NNP	O	(	nn	8	SENT_155	[p7l1193t3516r1478b3576],
8	Taxotere	NNP	O	Taxotere	appos	2	SENT_155	[p7l1193t3516r1478b3576],
9	)	NN	O	)	dep	8	SENT_155	[p7l1193t3516r1478b3576],
10	is	VBZ	O	be	auxpass	12	SENT_155	[p7l1513t3517r1547b3564],
11	not	RB	O	not	neg	12	SENT_155	[p7l1582t3521r1673b3564],
12	metabolized	VBN	O	metabolize	_	0	SENT_155	[p7l1706t3515r2045b3564],
13	by	IN	O	by	_	0	SENT_155	[p7l2082t3515r2147b3579],
14	recombinant	JJ	O	recombinant	amod	17	SENT_155	[p7l145t3591r501b3639],
15	human	JJ	O	human	amod	17	SENT_155	[p7l536t3591r728b3639],
16	CYP1	NN	O	cyp1	nn	17	SENT_155	[p7l765t3592r898b3639],
17	B1	NN	O	b1	agent	12	SENT_155	[p7l918t3592r971b3638],
18	in	FW	O	in	nn	19	SENT_155	[p7l1020t3592r1066b3638],
19	vitro	FW	O	vitro	advmod	12	SENT_155	[p7l1101t3592r1229b3649],
20	,	,	O	,	_	0	SENT_155	[p7l1101t3592r1229b3649],
21	but	CC	O	but	_	0	SENT_155	[p7l1269t3591r1362b3639],
22	acts	VBZ	O	act	conj_but	12	SENT_155	[p7l1394t3597r1499b3639],
23	as	IN	O	as	_	0	SENT_155	[p7l1534t3605r1586b3639],
24	an	DT	O	a	det	25	SENT_155	[p7l1621t3605r1684b3639],
25	effector	NN	O	effector	prep_as	22	SENT_155	[p7l1721t3591r1933b3639],
26	of	IN	O	of	_	0	SENT_155	[p7l1965t3591r2019b3639],
27	this	DT	O	this	det	28	SENT_155	[p7l2049t3591r2145b3639],
28	isozyme	NN	O	isozyme	prep_of	25	SENT_155	[p7l144t3668r380b3730],
29	.	.	O	.	_	0	SENT_155	[p7l144t3668r380b3730],

1	Drug	NN	MISC	drug	nn	3	SENT_156	[p7l412t3669r543b3730],
2	Metab	NNP	MISC	Metab	nn	3	SENT_156	[p7l568t3667r740b3715],
3	Dispos	NNP	MISC	Dispos	_	0	SENT_156	[p7l766t3668r938b3730],
4	2002	CD	DATE	2002	num	3	SENT_156	[p7l961t3668r1118b3725],
5	;	:	O	;	_	0	SENT_156	[p7l961t3668r1118b3725],
6	30	CD	NUMBER	30	num	8	SENT_156	[p7l1149t3668r1232b3715],
7	:	:	O	:	_	0	SENT_156	[p7l1149t3668r1232b3715],
8	1149-1152	CD	DATE	1149-1152	dep	3	SENT_156	[p7l1263t3668r1596b3715],
9	.	.	O	.	_	0	SENT_156	[p7l1263t3668r1596b3715],

1	Landi	NNP	PERSON	Landi	nn	2	SENT_157	[p7l146t3742r290b3791],
2	MT	NNP	O	MT	_	0	SENT_157	[p7l337t3745r439b3801],
3	,	,	O	,	_	0	SENT_157	[p7l337t3745r439b3801],
4	Bergen	NNP	LOCATION	Bergen	nn	5	SENT_157	[p7l487t3745r676b3806],
5	AW	NNP	O	AW	dep	2	SENT_157	[p7l718t3744r830b3801],
6	,	,	O	,	_	0	SENT_157	[p7l718t3744r830b3801],
7	Baccarelli	NNP	PERSON	Baccarelli	nn	8	SENT_157	[p7l878t3742r1131b3791],
8	A	NNP	O	A	appos	5	SENT_157	[p7l1173t3745r1225b3801],
9	,	,	O	,	_	0	SENT_157	[p7l1173t3745r1225b3801],
10	Patterson	NNP	PERSON	Patterson	nn	12	SENT_157	[p7l1273t3745r1528b3791],
11	Jr	NNP	PERSON	Jr	nn	12	SENT_157	[p7l1570t3745r1609b3802],
12	DC	NNP	O	DC	appos	5	SENT_157	[p7l1651t3744r1754b3801],
13	,	,	O	,	_	0	SENT_157	[p7l1651t3744r1754b3801],
14	Grassman	NNP	PERSON	Grassman	nn	15	SENT_157	[p7l1800t3744r2069b3791],
15	J	NNP	PERSON	J	appos	5	SENT_157	[p7l2112t3745r2142b3802],
16	,	,	O	,	_	0	SENT_157	[p7l2112t3745r2142b3802],

1	Paclitaxel	NN	O	paclitaxel	nn	2	SENT_158	[p8l10t3149r240b3194],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_158	[p8l262t3149r703b3208],
3	S	NN	O	s	nn	4	SENT_158	[p8l10t3222r30b3262],
4	Marsh	NNP	PERSON	Marsh	dep	2	SENT_158	[p8l51t3220r173b3262],
5	et	FW	O	et	nn	6	SENT_158	[p8l194t3225r230b3262],
6	al	FW	O	al	dep	2	SENT_158	[p8l247t3220r283b3262],

1	Ter	NN	PERSON	ter	_	0	SENT_159	[p8l141t15r524b62],
2	.	.	O	.	_	0	SENT_159	[p8l141t15r524b62],

1	—	NN	O	—	_	0	SENT_160	[p8l141t15r524b62],
2	.	.	O	.	_	0	SENT_160	[p8l141t15r524b62],

1	Minassian	JJ	PERSON	minassian	amod	2	SENT_161	[p8l141t15r524b62],
2	M	NN	O	m	_	0	SENT_161	[p8l549t16r599b61],
3	et	FW	O	et	nn	4	SENT_161	[p8l624t19r672b62],
4	al.	FW	O	al.	dep	2	SENT_161	[p8l689t13r747b62],
5	.	.	O	.	_	0	SENT_161	[p8l689t13r747b62],

1	CYP1A1	NN	O	cyp1a1	nn	5	SENT_162	[p8l771t15r980b62],
2	and	CC	O	and	_	0	SENT_162	[p8l1011t13r1112b62],
3	CYP1	NN	O	cyp1	conj_and	1	SENT_162	[p8l1135t15r1268b62],
4	B1	NN	O	b1	nn	5	SENT_162	[p8l1287t15r1340b61],
5	genotypes	NNS	O	genotype	_	0	SENT_162	[p8l1373t19r1676b77],
6	,	,	O	,	_	0	SENT_162	[p8l1373t19r1676b77],
7	haplotypes	NNS	O	haplotype	conj_and	5	SENT_162	[p8l1703t13r2019b77],
8	,	,	O	,	_	0	SENT_162	[p8l1703t13r2019b77],
9	and	CC	O	and	_	0	SENT_162	[p8l2043t13r2144b62],
10	TCDD-induced	JJ	O	tcdd-induced	amod	12	SENT_162	[p8l141t90r559b139],
11	gene	NN	O	gene	nn	12	SENT_162	[p8l622t104r757b154],
12	expression	NN	O	expression	conj_and	5	SENT_162	[p8l818t91r1108b154],
13	in	IN	O	in	_	0	SENT_162	[p8l1171t91r1216b138],
14	subjects	NNS	O	subject	prep_in	12	SENT_162	[p8l1278t90r1498b154],
15	from	IN	O	from	_	0	SENT_162	[p8l1555t90r1686b139],
16	Seveso	NNP	LOCATION	Seveso	nn	18	SENT_162	[p8l1749t92r1950b149],
17	,	,	O	,	_	0	SENT_162	[p8l1749t92r1950b149],
18	Italy	NNP	LOCATION	Italy	prep_from	14	SENT_162	[p8l2016t90r2142b154],
19	.	.	O	.	_	0	SENT_162	[p8l2016t90r2142b154],

1	Toxicology	NN	O	toxicology	_	0	SENT_163	[p8l149t166r429b229],
2	2005	CD	DATE	2005	num	1	SENT_163	[p8l449t167r606b224],
3	;	:	O	;	_	0	SENT_163	[p8l449t167r606b224],
4	207	CD	NUMBER	207	num	6	SENT_163	[p8l635t167r755b214],
5	:	:	O	:	_	0	SENT_163	[p8l635t167r755b214],
6	191-202	CD	NUMBER	191-202	dep	1	SENT_163	[p8l787t167r1047b214],
7	.	.	O	.	_	0	SENT_163	[p8l787t167r1047b214],

1	Shimada	NNP	PERSON	Shimada	nn	2	SENT_164	[p8l144t241r382b290],
2	T	NN	O	t	_	0	SENT_164	[p8l400t244r449b300],
3	,	,	O	,	_	0	SENT_164	[p8l400t244r449b300],
4	Watanabe	NNP	PERSON	Watanabe	nn	5	SENT_164	[p8l470t241r752b290],
5	J	NNP	PERSON	J	appos	2	SENT_164	[p8l770t244r800b301],
6	,	,	O	,	_	0	SENT_164	[p8l770t244r800b301],
7	Kawajiri	NNP	PERSON	Kawajiri	nn	8	SENT_164	[p8l826t243r1036b305],
8	K	NNP	O	K	appos	2	SENT_164	[p8l1061t243r1107b300],
9	,	,	O	,	_	0	SENT_164	[p8l1061t243r1107b300],
10	Sutter	NNP	ORGANIZATION	Sutter	nn	11	SENT_164	[p8l1131t243r1296b290],
11	TR	NN	ORGANIZATION	tr	appos	2	SENT_164	[p8l1311t244r1394b300],
12	,	,	O	,	_	0	SENT_164	[p8l1311t244r1394b300],
13	Guengerich	NNP	PERSON	Guengerich	nn	14	SENT_164	[p8l1418t241r1740b305],
14	FP	NN	O	fp	appos	2	SENT_164	[p8l1765t244r1838b300],
15	,	,	O	,	_	0	SENT_164	[p8l1765t244r1838b300],
16	Gillam	NNP	PERSON	Gillam	nn	17	SENT_164	[p8l1862t241r2036b290],
17	EM	NNP	O	EM	appos	2	SENT_164	[p8l2062t244r2142b289],
18	et	FW	O	et	nn	19	SENT_164	[p8l144t324r194b367],
19	al.	FW	O	al.	dep	17	SENT_164	[p8l212t318r270b367],
20	.	.	O	.	_	0	SENT_164	[p8l212t318r270b367],

1	Catalytic	JJ	O	catalytic	amod	2	SENT_165	[p8l296t318r536b382],
2	properties	NNS	O	property	_	0	SENT_165	[p8l559t319r836b382],
3	of	IN	O	of	_	0	SENT_165	[p8l858t318r912b367],
4	polymorphic	JJ	O	polymorphic	amod	9	SENT_165	[p8l932t318r1285b382],
5	human	JJ	O	human	amod	9	SENT_165	[p8l1308t318r1500b367],
6	cytochrome	NN	O	cytochrome	nn	9	SENT_165	[p8l1524t318r1857b382],
7	P450	NN	O	p450	nn	9	SENT_165	[p8l1881t320r2018b367],
8	1B1	NN	O	1b1	nn	9	SENT_165	[p8l2043t319r2133b366],
9	variants	NNS	O	variant	prep_of	2	SENT_165	[p8l141t394r370b440],
10	.	.	O	.	_	0	SENT_165	[p8l141t394r370b440],

1	Carcinogenesis	NN	O	carcinogenesis	_	0	SENT_166	[p8l403t394r795b455],
2	1999	CD	DATE	1999	num	1	SENT_166	[p8l821t394r976b450],
3	;	:	O	;	_	0	SENT_166	[p8l821t394r976b450],
4	20	CD	NUMBER	20	num	6	SENT_166	[p8l1004t394r1088b440],
5	:	:	O	:	_	0	SENT_166	[p8l1004t394r1088b440],
6	1607-1613	CD	DATE	1607-1613	dep	1	SENT_166	[p8l1121t394r1453b440],
7	.	.	O	.	_	0	SENT_166	[p8l1121t394r1453b440],

1	Hanna	NNP	PERSON	Hanna	nn	2	SENT_167	[p8l146t471r321b518],
2	IH	NN	PERSON	ih	_	0	SENT_167	[p8l357t471r427b528],
3	,	,	O	,	_	0	SENT_167	[p8l357t471r427b528],
4	Dawling	VBG	O	dawl	amod	5	SENT_167	[p8l465t469r691b533],
5	S	NN	O	s	appos	2	SENT_167	[p8l726t471r770b528],
6	,	,	O	,	_	0	SENT_167	[p8l726t471r770b528],
7	Roodi	NNP	ORGANIZATION	Roodi	nn	8	SENT_167	[p8l808t469r960b518],
8	N	NNP	ORGANIZATION	N	appos	5	SENT_167	[p8l997t471r1055b528],
9	,	,	O	,	_	0	SENT_167	[p8l997t471r1055b528],
10	Guengerich	NNP	PERSON	Guengerich	nn	11	SENT_167	[p8l1091t469r1414b533],
11	FP	NN	O	fp	appos	5	SENT_167	[p8l1451t471r1524b528],
12	,	,	O	,	_	0	SENT_167	[p8l1451t471r1524b528],
13	Parl	NN	O	parl	nn	14	SENT_167	[p8l1563t469r1657b518],
14	FF	NN	O	ff	appos	11	SENT_167	[p8l1694t471r1764b518],
15	.	.	O	.	_	0	SENT_167	[p8l1694t471r1764b518],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_168	[p8l1800t469r2145b533],
2	P450	NN	O	p450	nn	3	SENT_168	[p8l146t546r282b593],
3	1B1	NN	O	1b1	_	0	SENT_168	[p8l315t546r405b592],
4	(	CD	NUMBER	(	num	7	SENT_168	[p8l448t545r710b605],
5	CYP1B1	NN	O	cyp1b1	nn	7	SENT_168	[p8l448t545r710b605],
6	)	CD	NUMBER	)	num	7	SENT_168	[p8l448t545r710b605],
7	pharmacogenetics	NNS	O	pharmacogenetic	dep	3	SENT_168	[p8l743t544r1270b608],
8	:	:	O	:	_	0	SENT_168	[p8l743t544r1270b608],
9	association	NN	O	association	dep	3	SENT_168	[p8l1303t546r1603b593],
10	of	IN	O	of	_	0	SENT_168	[p8l1635t544r1689b593],
11	polymorphisms	NNS	O	polymorphism	prep_of	9	SENT_168	[p8l1718t544r2145b608],
12	with	IN	O	with	_	0	SENT_168	[p8l141t621r260b670],
13	functional	JJ	O	functional	amod	14	SENT_168	[p8l294t621r571b670],
14	differences	NNS	O	difference	prep_with	11	SENT_168	[p8l607t621r906b670],
15	in	IN	O	in	_	0	SENT_168	[p8l941t622r985b669],
16	estrogen	NN	O	estrogen	nn	18	SENT_168	[p8l1021t627r1260b685],
17	hydroxylation	NN	O	hydroxylation	nn	18	SENT_168	[p8l1298t621r1678b685],
18	activity	NN	O	activity	prep_in	14	SENT_168	[p8l1714t622r1926b685],
19	.	.	O	.	_	0	SENT_168	[p8l1714t622r1926b685],

1	Cancer	NNP	O	Cancer	nn	2	SENT_169	[p8l1966t623r2152b670],
2	Res	NNP	O	Res	_	0	SENT_169	[p8l145t698r230b743],
3	2000	CD	DATE	2000	num	2	SENT_169	[p8l253t697r410b753],
4	;	:	O	;	_	0	SENT_169	[p8l253t697r410b753],
5	60	CD	NUMBER	60	num	7	SENT_169	[p8l438t697r523b743],
6	:	:	O	:	_	0	SENT_169	[p8l438t697r523b743],
7	3440-3444	CD	DURATION	3440-3444	dep	2	SENT_169	[p8l555t697r887b743],
8	.	.	O	.	_	0	SENT_169	[p8l555t697r887b743],

1	Li	NNP	PERSON	Li	nn	5	SENT_170	[p8l146t773r183b819],
2	DN	JJ	PERSON	dn	amod	5	SENT_170	[p8l212t774r317b830],
3	,	,	O	,	_	0	SENT_170	[p8l212t774r317b830],
4	Seidel	NNP	PERSON	Seidel	dep	5	SENT_170	[p8l346t771r504b820],
5	A	NNP	O	A	nsubj	19	SENT_170	[p8l529t774r582b830],
6	,	,	O	,	_	0	SENT_170	[p8l529t774r582b830],
7	Pritchard	NNP	PERSON	Pritchard	nn	8	SENT_170	[p8l612t771r856b820],
8	MP	NNP	O	MP	appos	5	SENT_170	[p8l886t774r988b830],
9	,	,	O	,	_	0	SENT_170	[p8l886t774r988b830],
10	Wolf	NNP	PERSON	Wolf	nn	11	SENT_170	[p8l1013t771r1144b820],
11	CR	NN	O	cr	appos	5	SENT_170	[p8l1166t773r1255b830],
12	,	,	O	,	_	0	SENT_170	[p8l1166t773r1255b830],
13	Friedberg	NNP	ORGANIZATION	Friedberg	nn	15	SENT_170	[p8l1286t771r1545b835],
14	T.	NNP	ORGANIZATION	T.	nn	15	SENT_170	[p8l1570t774r1618b820],
15	Polymorphisms	NNP	ORGANIZATION	Polymorphisms	appos	5	SENT_170	[p8l1649t771r2072b835],
16	in	IN	O	in	_	0	SENT_170	[p8l2099t773r2143b819],
17	P450	NN	O	p450	nn	18	SENT_170	[p8l146t849r282b897],
18	CYP1B1	NN	O	cyp1b1	prep_in	15	SENT_170	[p8l327t849r532b897],
19	affect	VBP	O	affect	_	0	SENT_170	[p8l587t848r739b897],
20	the	DT	O	the	det	21	SENT_170	[p8l779t848r867b897],
21	conversion	NN	O	conversion	dobj	19	SENT_170	[p8l911t849r1208b897],
22	of	IN	O	of	_	0	SENT_170	[p8l1253t848r1307b897],
23	estradiol	NN	O	estradiol	prep_of	21	SENT_170	[p8l1347t848r1578b897],
24	to	TO	O	to	_	0	SENT_170	[p8l1623t854r1678b897],
25	the	DT	O	the	det	29	SENT_170	[p8l1720t848r1809b897],
26	potentially	RB	O	potentially	advmod	27	SENT_170	[p8l1854t848r2147b912],
27	carcinogenic	JJ	O	carcinogenic	amod	29	SENT_170	[p8l143t925r496b987],
28	metabolite	NN	O	metabolite	nn	29	SENT_170	[p8l540t924r836b972],
29	4-hydroxyestradiol	NN	O	4-hydroxyestradiol	prep_to	19	SENT_170	[p8l876t924r1415b987],
30	.	.	O	.	_	0	SENT_170	[p8l876t924r1415b987],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_171	[p8l1462t924r1947b987],
2	2000	CD	DATE	2000	num	1	SENT_171	[p8l1985t925r2142b982],
3	;	:	O	;	_	0	SENT_171	[p8l1985t925r2142b982],
4	10	CD	NUMBER	10	num	6	SENT_171	[p8l146t1001r227b1048],
5	:	:	O	:	_	0	SENT_171	[p8l146t1001r227b1048],
6	343-353	CD	NUMBER	343-353	dep	1	SENT_171	[p8l259t1001r519b1048],
7	.	.	O	.	_	0	SENT_171	[p8l259t1001r519b1048],

1	Aklillu	NN	O	aklillu	nn	2	SENT_172	[p8l140t1075r303b1124],
2	E	NN	O	e	nsubj	33	SENT_172	[p8l345t1078r385b1134],
3	,	,	O	,	_	0	SENT_172	[p8l345t1078r385b1134],
4	Oscarson	NN	O	oscarson	nn	5	SENT_172	[p8l426t1077r676b1124],
5	M	NN	O	m	dep	24	SENT_172	[p8l718t1078r785b1134],
6	,	,	O	,	_	0	SENT_172	[p8l718t1078r785b1134],
7	Hidestrand	NN	O	hidestrand	nn	8	SENT_172	[p8l828t1075r1125b1124],
8	M	NN	O	m	appos	5	SENT_172	[p8l1167t1078r1234b1134],
9	,	,	O	,	_	0	SENT_172	[p8l1167t1078r1234b1134],
10	Leidvik	NN	PERSON	leidvik	nn	11	SENT_172	[p8l1277t1075r1464b1124],
11	B	NN	PERSON	b	appos	5	SENT_172	[p8l1502t1078r1547b1134],
12	,	,	O	,	_	0	SENT_172	[p8l1502t1078r1547b1134],
13	Otter	NN	ORGANIZATION	otter	nn	14	SENT_172	[p8l1587t1077r1734b1124],
14	C	NN	ORGANIZATION	c	appos	5	SENT_172	[p8l1768t1077r1822b1134],
15	,	,	O	,	_	0	SENT_172	[p8l1768t1077r1822b1134],
16	|	NN	O	|	nn	17	SENT_172	[p8l1865t1075r2144b1139],
17	nge	NN	O	nge	appos	5	SENT_172	[p8l1865t1075r2144b1139],
18	|	CD	NUMBER	|	num	19	SENT_172	[p8l1865t1075r2144b1139],
19	man	NN	O	man	dep	24	SENT_172	[p8l1865t1075r2144b1139],
20	—	CD	NUMBER	—	num	24	SENT_172	[p8l1865t1075r2144b1139],
21	Sundberg	NNP	PERSON	Sundberg	nn	24	SENT_172	[p8l144t1152r411b1216],
22	M.	NNP	O	M.	nn	24	SENT_172	[p8l446t1154r513b1201],
23	Functional	JJ	O	functional	amod	24	SENT_172	[p8l549t1152r833b1201],
24	analysis	NN	O	analysis	dep	2	SENT_172	[p8l865t1152r1073b1216],
25	of	IN	O	of	_	0	SENT_172	[p8l1102t1152r1156b1201],
26	six	CD	NUMBER	six	num	32	SENT_172	[p8l1182t1153r1252b1201],
27	different	JJ	O	different	amod	32	SENT_172	[p8l1281t1152r1515b1201],
28	polymorphic	JJ	O	polymorphic	amod	32	SENT_172	[p8l1545t1152r1898b1216],
29	CYP1	NN	O	cyp1	nn	32	SENT_172	[p8l1927t1153r2060b1201],
30	B1	NN	O	b1	nn	32	SENT_172	[p8l2079t1153r2133b1200],
31	enzyme	NN	O	enzyme	nn	32	SENT_172	[p8l143t1242r358b1291],
32	variants	NNS	O	variant	prep_of	24	SENT_172	[p8l376t1229r590b1276],
33	found	VBN	O	find	_	0	SENT_172	[p8l607t1228r770b1276],
34	in	IN	O	in	_	0	SENT_172	[p8l793t1229r837b1276],
35	an	DT	O	a	det	37	SENT_172	[p8l858t1242r921b1276],
36	Ethiopian	JJ	MISC	ethiopian	amod	37	SENT_172	[p8l946t1228r1202b1291],
37	population	NN	O	population	prep_in	33	SENT_172	[p8l1225t1228r1541b1291],
38	.	.	O	.	_	0	SENT_172	[p8l1225t1228r1541b1291],

1	Mol	NNP	O	Mol	nn	2	SENT_173	[p8l1567t1228r1669b1276],
2	PharmacoI2002	NN	O	pharmacoi2002	_	0	SENT_173	[p8l1685t1228r2142b1286],
3	;	:	O	;	_	0	SENT_173	[p8l1685t1228r2142b1286],
4	61	CD	NUMBER	61	num	6	SENT_173	[p8l142t1305r227b1351],
5	:	:	O	:	_	0	SENT_173	[p8l142t1305r227b1351],
6	586-594	CD	NUMBER	586-594	dep	2	SENT_173	[p8l256t1305r519b1351],
7	.	.	O	.	_	0	SENT_173	[p8l256t1305r519b1351],

1	Tang	NNP	PERSON	Tang	nn	2	SENT_174	[p8l141t1382r279b1444],
2	YM	NNP	PERSON	YM	_	0	SENT_174	[p8l303t1382r410b1439],
3	,	,	O	,	_	0	SENT_174	[p8l303t1382r410b1439],
4	Green	NNP	O	Green	nn	5	SENT_174	[p8l438t1381r603b1429],
5	BL	NN	O	bl	appos	2	SENT_174	[p8l632t1382r707b1439],
6	,	,	O	,	_	0	SENT_174	[p8l632t1382r707b1439],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_174	[p8l736t1380r879b1429],
8	GF	NN	O	gf	appos	2	SENT_174	[p8l907t1381r995b1439],
9	,	,	O	,	_	0	SENT_174	[p8l907t1381r995b1439],
10	Thompson	NNP	ORGANIZATION	Thompson	nn	11	SENT_174	[p8l1020t1380r1319b1444],
11	PA	NN	ORGANIZATION	pa	appos	2	SENT_174	[p8l1348t1382r1430b1439],
12	,	,	O	,	_	0	SENT_174	[p8l1348t1382r1430b1439],
13	Lang	NNP	ORGANIZATION	Lang	nn	14	SENT_174	[p8l1461t1382r1590b1444],
14	NP	NNP	ORGANIZATION	NP	appos	2	SENT_174	[p8l1619t1382r1711b1439],
15	,	,	O	,	_	0	SENT_174	[p8l1619t1382r1711b1439],
16	Shinde	NNP	O	Shinde	nn	17	SENT_174	[p8l1741t1380r1928b1429],
17	A	NNP	O	A	appos	2	SENT_174	[p8l1950t1382r1990b1428],
18	et	FW	O	et	nn	19	SENT_174	[p8l2013t1386r2062b1429],
19	al.	FW	O	al.	dep	17	SENT_174	[p8l2084t1380r2142b1429],
20	.	.	O	.	_	0	SENT_174	[p8l2084t1380r2142b1429],

1	Human	JJ	O	human	amod	6	SENT_175	[p8l146t1458r344b1504],
2	CYP1B1	NN	O	cyp1b1	nn	6	SENT_175	[p8l375t1457r580b1504],
3	Leu432Va	NN	O	leu432va	nn	6	SENT_175	[p8l623t1456r908b1504],
4	|	NN	O	|	nn	6	SENT_175	[p8l623t1456r908b1504],
5	gene	NN	O	gene	nn	6	SENT_175	[p8l938t1470r1074b1519],
6	polymorphism	NN	O	polymorphism	_	0	SENT_175	[p8l1103t1456r1523b1519],
7	:	:	O	:	_	0	SENT_175	[p8l1103t1456r1523b1519],
8	ethnic	JJ	O	ethnic	amod	9	SENT_175	[p8l1553t1456r1725b1504],
9	distribution	NN	O	distribution	dep	6	SENT_175	[p8l1751t1456r2068b1504],
10	in	IN	O	in	_	0	SENT_175	[p8l2099t1457r2143b1504],
11	African-Americans	NNPS	MISC	African-Americans	prep_in	9	SENT_175	[p8l140t1532r660b1591],
12	,	,	O	,	_	0	SENT_175	[p8l140t1532r660b1591],
13	Caucasians	NNPS	MISC	Caucasians	conj_and	11	SENT_175	[p8l711t1533r1016b1580],
14	and	CC	O	and	_	0	SENT_175	[p8l1062t1532r1163b1580],
15	Chinese	NNPS	LOCATION	Chinese	conj_and	11	SENT_175	[p8l1212t1532r1447b1591],
16	;	:	O	;	_	0	SENT_175	[p8l1212t1532r1447b1591],
17	oestradiol	NN	O	oestradiol	nn	19	SENT_175	[p8l1497t1532r1765b1580],
18	hydroxylase	NN	O	hydroxylase	nn	19	SENT_175	[p8l1816t1532r2145b1596],
19	activity	NN	O	activity	prep_in	9	SENT_175	[p8l143t1609r354b1671],
20	;	:	O	;	_	0	SENT_175	[p8l143t1609r354b1671],
21	and	CC	O	and	_	0	SENT_175	[p8l411t1607r512b1656],
22	distribution	NN	O	distribution	conj_and	11	SENT_175	[p8l568t1607r883b1656],
23	in	IN	O	in	_	0	SENT_175	[p8l941t1609r986b1655],
24	prostate	NN	O	prostate	nn	26	SENT_175	[p8l1044t1613r1267b1671],
25	cancer	NN	O	cancer	nn	26	SENT_175	[p8l1321t1622r1504b1656],
26	cases	NNS	O	case	prep_in	22	SENT_175	[p8l1555t1622r1696b1656],
27	and	CC	O	and	_	0	SENT_175	[p8l1749t1607r1850b1656],
28	controls	NNS	O	control	prep_in	22	SENT_175	[p8l1906t1607r2142b1656],
29	.	.	O	.	_	0	SENT_175	[p8l1906t1607r2142b1656],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_176	[p8l145t1684r630b1748],
2	2000	CD	DATE	2000	num	1	SENT_176	[p8l652t1685r810b1743],
3	;	:	O	;	_	0	SENT_176	[p8l652t1685r810b1743],
4	10	CD	NUMBER	10	num	6	SENT_176	[p8l842t1685r923b1733],
5	:	:	O	:	_	0	SENT_176	[p8l842t1685r923b1733],
6	761-766	CD	NUMBER	761-766	dep	1	SENT_176	[p8l955t1685r1214b1733],
7	.	.	O	.	_	0	SENT_176	[p8l955t1685r1214b1733],

1	Sissung	NNP	O	Sissung	nn	2	SENT_177	[p8l144t1761r346b1823],
2	TM	NNP	O	TM	_	0	SENT_177	[p8l369t1762r477b1818],
3	,	,	O	,	_	0	SENT_177	[p8l369t1762r477b1818],
4	Price	NNP	O	Price	nn	5	SENT_177	[p8l506t1761r634b1808],
5	DK	NNP	O	DK	appos	2	SENT_177	[p8l660t1762r753b1818],
6	,	,	O	,	_	0	SENT_177	[p8l660t1762r753b1818],
7	Sparreboom	NNP	O	Sparreboom	nn	8	SENT_177	[p8l781t1760r1121b1823],
8	A	NNP	O	A	appos	2	SENT_177	[p8l1145t1762r1197b1818],
9	,	,	O	,	_	0	SENT_177	[p8l1145t1762r1197b1818],
10	Figg	NNP	PERSON	Figg	nn	11	SENT_177	[p8l1227t1761r1339b1823],
11	WD	NNP	O	WD	appos	2	SENT_177	[p8l1362t1761r1482b1808],
12	.	.	O	.	_	0	SENT_177	[p8l1362t1761r1482b1808],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_178	[p8l1511t1760r2020b1823],
2	and	CC	O	and	_	0	SENT_178	[p8l2043t1760r2144b1808],
3	regulation	NN	O	regulation	conj_and	1	SENT_178	[p8l145t1836r423b1900],
4	of	IN	O	of	_	0	SENT_178	[p8l453t1836r506b1885],
5	human	JJ	O	human	amod	8	SENT_178	[p8l533t1836r724b1885],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_178	[p8l754t1836r1086b1900],
7	P450	NN	O	p450	nn	8	SENT_178	[p8l1117t1838r1253b1885],
8	1B1	NN	O	1b1	prep_of	1	SENT_178	[p8l1284t1838r1402b1885],
9	:	:	O	:	_	0	SENT_178	[p8l1284t1838r1402b1885],
10	implications	NNS	O	implication	dep	1	SENT_178	[p8l1433t1836r1767b1900],
11	in	IN	O	in	_	0	SENT_178	[p8l1795t1837r1840b1884],
12	hormonemediated	JJ	O	hormonemediated	amod	14	SENT_178	[p8l1871t1836r2145b1885, p8l145t1912r404b1961],
13	tumor	NN	O	tumor	nn	14	SENT_178	[p8l456t1918r629b1961],
14	metabolism	NN	O	metabolism	prep_in	10	SENT_178	[p8l680t1912r1002b1961],
15	and	CC	O	and	_	0	SENT_178	[p8l1056t1912r1157b1961],
16	a	DT	O	a	det	18	SENT_178	[p8l1210t1926r1237b1961],
17	novel	JJ	O	novel	amod	18	SENT_178	[p8l1291t1912r1435b1961],
18	target	NN	O	target	conj_and	10	SENT_178	[p8l1488t1918r1655b1976],
19	for	IN	O	for	_	0	SENT_178	[p8l1702t1912r1780b1961],
20	therapeutic	JJ	O	therapeutic	amod	21	SENT_178	[p8l1828t1912r2146b1976],
21	intervention	NN	O	intervention	prep_for	18	SENT_178	[p8l144t1988r495b2035],
22	.	.	O	.	_	0	SENT_178	[p8l144t1988r495b2035],

1	Mol	NNP	O	Mol	nn	3	SENT_179	[p8l526t1987r629b2035],
2	Cancer	NNP	O	Cancer	nn	3	SENT_179	[p8l652t1989r839b2035],
3	Res	NNP	O	Res	_	0	SENT_179	[p8l860t1989r944b2035],
4	2006	CD	DATE	2006	num	3	SENT_179	[p8l967t1988r1124b2045],
5	;	:	O	;	_	0	SENT_179	[p8l967t1988r1124b2045],
6	4	CD	NUMBER	4	num	8	SENT_179	[p8l1152t1989r1201b2035],
7	:	:	O	:	_	0	SENT_179	[p8l1152t1989r1201b2035],
8	135-150	CD	NUMBER	135-150	dep	3	SENT_179	[p8l1233t1988r1493b2035],
9	.	.	O	.	_	0	SENT_179	[p8l1233t1988r1493b2035],

1	Brooks	NNP	ORGANIZATION	Brooks	nn	2	SENT_180	[p8l146t2063r325b2111],
2	TA	NNP	ORGANIZATION	TA	_	0	SENT_180	[p8l344t2065r431b2122],
3	,	,	O	,	_	0	SENT_180	[p8l344t2065r431b2122],
4	Minderman	NNP	PERSON	Minderman	nn	5	SENT_180	[p8l459t2063r780b2111],
5	H	NNP	PERSON	H	appos	2	SENT_180	[p8l806t2065r860b2121],
6	,	,	O	,	_	0	SENT_180	[p8l806t2065r860b2121],
7	O’Loughlin	NNP	O	O’Loughlin	nn	8	SENT_180	[p8l884t2063r1192b2126],
8	KL	NNP	O	KL	appos	2	SENT_180	[p8l1218t2064r1294b2122],
9	,	,	O	,	_	0	SENT_180	[p8l1218t2064r1294b2122],
10	Pera	NNP	PERSON	Pera	nn	11	SENT_180	[p8l1322t2065r1435b2111],
11	P	NN	PERSON	p	appos	2	SENT_180	[p8l1459t2065r1502b2121],
12	,	,	O	,	_	0	SENT_180	[p8l1459t2065r1502b2121],
13	Ojima	NNP	O	Ojima	appos	2	SENT_180	[p8l1527t2064r1691b2126],
14	I	PRP	O	I	dep	13	SENT_180	[p8l1716t2065r1740b2121],
15	,	,	O	,	_	0	SENT_180	[p8l1716t2065r1740b2121],
16	Baer	NNP	PERSON	Baer	nn	17	SENT_180	[p8l1768t2065r1887b2111],
17	MR	NN	O	mr	appos	2	SENT_180	[p8l1908t2065r1996b2111],
18	et	FW	O	et	nn	19	SENT_180	[p8l2017t2068r2066b2111],
19	al.	FW	O	al.	dep	17	SENT_180	[p8l2084t2063r2142b2111],
20	.	.	O	.	_	0	SENT_180	[p8l2084t2063r2142b2111],

1	Taxane	NN	O	taxane	nn	2	SENT_181	[p8l141t2138r525b2187],
2	—	NN	O	—	nsubj	6	SENT_181	[p8l141t2138r525b2187],
3	based	VBN	O	base	partmod	2	SENT_181	[p8l141t2138r525b2187],
4	reversal	NN	O	reversal	nn	5	SENT_181	[p8l563t2138r766b2187],
5	agents	NNS	O	agent	dobj	3	SENT_181	[p8l802t2144r984b2202],
6	modulate	VBP	O	modulate	_	0	SENT_181	[p8l1020t2138r1283b2187],
7	drug	NN	O	drug	nn	8	SENT_181	[p8l1317t2138r1445b2202],
8	resistance	NN	O	resistance	dobj	6	SENT_181	[p8l1483t2140r1749b2187],
9	mediated	VBN	O	mediate	partmod	8	SENT_181	[p8l1785t2138r2044b2187],
10	by	IN	O	by	_	0	SENT_181	[p8l2082t2138r2147b2202],
11	P-glycoprotein	NN	O	p-glycoprotein	agent	9	SENT_181	[p8l146t2215r565b2279],
12	,	,	O	,	_	0	SENT_181	[p8l146t2215r565b2279],
13	multidrug	JJ	O	multidrug	amod	15	SENT_181	[p8l632t2215r903b2279],
14	resistance	NN	O	resistance	nn	15	SENT_181	[p8l968t2216r1235b2264],
15	protein	NN	O	protein	agent	9	SENT_181	[p8l1298t2216r1510b2279],
16	,	,	O	,	_	0	SENT_181	[p8l1298t2216r1510b2279],
17	and	CC	O	and	_	0	SENT_181	[p8l1575t2215r1675b2264],
18	breast	NN	O	breast	nn	21	SENT_181	[p8l1740t2215r1906b2264],
19	cancer	NN	O	cancer	nn	21	SENT_181	[p8l1965t2229r2148b2264],
20	resistance	NN	O	resistance	nn	21	SENT_181	[p8l145t2292r411b2339],
21	protein	NN	O	protein	conj_and	11	SENT_181	[p8l440t2292r652b2354],
22	.	.	O	.	_	0	SENT_181	[p8l440t2292r652b2354],

1	Mol	NNP	O	Mol	nn	3	SENT_182	[p8l683t2291r786b2339],
2	Cancer	NNP	O	Cancer	nn	3	SENT_182	[p8l810t2292r996b2339],
3	Ther	NNP	O	Ther	_	0	SENT_182	[p8l1020t2291r1138b2339],
4	2003	CD	DATE	2003	num	3	SENT_182	[p8l1157t2292r1314b2349],
5	;	:	O	;	_	0	SENT_182	[p8l1157t2292r1314b2349],
6	2	CD	NUMBER	2	num	8	SENT_182	[p8l1342t2292r1390b2339],
7	:	:	O	:	_	0	SENT_182	[p8l1342t2292r1390b2339],
8	1195-1205	CD	DATE	1195-1205	dep	3	SENT_182	[p8l1422t2292r1755b2339],
9	.	.	O	.	_	0	SENT_182	[p8l1422t2292r1755b2339],

1	Litman	NNP	PERSON	Litman	nn	2	SENT_183	[p8l146t2368r330b2416],
2	T	NN	PERSON	t	_	0	SENT_183	[p8l371t2369r419b2426],
3	,	,	O	,	_	0	SENT_183	[p8l371t2369r419b2426],
4	Brangi	NNP	PERSON	Brangi	nn	5	SENT_183	[p8l465t2368r637b2431],
5	M	NNP	PERSON	M	appos	2	SENT_183	[p8l682t2369r749b2426],
6	,	,	O	,	_	0	SENT_183	[p8l682t2369r749b2426],
7	Hudson	NNP	ORGANIZATION	Hudson	nn	8	SENT_183	[p8l795t2367r1003b2416],
8	E	NNP	ORGANIZATION	E	appos	2	SENT_183	[p8l1048t2369r1088b2426],
9	,	,	O	,	_	0	SENT_183	[p8l1048t2369r1088b2426],
10	Fetsch	NNP	PERSON	Fetsch	nn	11	SENT_183	[p8l1135t2367r1303b2416],
11	P	NN	PERSON	p	appos	2	SENT_183	[p8l1348t2369r1391b2426],
12	,	,	O	,	_	0	SENT_183	[p8l1348t2369r1391b2426],
13	Abati	NNP	O	Abati	nn	14	SENT_183	[p8l1432t2367r1574b2416],
14	A	NNP	O	A	appos	2	SENT_183	[p8l1614t2369r1666b2426],
15	,	,	O	,	_	0	SENT_183	[p8l1614t2369r1666b2426],
16	Ross	NNP	PERSON	Ross	nn	17	SENT_183	[p8l1712t2369r1826b2416],
17	DD	NNP	O	DD	appos	2	SENT_183	[p8l1869t2369r1955b2415],
18	et	FW	O	et	nn	19	SENT_183	[p8l1998t2373r2047b2416],
19	al.	FW	O	al.	dep	17	SENT_183	[p8l2084t2367r2142b2416],
20	.	.	O	.	_	0	SENT_183	[p8l2084t2367r2142b2416],

1	The	DT	O	the	det	3	SENT_184	[p8l141t2443r243b2492],
2	multidrug-resistant	JJ	O	multidrug-resistant	amod	3	SENT_184	[p8l279t2443r809b2507],
3	phenotype	NN	O	phenotype	nsubj	4	SENT_184	[p8l843t2443r1142b2507],
4	associated	VBN	O	associate	_	0	SENT_184	[p8l1175t2443r1456b2492],
5	with	IN	O	with	_	0	SENT_184	[p8l1491t2443r1610b2492],
6	overexpression	NN	O	overexpression	prep_with	4	SENT_184	[p8l1646t2444r2059b2507],
7	of	IN	O	of	_	0	SENT_184	[p8l2094t2443r2148b2492],
8	the	DT	O	the	det	11	SENT_184	[p8l142t2519r230b2568],
9	new	JJ	O	new	amod	11	SENT_184	[p8l270t2533r385b2568],
10	ABC	NNP	ORGANIZATION	ABC	nn	11	SENT_184	[p8l420t2520r537b2568],
11	half-transporter	NN	O	half-transporter	prep_of	6	SENT_184	[p8l577t2519r1020b2583],
12	,	,	O	,	_	0	SENT_184	[p8l577t2519r1020b2583],
13	MXR	NN	O	mxr	nn	16	SENT_184	[p8l1065t2521r1195b2567],
14	(	CD	NUMBER	(	num	16	SENT_184	[p8l1232t2519r1491b2580],
15	ABCG2	NN	O	abcg2	nn	16	SENT_184	[p8l1232t2519r1491b2580],
16	)	NN	O	)	appos	11	SENT_184	[p8l1232t2519r1491b2580],
17	.	.	O	.	_	0	SENT_184	[p8l1232t2519r1491b2580],

1	/	:	O	/	punct	2	SENT_185	[p8l1529t2521r1550b2579],
2	Cell	NN	O	cell	_	0	SENT_185	[p8l1587t2519r1683b2568],
3	Sci	NNP	O	Sci	dep	2	SENT_185	[p8l1717t2520r1790b2568],
4	2000	CD	DATE	2000	num	3	SENT_185	[p8l1823t2520r1980b2578],
5	;	:	O	;	_	0	SENT_185	[p8l1823t2520r1980b2578],
6	113	CD	NUMBER	113	dep	2	SENT_185	[p8l2025t2520r2143b2568],
7	:	:	O	:	_	0	SENT_185	[p8l2025t2520r2143b2568],
8	2011-2021	CD	DATE	2011-2021	dep	6	SENT_185	[p8l143t2596r478b2642],
9	.	.	O	.	_	0	SENT_185	[p8l143t2596r478b2642],

1	Brooks	NNP	ORGANIZATION	Brooks	nn	2	SENT_186	[p8l146t2670r325b2719],
2	TA	NNP	ORGANIZATION	TA	_	0	SENT_186	[p8l363t2673r450b2729],
3	,	,	O	,	_	0	SENT_186	[p8l363t2673r450b2729],
4	Kennedy	NNP	PERSON	Kennedy	nn	5	SENT_186	[p8l496t2670r738b2734],
5	DR	NN	O	dr	appos	2	SENT_186	[p8l779t2673r869b2729],
6	,	,	O	,	_	0	SENT_186	[p8l779t2673r869b2729],
7	Gruol	NNP	O	Gruol	nn	8	SENT_186	[p8l913t2670r1064b2719],
8	DJ	NNP	O	DJ	appos	2	SENT_186	[p8l1108t2673r1181b2730],
9	,	,	O	,	_	0	SENT_186	[p8l1108t2673r1181b2730],
10	Ojima	NNP	O	Ojima	appos	2	SENT_186	[p8l1224t2672r1389b2734],
11	I	PRP	O	I	dep	10	SENT_186	[p8l1432t2673r1457b2729],
12	,	,	O	,	_	0	SENT_186	[p8l1432t2673r1457b2729],
13	Baer	NNP	PERSON	Baer	nn	14	SENT_186	[p8l1503t2673r1621b2719],
14	MR	NN	PERSON	mr	appos	2	SENT_186	[p8l1661t2673r1764b2729],
15	,	,	O	,	_	0	SENT_186	[p8l1661t2673r1764b2729],
16	Bernacki	NNP	PERSON	Bernacki	nn	17	SENT_186	[p8l1809t2670r2037b2719],
17	R	NNP	O	R	appos	2	SENT_186	[p8l2081t2673r2142b2730],
18	]	NN	O	]	dep	17	SENT_186	[p8l2081t2673r2142b2730],
19	.	.	O	.	_	0	SENT_186	[p8l2081t2673r2142b2730],

1	Structure-activity	JJ	O	structure-activity	amod	2	SENT_187	[p8l144t2748r618b2811],
2	analysis	NN	O	analysis	_	0	SENT_187	[p8l652t2747r861b2811],
3	of	IN	O	of	_	0	SENT_187	[p8l896t2747r950b2796],
4	taxane-based	JJ	O	taxane-based	amod	8	SENT_187	[p8l980t2747r1350b2796],
5	broad-spectrum	JJ	O	broad-spectrum	amod	8	SENT_187	[p8l1389t2747r1831b2811],
6	multidrug	JJ	O	multidrug	amod	8	SENT_187	[p8l1871t2747r2143b2811],
7	resistance	NN	O	resistance	nn	8	SENT_187	[p8l145t2823r411b2869],
8	modulators	NNS	O	modulator	prep_of	2	SENT_187	[p8l440t2822r769b2869],
9	.	.	O	.	_	0	SENT_187	[p8l440t2822r769b2869],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_188	[p8l796t2823r1084b2869],
2	Res	NNP	O	Res	_	0	SENT_188	[p8l1104t2824r1189b2869],
3	2004	CD	DATE	2004	dep	2	SENT_188	[p8l1212t2823r1369b2879],
4	;	:	O	;	_	0	SENT_188	[p8l1212t2823r1369b2879],
5	24	CD	NUMBER	24	num	7	SENT_188	[p8l1399t2823r1483b2869],
6	:	:	O	:	_	0	SENT_188	[p8l1399t2823r1483b2869],
7	409-415	CD	NUMBER	409-415	dep	2	SENT_188	[p8l1510t2823r1774b2869],
8	.	.	O	.	_	0	SENT_188	[p8l1510t2823r1774b2869],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_189	[p8l146t2898r436b2962],
2	S	NNP	O	S	_	0	SENT_189	[p8l459t2900r502b2957],
3	,	,	O	,	_	0	SENT_189	[p8l459t2900r502b2957],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_189	[p8l533t2898r653b2947],
5	o	NN	O	o	appos	2	SENT_189	[p8l675t2900r736b2957],
6	,	,	O	,	_	0	SENT_189	[p8l675t2900r736b2957],
7	von	NNP	PERSON	von	nn	9	SENT_189	[p8l762t2912r863b2947],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_189	[p8l892t2898r1082b2947],
9	o	NN	O	o	appos	2	SENT_189	[p8l1104t2900r1165b2957],
10	,	,	O	,	_	0	SENT_189	[p8l1104t2900r1165b2957],
11	Arnold	NNP	ORGANIZATION	Arnold	nn	12	SENT_189	[p8l1190t2898r1374b2947],
12	HP	NNP	ORGANIZATION	HP	appos	2	SENT_189	[p8l1404t2900r1491b2957],
13	,	,	O	,	_	0	SENT_189	[p8l1404t2900r1491b2957],
14	Brockmoller	NNP	PERSON	Brockmoller	nn	15	SENT_189	[p8l1522t2898r1852b2947],
15	J	NNP	PERSON	J	appos	2	SENT_189	[p8l1873t2900r1902b2958],
16	,	,	O	,	_	0	SENT_189	[p8l1873t2900r1902b2958],
17	Johne	NNP	O	Johne	nn	18	SENT_189	[p8l1928t2898r2087b2958],
18	A	NNP	O	A	appos	2	SENT_189	[p8l2109t2900r2148b2946],
19	et	FW	O	et	nn	20	SENT_189	[p8l144t2979r194b3022],
20	al.	FW	O	al.	dep	18	SENT_189	[p8l229t2973r287b3022],
21	.	.	O	.	_	0	SENT_189	[p8l229t2973r287b3022],

1	Functional	JJ	O	functional	amod	2	SENT_190	[p8l332t2973r615b3022],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_190	[p8l658t2973r1086b3037],
3	of	IN	O	of	_	0	SENT_190	[p8l1125t2973r1179b3022],
4	the	DT	O	the	det	7	SENT_190	[p8l1213t2973r1301b3022],
5	human	JJ	O	human	amod	7	SENT_190	[p8l1342t2973r1533b3022],
6	mu	NN	O	mu	nn	7	SENT_190	[p8l1576t2973r2145b3037],
7	|	NN	O	|	prep_of	2	SENT_190	[p8l1576t2973r2145b3037],
8	tidrug	NN	O	tidrug	nn	11	SENT_190	[p8l1576t2973r2145b3037],
9	—	CD	NUMBER	—	num	11	SENT_190	[p8l1576t2973r2145b3037],
10	resistance	NN	O	resistance	nn	11	SENT_190	[p8l1576t2973r2145b3037],
11	gene	NN	O	gene	dep	2	SENT_190	[p9l146t98r298b147],
12	:	:	O	:	_	0	SENT_190	[p9l146t98r298b147],
13	multiple	JJ	O	multiple	amod	15	SENT_190	[p9l335t84r560b147],
14	sequence	NN	O	sequence	nn	15	SENT_190	[p9l590t98r851b147],
15	variations	NNS	O	variation	dep	2	SENT_190	[p9l881t85r1146b132],
16	and	CC	O	and	_	0	SENT_190	[p9l1178t84r1278b132],
17	correlation	NN	O	correlation	dep	2	SENT_190	[p9l1312t84r1607b132],
18	of	IN	O	of	_	0	SENT_190	[p9l1641t84r1694b132],
19	one	CD	NUMBER	one	num	20	SENT_190	[p9l1723t98r1825b132],
20	allele	NN	O	allele	prep_of	17	SENT_190	[p9l1856t84r1994b132],
21	with	IN	O	with	_	0	SENT_190	[p9l2024t84r2144b132],
22	P-glycoprotein	NN	MISC	p-glycoprotein	nn	23	SENT_190	[p9l149t159r551b222],
23	expression	NN	O	expression	prep_with	20	SENT_190	[p9l584t160r874b222],
24	and	CC	O	and	_	0	SENT_190	[p9l907t159r1007b207],
25	activity	NN	O	activity	prep_with	20	SENT_190	[p9l1040t160r1237b222],
26	in	FW	O	in	prep	17	SENT_190	[p9l1269t160r1314b206],
27	vivo	FW	O	vivo	pobj	26	SENT_190	[p9l1346t160r1460b207],
28	.	.	O	.	_	0	SENT_190	[p9l1346t160r1460b207],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_191	[p9l1497t161r1610b207],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_191	[p9l1638t159r1755b207],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_191	[p9l1778t159r1914b207],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_191	[p9l1941t160r2014b207],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_191	[p9l2044t160r2147b207],
6	2000	CD	DATE	2000	num	5	SENT_191	[p9l147t235r304b291],
7	;	:	O	;	_	0	SENT_191	[p9l147t235r304b291],
8	97	CD	NUMBER	97	num	10	SENT_191	[p9l332t235r417b281],
9	:	:	O	:	_	0	SENT_191	[p9l332t235r417b281],
10	3473-3478	CD	DURATION	3473-3478	dep	5	SENT_191	[p9l448t235r781b281],
11	.	.	O	.	_	0	SENT_191	[p9l448t235r781b281],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_192	[p9l149t310r250b357],
2	RB	NN	O	rb	_	0	SENT_192	[p9l285t311r365b367],
3	,	,	O	,	_	0	SENT_192	[p9l285t311r365b367],
4	Leake	NNP	PERSON	Leake	nn	5	SENT_192	[p9l401t309r552b357],
5	BF	NNP	O	BF	appos	2	SENT_192	[p9l585t311r660b367],
6	,	,	O	,	_	0	SENT_192	[p9l585t311r660b367],
7	Choo	NNP	ORGANIZATION	Choo	nn	8	SENT_192	[p9l694t309r843b357],
8	EF	NNP	ORGANIZATION	EF	appos	2	SENT_192	[p9l876t311r946b367],
9	,	,	O	,	_	0	SENT_192	[p9l876t311r946b367],
10	Dresser	NNP	ORGANIZATION	Dresser	nn	11	SENT_192	[p9l982t311r1184b357],
11	GK	NNP	ORGANIZATION	GK	appos	2	SENT_192	[p9l1211t311r1306b367],
12	,	,	O	,	_	0	SENT_192	[p9l1211t311r1306b367],
13	Kubba	NNP	ORGANIZATION	Kubba	nn	14	SENT_192	[p9l1342t309r1516b357],
14	SV	NNP	ORGANIZATION	SV	appos	2	SENT_192	[p9l1549t311r1629b367],
15	,	,	O	,	_	0	SENT_192	[p9l1549t311r1629b367],
16	Schwarz	NNP	PERSON	Schwarz	nn	17	SENT_192	[p9l1664t309r1892b357],
17	Ul	NNP	PERSON	Ul	appos	2	SENT_192	[p9l1924t311r1975b357],
18	et	FW	O	et	nn	19	SENT_192	[p9l2009t315r2058b357],
19	al.	FW	O	al.	dep	17	SENT_192	[p9l2085t309r2142b357],
20	.	.	O	.	_	0	SENT_192	[p9l2085t309r2142b357],

1	Identification	NN	O	identification	_	0	SENT_193	[p9l149t383r509b431],
2	of	IN	O	of	_	0	SENT_193	[p9l551t383r604b431],
3	functionally	RB	O	functionally	advmod	4	SENT_193	[p9l638t383r966b446],
4	variant	JJ	O	variant	amod	6	SENT_193	[p9l1003t385r1194b431],
5	MDR1	NN	O	mdr1	nn	6	SENT_193	[p9l1235t385r1393b431],
6	alleles	NNS	O	allele	prep_of	1	SENT_193	[p9l1445t383r1608b431],
7	among	IN	O	among	_	0	SENT_193	[p9l1648t397r1842b446],
8	European	JJ	MISC	european	amod	9	SENT_193	[p9l1887t386r2143b446],
9	Americans	NNPS	MISC	Americans	prep_among	1	SENT_193	[p9l144t460r432b507],
10	and	CC	O	and	_	0	SENT_193	[p9l479t459r579b507],
11	African	NNP	MISC	African	nn	12	SENT_193	[p9l625t459r816b507],
12	Americans	NNPS	MISC	Americans	prep_among	1	SENT_193	[p9l862t460r1166b507],
13	.	.	O	.	_	0	SENT_193	[p9l862t460r1166b507],

1	Clin	NNP	O	Clin	nn	3	SENT_194	[p9l1219t459r1317b507],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_194	[p9l1364t459r1648b507],
3	Ther	NNP	O	Ther	_	0	SENT_194	[p9l1695t459r1813b507],
4	2001	CD	DATE	2001	num	3	SENT_194	[p9l1852t460r2009b517],
5	;	:	O	;	_	0	SENT_194	[p9l1852t460r2009b517],
6	70	CD	NUMBER	70	num	8	SENT_194	[p9l2062t460r2143b507],
7	:	:	O	:	_	0	SENT_194	[p9l2062t460r2143b507],
8	189-199	CD	NUMBER	189-199	dep	3	SENT_194	[p9l149t537r409b583],
9	.	.	O	.	_	0	SENT_194	[p9l149t537r409b583],

1	de	IN	O	de	dep	5	SENT_195	[p9l146t610r212b658],
2	Jong	NNP	ORGANIZATION	Jong	nn	3	SENT_195	[p9l233t612r356b673],
3	FA	NNP	ORGANIZATION	FA	pobj	1	SENT_195	[p9l383t612r460b668],
4	,	,	O	,	_	0	SENT_195	[p9l383t612r460b668],
5	Marsh	NNP	ORGANIZATION	Marsh	_	0	SENT_195	[p9l488t610r653b658],
6	5	CD	NUMBER	5	num	5	SENT_195	[p9l678t612r721b668],
7	,	,	O	,	_	0	SENT_195	[p9l678t612r721b668],
8	Mathijssen	NNP	PERSON	Mathijssen	nn	9	SENT_195	[p9l749t610r1039b673],
9	RH	NNP	O	RH	appos	5	SENT_195	[p9l1066t612r1154b668],
10	,	,	O	,	_	0	SENT_195	[p9l1066t612r1154b668],
11	King	NNP	O	King	nn	12	SENT_195	[p9l1182t611r1301b673],
12	C	NNP	O	C	appos	5	SENT_195	[p9l1325t612r1379b668],
13	,	,	O	,	_	0	SENT_195	[p9l1325t612r1379b668],
14	Verweij	NNP	PERSON	Verweij	nn	15	SENT_195	[p9l1401t611r1603b673],
15	J	NNP	PERSON	J	appos	5	SENT_195	[p9l1625t612r1654b669],
16	,	,	O	,	_	0	SENT_195	[p9l1625t612r1654b669],
17	Sparreboom	NNP	O	Sparreboom	nn	18	SENT_195	[p9l1680t610r2020b673],
18	A	NNP	O	A	appos	5	SENT_195	[p9l2041t612r2080b657],
19	et	FW	O	et	nn	20	SENT_195	[p9l2102t616r2151b658],
20	al.	FW	O	al.	dep	18	SENT_195	[p9l148t685r206b733],
21	.	.	O	.	_	0	SENT_195	[p9l148t685r206b733],

1	ABCG2	NN	O	abcg2	nn	2	SENT_196	[p9l229t686r428b733],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_196	[p9l454t685r980b748],
3	:	:	O	:	_	0	SENT_196	[p9l454t685r980b748],
4	ethnic	JJ	O	ethnic	amod	5	SENT_196	[p9l1005t685r1176b733],
5	differences	NNS	O	difference	dep	2	SENT_196	[p9l1197t685r1495b733],
6	in	IN	O	in	_	0	SENT_196	[p9l1518t686r1563b732],
7	allele	NN	O	allele	nn	8	SENT_196	[p9l1586t685r1725b733],
8	frequency	NN	O	frequency	prep_in	5	SENT_196	[p9l1744t685r2023b748],
9	and	CC	O	and	_	0	SENT_196	[p9l2043t685r2144b733],
10	assessment	NN	O	assessment	conj_and	8	SENT_196	[p9l146t765r455b807],
11	of	IN	O	of	_	0	SENT_196	[p9l476t760r530b807],
12	influence	NN	O	influence	prep_of	5	SENT_196	[p9l550t760r801b807],
13	on	IN	O	on	_	0	SENT_196	[p9l823t774r890b807],
14	irinotecan	NN	O	irinotecan	nn	15	SENT_196	[p9l917t761r1188b807],
15	disposition	NN	O	disposition	prep_on	12	SENT_196	[p9l1213t760r1527b822],
16	.	.	O	.	_	0	SENT_196	[p9l1213t760r1527b822],

1	Clin	NNP	O	Clin	nn	3	SENT_197	[p9l1556t760r1654b807],
2	Cancer	NNP	O	Cancer	nn	3	SENT_197	[p9l1678t761r1864b807],
3	Res	NNP	O	Res	_	0	SENT_197	[p9l1882t762r1966b807],
4	2004	CD	DATE	2004	num	3	SENT_197	[p9l1986t761r2143b817],
5	;	:	O	;	_	0	SENT_197	[p9l1986t761r2143b817],
6	10	CD	NUMBER	10	num	8	SENT_197	[p9l150t837r231b883],
7	:	:	O	:	_	0	SENT_197	[p9l150t837r231b883],
8	5889-5894	CD	DURATION	5889-5894	dep	3	SENT_197	[p9l260t837r594b883],
9	.	.	O	.	_	0	SENT_197	[p9l260t837r594b883],

1	Sparreboom	NNP	MISC	Sparreboom	nn	2	SENT_198	[p9l147t910r487b973],
2	A	NNP	MISC	A	_	0	SENT_198	[p9l509t913r562b968],
3	,	,	O	,	_	0	SENT_198	[p9l509t913r562b968],
4	Gelderblom	NNP	PERSON	Gelderblom	nn	5	SENT_198	[p9l588t910r915b958],
5	H	NNP	O	H	appos	2	SENT_198	[p9l943t913r996b968],
6	,	,	O	,	_	0	SENT_198	[p9l943t913r996b968],
7	Marsh	NNP	ORGANIZATION	Marsh	appos	2	SENT_198	[p9l1025t910r1190b958],
8	5	CD	NUMBER	5	num	7	SENT_198	[p9l1216t912r1259b968],
9	,	,	O	,	_	0	SENT_198	[p9l1216t912r1259b968],
10	Ahluwalia	NNP	PERSON	Ahluwalia	nn	11	SENT_198	[p9l1283t910r1551b958],
11	R	NNP	PERSON	R	appos	2	SENT_198	[p9l1578t913r1621b968],
12	,	,	O	,	_	0	SENT_198	[p9l1578t913r1621b968],
13	Obach	NNP	ORGANIZATION	Obach	nn	14	SENT_198	[p9l1647t910r1828b958],
14	R	NNP	ORGANIZATION	R	appos	2	SENT_198	[p9l1856t913r1899b968],
15	,	,	O	,	_	0	SENT_198	[p9l1856t913r1899b968],
16	Principe	NNP	O	Principe	nn	17	SENT_198	[p9l1928t912r2146b973],
17	P	NN	O	p	appos	2	SENT_198	[p9l149t988r176b1033],
18	et	FW	O	et	nn	19	SENT_198	[p9l204t992r253b1034],
19	al.	FW	O	al.	dep	17	SENT_198	[p9l277t986r334b1034],
20	.	.	O	.	_	0	SENT_198	[p9l277t986r334b1034],

1	Diflomotecan	NNP	MISC	Diflomotecan	nn	2	SENT_199	[p9l366t986r738b1034],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_199	[p9l768t986r1255b1049],
3	in	IN	O	in	_	0	SENT_199	[p9l1282t987r1326b1033],
4	relation	NN	O	relation	prep_in	2	SENT_199	[p9l1357t986r1560b1034],
5	to	TO	O	to	_	0	SENT_199	[p9l1588t992r1643b1034],
6	ABCG2	NN	O	abcg2	nn	7	SENT_199	[p9l1667t987r1867b1034],
7	421C	NN	O	421c	prep_to	4	SENT_199	[p9l1893t987r2148b1034],
8	>	JJR	O	>	dep	2	SENT_199	[p9l1893t987r2148b1034],
9	A	DT	O	a	det	10	SENT_199	[p9l1893t987r2148b1034],
10	genotype	NN	O	genotype	dep	8	SENT_199	[p9l146t1066r426b1123],
11	.	.	O	.	_	0	SENT_199	[p9l146t1066r426b1123],

1	Clin	NNP	O	Clin	nn	3	SENT_200	[p9l458t1061r556b1108],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_200	[p9l582t1061r867b1108],
3	Ther	NNP	O	Ther	_	0	SENT_200	[p9l893t1061r1010b1108],
4	2004	CD	DATE	2004	num	3	SENT_200	[p9l1029t1062r1186b1118],
5	;	:	O	;	_	0	SENT_200	[p9l1029t1062r1186b1118],
6	76	CD	NUMBER	76	num	8	SENT_200	[p9l1217t1062r1299b1108],
7	:	:	O	:	_	0	SENT_200	[p9l1217t1062r1299b1108],
8	38-44	CD	NUMBER	38-44	dep	3	SENT_200	[p9l1330t1062r1516b1108],
9	.	.	O	.	_	0	SENT_200	[p9l1330t1062r1516b1108],

1	Bates	NNP	PERSON	Bates	nn	2	SENT_201	[p9l149t1138r290b1184],
2	SE	NN	O	se	_	0	SENT_201	[p9l315t1138r390b1194],
3	,	,	O	,	_	0	SENT_201	[p9l315t1138r390b1194],
4	Medina-Perez	NNP	O	Medina-Perez	nn	5	SENT_201	[p9l420t1136r799b1184],
5	WY	NN	O	wy	appos	2	SENT_201	[p9l820t1138r927b1194],
6	,	,	O	,	_	0	SENT_201	[p9l820t1138r927b1194],
7	Kohlhagen	NN	LOCATION	kohlhagen	nn	8	SENT_201	[p9l957t1136r1251b1199],
8	G	NN	LOCATION	g	appos	2	SENT_201	[p9l1278t1138r1336b1194],
9	,	,	O	,	_	0	SENT_201	[p9l1278t1138r1336b1194],
10	Antony	NNP	PERSON	Antony	nn	11	SENT_201	[p9l1361t1138r1564b1199],
11	S	NNP	PERSON	S	appos	2	SENT_201	[p9l1588t1138r1631b1194],
12	,	,	O	,	_	0	SENT_201	[p9l1588t1138r1631b1194],
13	Nadjem	NNP	ORGANIZATION	Nadjem	nn	14	SENT_201	[p9l1662t1136r1876b1199],
14	T	NN	ORGANIZATION	t	appos	2	SENT_201	[p9l1901t1138r1949b1194],
15	,	,	O	,	_	0	SENT_201	[p9l1901t1138r1949b1194],
16	Robey	NNP	PERSON	Robey	nn	17	SENT_201	[p9l1979t1136r2147b1199],
17	RW	NNP	O	RW	appos	2	SENT_201	[p9l149t1212r239b1258],
18	et	FW	O	et	nn	19	SENT_201	[p9l264t1216r312b1259],
19	al.	FW	O	al.	dep	17	SENT_201	[p9l336t1211r393b1259],
20	.	.	O	.	_	0	SENT_201	[p9l336t1211r393b1259],

1	ABCG2	NN	O	abcg2	nsubj	2	SENT_202	[p9l420t1212r620b1259],
2	mediates	VBZ	O	mediate	_	0	SENT_202	[p9l649t1211r896b1259],
3	differential	JJ	O	differential	amod	4	SENT_202	[p9l922t1211r1214b1259],
4	resistance	NN	O	resistance	dobj	2	SENT_202	[p9l1244t1212r1511b1259],
5	to	TO	O	to	_	0	SENT_202	[p9l1536t1216r1590b1259],
6	SN-38	NN	O	sn-38	prep_to	2	SENT_202	[p9l1618t1212r1789b1259],
7	(	CD	NUMBER	(	num	6	SENT_202	[p9l1816t1211r2145b1274, p9l148t1286r785b1348],
8	7ethy	CD	NUMBER	7ethy	num	11	SENT_202	[p9l1816t1211r2145b1274, p9l148t1286r785b1348],
9	|	NN	O	|	nn	11	SENT_202	[p9l1816t1211r2145b1274, p9l148t1286r785b1348],
10	10hydroxycamptothecin	NN	O	10hydroxycamptothecin	nn	11	SENT_202	[p9l1816t1211r2145b1274, p9l148t1286r785b1348],
11	)	NN	O	)	dep	6	SENT_202	[p9l1816t1211r2145b1274, p9l148t1286r785b1348],
12	and	CC	O	and	_	0	SENT_202	[p9l812t1286r913b1333],
13	homocamptothecins	NNS	O	homocamptothecin	conj_and	6	SENT_202	[p9l944t1286r1536b1348],
14	.	.	O	.	_	0	SENT_202	[p9l944t1286r1536b1348],

1	/	:	O	/	punct	4	SENT_203	[p9l1562t1288r1583b1344],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_203	[p9l1608t1286r1893b1333],
3	Exp	NNP	O	Exp	nn	4	SENT_203	[p9l1917t1288r2006b1348],
4	Ther	NNP	O	Ther	_	0	SENT_203	[p9l2036t1286r2153b1333],
5	2004	CD	DATE	2004	dep	4	SENT_203	[p9l147t1362r304b1418],
6	;	:	O	;	_	0	SENT_203	[p9l147t1362r304b1418],
7	310	CD	NUMBER	310	dep	4	SENT_203	[p9l334t1362r453b1408],
8	:	:	O	:	_	0	SENT_203	[p9l334t1362r453b1408],
9	836-842	CD	NUMBER	836-842	dep	7	SENT_203	[p9l483t1362r744b1408],
10	.	.	O	.	_	0	SENT_203	[p9l483t1362r744b1408],

1	Hahn	NNP	PERSON	Hahn	nn	2	SENT_204	[p9l149t1436r291b1484],
2	NM	NNP	O	NM	_	0	SENT_204	[p9l326t1438r444b1494],
3	,	,	O	,	_	0	SENT_204	[p9l326t1438r444b1494],
4	Marsh	NNP	ORGANIZATION	Marsh	appos	2	SENT_204	[p9l480t1436r646b1484],
5	5	CD	NUMBER	5	num	4	SENT_204	[p9l680t1438r723b1494],
6	,	,	O	,	_	0	SENT_204	[p9l680t1438r723b1494],
7	Fisher	NNP	PERSON	Fisher	nn	8	SENT_204	[p9l759t1436r917b1484],
8	W	NNP	O	W	appos	2	SENT_204	[p9l942t1438r1014b1494],
9	,	,	O	,	_	0	SENT_204	[p9l942t1438r1014b1494],
10	Langdon	NNP	PERSON	Langdon	nn	11	SENT_204	[p9l1051t1436r1291b1499],
11	R	NNP	PERSON	R	appos	2	SENT_204	[p9l1327t1438r1370b1494],
12	,	,	O	,	_	0	SENT_204	[p9l1327t1438r1370b1494],
13	Zon	NNP	PERSON	Zon	nn	14	SENT_204	[p9l1404t1438r1510b1484],
14	R	NNP	O	R	appos	2	SENT_204	[p9l1546t1438r1589b1494],
15	,	,	O	,	_	0	SENT_204	[p9l1546t1438r1589b1494],
16	Browning	NNP	PERSON	Browning	nn	17	SENT_204	[p9l1626t1437r1888b1499],
17	M	NNP	O	M	appos	2	SENT_204	[p9l1925t1438r1974b1483],
18	et	FW	O	et	nn	19	SENT_204	[p9l2009t1442r2058b1484],
19	al.	FW	O	al.	dep	17	SENT_204	[p9l2085t1436r2143b1484],
20	.	.	O	.	_	0	SENT_204	[p9l2085t1436r2143b1484],

1	Hoosier	NNP	ORGANIZATION	Hoosier	nn	7	SENT_205	[p9l149t1512r357b1559],
2	Oncology	NNP	ORGANIZATION	Oncology	nn	7	SENT_205	[p9l394t1511r666b1574],
3	Group	NNP	ORGANIZATION	Group	nn	7	SENT_205	[p9l705t1512r879b1574],
4	Randomized	NNP	ORGANIZATION	Randomized	nn	7	SENT_205	[p9l921t1511r1262b1559],
5	Phase	NN	ORGANIZATION	phase	nn	7	SENT_205	[p9l1306t1511r1459b1559],
6	II	CD	ORGANIZATION	ii	num	7	SENT_205	[p9l1501t1513r1524b1558],
7	Study	NN	ORGANIZATION	study	_	0	SENT_205	[p9l1566t1511r1724b1574],
8	of	IN	ORGANIZATION	of	_	0	SENT_205	[p9l1761t1511r1814b1559],
9	Docetaxel	NNP	ORGANIZATION	Docetaxel	prep_of	7	SENT_205	[p9l1853t1511r2142b1569],
10	,	,	O	,	_	0	SENT_205	[p9l1853t1511r2142b1569],
11	Vinorelbine	NNP	O	Vinorelbine	prep_of	7	SENT_205	[p9l144t1586r476b1643],
12	,	,	O	,	_	0	SENT_205	[p9l144t1586r476b1643],
13	and	CC	O	and	_	0	SENT_205	[p9l510t1586r611b1633],
14	Estramustine	NNP	LOCATION	Estramustine	conj_and	9	SENT_205	[p9l645t1587r996b1633],
15	in	IN	O	in	_	0	SENT_205	[p9l1028t1587r1072b1633],
16	Combination	NNP	O	Combination	prep_in	7	SENT_205	[p9l1105t1586r1468b1633],
17	in	IN	O	in	_	0	SENT_205	[p9l1503t1587r1547b1633],
18	Hormone-Refractory	NNP	O	Hormone-Refractory	nn	20	SENT_205	[p9l1582t1586r2147b1648],
19	Prostate	NNP	O	Prostate	nn	20	SENT_205	[p9l149t1663r367b1709],
20	Cancer	NNP	O	Cancer	prep_in	7	SENT_205	[p9l390t1663r585b1709],
21	with	IN	O	with	_	0	SENT_205	[p9l601t1661r721b1709],
22	Pharmacogenetic	NNP	O	Pharmacogenetic	nn	24	SENT_205	[p9l747t1661r1230b1724],
23	Survival	NNP	O	Survival	nn	24	SENT_205	[p9l1252t1661r1460b1709],
24	Analysis	NN	O	analysis	prep_with	20	SENT_205	[p9l1481t1661r1714b1724],
25	.	.	O	.	_	0	SENT_205	[p9l1481t1661r1714b1724],

1	Clin	NNP	O	Clin	nn	3	SENT_206	[p9l1743t1661r1840b1709],
2	Cancer	NNP	O	Cancer	nn	3	SENT_206	[p9l1862t1663r2049b1709],
3	Res	NNP	O	Res	_	0	SENT_206	[p9l2065t1663r2149b1709],
4	2006	CD	DATE	2006	num	3	SENT_206	[p9l147t1737r304b1794],
5	;	:	O	;	_	0	SENT_206	[p9l147t1737r304b1794],
6	12	CD	NUMBER	12	num	8	SENT_206	[p9l336t1737r417b1784],
7	:	:	O	:	_	0	SENT_206	[p9l336t1737r417b1784],
8	6094-6099	CD	DURATION	6094-6099	dep	3	SENT_206	[p9l446t1737r781b1784],
9	.	.	O	.	_	0	SENT_206	[p9l446t1737r781b1784],

1	Ameyaw	NNP	O	Ameyaw	nn	2	SENT_207	[p9l144t1813r386b1874],
2	MM	NN	O	mm	_	0	SENT_207	[p9l410t1813r536b1869],
3	,	,	O	,	_	0	SENT_207	[p9l410t1813r536b1869],
4	Regateiro	NN	O	regateiro	nn	5	SENT_207	[p9l566t1812r825b1874],
5	F	NN	O	f	appos	2	SENT_207	[p9l850t1813r889b1869],
6	,	,	O	,	_	0	SENT_207	[p9l850t1813r889b1869],
7	Li	NNP	PERSON	Li	nn	8	SENT_207	[p9l918t1812r955b1858],
8	T	NN	PERSON	t	appos	2	SENT_207	[p9l978t1813r1026b1869],
9	,	,	O	,	_	0	SENT_207	[p9l978t1813r1026b1869],
10	Liu	NNP	LOCATION	Liu	nn	11	SENT_207	[p9l1056t1812r1129b1859],
11	X	NNP	LOCATION	X	appos	2	SENT_207	[p9l1154t1813r1206b1869],
12	,	,	O	,	_	0	SENT_207	[p9l1154t1813r1206b1869],
13	Tariq	NNP	PERSON	Tariq	nn	14	SENT_207	[p9l1231t1812r1368b1874],
14	M	NNP	PERSON	M	appos	2	SENT_207	[p9l1397t1813r1463b1869],
15	,	,	O	,	_	0	SENT_207	[p9l1397t1813r1463b1869],
16	Mobarek	NNP	O	Mobarek	nn	17	SENT_207	[p9l1493t1811r1738b1859],
17	A	NNP	O	A	appos	2	SENT_207	[p9l1757t1813r1796b1858],
18	et	FW	O	et	nn	19	SENT_207	[p9l1819t1817r1868b1859],
19	al.	FW	O	al.	dep	17	SENT_207	[p9l1888t1811r1945b1859],
20	.	.	O	.	_	0	SENT_207	[p9l1888t1811r1945b1859],

1	MDR1	NN	O	mdr1	nn	2	SENT_208	[p9l1975t1812r2134b1859],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_208	[p9l148t1886r675b1948],
3	:	:	O	:	_	0	SENT_208	[p9l148t1886r675b1948],
4	frequency	NN	O	frequency	nsubjpass	14	SENT_208	[p9l717t1886r996b1948],
5	of	IN	O	of	_	0	SENT_208	[p9l1036t1886r1090b1933],
6	the	DT	O	the	det	8	SENT_208	[p9l1127t1886r1215b1933],
7	C3435T	NN	O	c3435t	nn	8	SENT_208	[p9l1256t1887r1479b1933],
8	mutation	NN	O	mutation	prep_of	4	SENT_208	[p9l1519t1887r1769b1933],
9	in	IN	O	in	_	0	SENT_208	[p9l1814t1887r1858b1933],
10	exon	NN	O	exon	prep_in	8	SENT_208	[p9l1902t1900r2034b1933],
11	26	CD	NUMBER	26	num	10	SENT_208	[p9l2078t1887r2146b1933],
12	is	VBZ	O	be	auxpass	14	SENT_208	[p9l148t1962r182b2009],
13	significantly	RB	O	significantly	advmod	14	SENT_208	[p9l223t1961r553b2024],
14	influenced	VBN	O	influence	dep	2	SENT_208	[p9l595t1961r881b2009],
15	by	IN	O	by	_	0	SENT_208	[p9l927t1961r992b2024],
16	ethnicity	NN	O	ethnicity	agent	14	SENT_208	[p9l1032t1961r1286b2024],
17	.	.	O	.	_	0	SENT_208	[p9l1032t1961r1286b2024],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_209	[p9l1334t1961r1818b2024],
2	2001	CD	DATE	2001	num	1	SENT_209	[p9l1857t1963r2014b2019],
3	;	:	O	;	_	0	SENT_209	[p9l1857t1963r2014b2019],
4	11	CD	NUMBER	11	num	6	SENT_209	[p9l2063t1963r2143b2009],
5	:	:	O	:	_	0	SENT_209	[p9l2063t1963r2143b2009],
6	217-221	CD	NUMBER	217-221	dep	1	SENT_209	[p9l147t2038r409b2085],
7	.	.	O	.	_	0	SENT_209	[p9l147t2038r409b2085],

1	Tayeb	NNP	O	Tayeb	nn	2	SENT_210	[p9l144t2112r311b2174],
2	MT	NNP	O	MT	nsubj	10	SENT_210	[p9l341t2114r443b2169],
3	,	,	O	,	_	0	SENT_210	[p9l341t2114r443b2169],
4	Clark	NNP	PERSON	Clark	nn	5	SENT_210	[p9l473t2112r613b2159],
5	C	NNP	PERSON	C	appos	2	SENT_210	[p9l638t2113r692b2169],
6	,	,	O	,	_	0	SENT_210	[p9l638t2113r692b2169],
7	Ameyaw	NNP	ORGANIZATION	Ameyaw	nn	8	SENT_210	[p9l720t2114r962b2174],
8	MM	NN	ORGANIZATION	mm	appos	5	SENT_210	[p9l989t2114r1116b2170],
9	,	,	O	,	_	0	SENT_210	[p9l989t2114r1116b2170],
10	Haites	VBZ	ORGANIZATION	haite	_	0	SENT_210	[p9l1148t2113r1312b2159],
11	NE	NN	ORGANIZATION	ne	dobj	10	SENT_210	[p9l1341t2114r1431b2169],
12	,	,	O	,	_	0	SENT_210	[p9l1341t2114r1431b2169],
13	Evans	NNP	ORGANIZATION	Evans	nn	14	SENT_210	[p9l1463t2114r1613b2159],
14	DA	NNP	ORGANIZATION	DA	appos	11	SENT_210	[p9l1642t2114r1736b2169],
15	,	,	O	,	_	0	SENT_210	[p9l1642t2114r1736b2169],
16	Tariq	NNP	PERSON	Tariq	nn	17	SENT_210	[p9l1764t2113r1902b2174],
17	M	NNP	O	M	appos	11	SENT_210	[p9l1933t2114r1982b2159],
18	et	FW	O	et	nn	19	SENT_210	[p9l2013t2117r2062b2159],
19	al.	FW	O	al.	dep	17	SENT_210	[p9l2085t2112r2143b2159],
20	.	.	O	.	_	0	SENT_210	[p9l2085t2112r2143b2159],

1	CYP3A4	NN	O	cyp3a4	nn	3	SENT_211	[p9l147t2189r366b2235],
2	promoter	NN	O	promoter	nn	3	SENT_211	[p9l401t2193r664b2250],
3	variant	NN	O	variant	_	0	SENT_211	[p9l689t2188r880b2235],
4	in	IN	O	in	_	0	SENT_211	[p9l911t2188r955b2234],
5	Saudi	NNP	LOCATION	Saudi	prep_in	3	SENT_211	[p9l990t2187r1154b2245],
6	,	,	O	,	_	0	SENT_211	[p9l990t2187r1154b2245],
7	Ghanaian	JJ	MISC	ghanaian	prep_in	3	SENT_211	[p9l1189t2187r1451b2235],
8	and	CC	O	and	_	0	SENT_211	[p9l1485t2187r1585b2235],
9	Scottish	JJ	MISC	scottish	amod	11	SENT_211	[p9l1620t2187r1833b2235],
10	Caucasian	JJ	MISC	caucasian	amod	11	SENT_211	[p9l1867t2188r2144b2235],
11	populations	NNS	O	population	conj_and	5	SENT_211	[p9l148t2261r488b2324],
12	.	.	O	.	_	0	SENT_211	[p9l148t2261r488b2324],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_212	[p9l520t2261r1004b2324],
2	2000	CD	DATE	2000	num	1	SENT_212	[p9l1027t2263r1184b2319],
3	;	:	O	;	_	0	SENT_212	[p9l1027t2263r1184b2319],
4	10	CD	NUMBER	10	num	6	SENT_212	[p9l1217t2263r1297b2309],
5	:	:	O	:	_	0	SENT_212	[p9l1217t2263r1297b2309],
6	753-756	CD	NUMBER	753-756	dep	1	SENT_212	[p9l1329t2263r1588b2309],
7	.	.	O	.	_	0	SENT_212	[p9l1329t2263r1588b2309],

1	Mathijssen	NNP	PERSON	Mathijssen	nn	2	SENT_213	[p9l149t2337r439b2400],
2	RH	NNP	O	RH	_	0	SENT_213	[p9l471t2339r559b2395],
3	,	,	O	,	_	0	SENT_213	[p9l471t2339r559b2395],
4	Marsh	NNP	PERSON	Marsh	nn	5	SENT_213	[p9l591t2337r756b2385],
5	S	NNP	O	S	appos	2	SENT_213	[p9l787t2338r830b2395],
6	,	,	O	,	_	0	SENT_213	[p9l787t2338r830b2395],
7	Karlsson	NNP	PERSON	Karlsson	nn	8	SENT_213	[p9l862t2337r1082b2385],
8	MO	NNP	PERSON	MO	appos	2	SENT_213	[p9l1114t2338r1232b2395],
9	,	,	O	,	_	0	SENT_213	[p9l1114t2338r1232b2395],
10	Xie	NNP	O	Xie	nn	11	SENT_213	[p9l1261t2338r1346b2385],
11	R	NNP	O	R	appos	2	SENT_213	[p9l1375t2339r1418b2395],
12	,	,	O	,	_	0	SENT_213	[p9l1375t2339r1418b2395],
13	Baker	NNP	LOCATION	Baker	nn	14	SENT_213	[p9l1451t2337r1600b2385],
14	SD	NN	LOCATION	sd	appos	2	SENT_213	[p9l1625t2339r1714b2395],
15	,	,	O	,	_	0	SENT_213	[p9l1625t2339r1714b2395],
16	Verweij	NNP	O	Verweij	nn	17	SENT_213	[p9l1742t2338r1943b2400],
17	J	NNP	O	J	appos	2	SENT_213	[p9l1971t2339r1982b2396],
18	et	FW	O	et	nn	21	SENT_213	[p9l2013t2343r2062b2385],
19	al.	FW	O	al.	nn	21	SENT_213	[p9l2085t2337r2143b2385],
20	lrinotecan	NN	O	lrinotecan	nn	21	SENT_213	[p9l149t2413r421b2459],
21	pathway	NN	O	pathway	dep	17	SENT_213	[p9l448t2412r686b2474],
22	genotype	NN	O	genotype	nn	23	SENT_213	[p9l707t2417r971b2474],
23	analysis	NN	O	analysis	nsubj	25	SENT_213	[p9l993t2412r1202b2474],
24	to	TO	O	to	aux	25	SENT_213	[p9l1224t2417r1278b2459],
25	predict	VB	O	predict	infmod	2	SENT_213	[p9l1303t2412r1496b2474],
26	pharmacokinetics	NNS	O	pharmacokinetic	dobj	25	SENT_213	[p9l1519t2412r2021b2474],
27	.	.	O	.	_	0	SENT_213	[p9l1519t2412r2021b2474],

1	Clin	NNP	O	Clin	nn	3	SENT_214	[p9l2051t2412r2148b2459],
2	Cancer	NNP	O	Cancer	nn	3	SENT_214	[p9l150t2489r336b2535],
3	Res	NNP	O	Res	_	0	SENT_214	[p9l357t2489r441b2535],
4	2003	CD	DATE	2003	num	3	SENT_214	[p9l464t2489r621b2545],
5	;	:	O	;	_	0	SENT_214	[p9l464t2489r621b2545],
6	9	CD	NUMBER	9	num	8	SENT_214	[p9l649t2489r698b2535],
7	:	:	O	:	_	0	SENT_214	[p9l649t2489r698b2535],
8	3246-3253	CD	DURATION	3246-3253	dep	3	SENT_214	[p9l730t2489r1061b2535],
9	.	.	O	.	_	0	SENT_214	[p9l730t2489r1061b2535],

1	Henningsson	NN	MISC	henningsson	nn	2	SENT_215	[p9l149t2563r505b2624],
2	A	NN	MISC	a	_	0	SENT_215	[p9l527t2564r579b2620],
3	,	,	O	,	_	0	SENT_215	[p9l527t2564r579b2620],
4	Marsh	NNP	PERSON	Marsh	nn	5	SENT_215	[p9l609t2562r774b2610],
5	S	NNP	O	S	appos	2	SENT_215	[p9l800t2563r842b2620],
6	,	,	O	,	_	0	SENT_215	[p9l800t2563r842b2620],
7	Loos	NNP	PERSON	Loos	nn	9	SENT_215	[p9l872t2564r993b2610],
8	W	NNP	O	W	nn	9	SENT_215	[p9l1013t2563r1102b2621],
9	]	NN	O	]	appos	2	SENT_215	[p9l1013t2563r1102b2621],
10	,	,	O	,	_	0	SENT_215	[p9l1013t2563r1102b2621],
11	Karlsson	NNP	PERSON	Karlsson	nn	12	SENT_215	[p9l1131t2562r1351b2610],
12	MO	NNP	PERSON	MO	appos	2	SENT_215	[p9l1379t2563r1496b2620],
13	,	,	O	,	_	0	SENT_215	[p9l1379t2563r1496b2620],
14	Garsa	NNP	O	Garsa	nn	15	SENT_215	[p9l1523t2563r1674b2610],
15	A	NNP	O	A	appos	2	SENT_215	[p9l1695t2564r1748b2620],
16	,	,	O	,	_	0	SENT_215	[p9l1695t2564r1748b2620],
17	Mross	NNP	PERSON	Mross	nn	18	SENT_215	[p9l1776t2564r1937b2610],
18	K	NNP	O	K	appos	2	SENT_215	[p9l1962t2564r1994b2609],
19	et	FW	O	et	nn	20	SENT_215	[p9l2017t2567r2066b2610],
20	al.	FW	O	al.	dep	18	SENT_215	[p9l2085t2562r2143b2610],
21	.	.	O	.	_	0	SENT_215	[p9l2085t2562r2143b2610],

1	Association	NNP	O	Association	_	0	SENT_216	[p9l144t2638r453b2684],
2	of	IN	O	of	_	0	SENT_216	[p9l484t2637r537b2684],
3	CYPZC8	NNP	O	CYPZC8	prep_of	1	SENT_216	[p9l563t2638r803b2694],
4	,	,	O	,	_	0	SENT_216	[p9l563t2638r803b2694],
5	CYP3A4	NN	O	cyp3a4	prep_of	1	SENT_216	[p9l836t2638r1070b2695],
6	,	,	O	,	_	0	SENT_216	[p9l836t2638r1070b2695],
7	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_216	[p9l1103t2638r1338b2694],
8	,	,	O	,	_	0	SENT_216	[p9l1103t2638r1338b2694],
9	and	CC	O	and	_	0	SENT_216	[p9l1370t2637r1470b2684],
10	ABCB1	NN	O	abcb1	nn	11	SENT_216	[p9l1498t2638r1676b2684],
11	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_216	[p9l1719t2637r2146b2699],
12	with	IN	O	with	_	0	SENT_216	[p9l144t2712r264b2760],
13	the	DT	O	the	det	14	SENT_216	[p9l306t2712r393b2760],
14	pharmacokinetics	NNS	O	pharmacokinetic	prep_with	1	SENT_216	[p9l436t2712r922b2775],
15	of	IN	O	of	_	0	SENT_216	[p9l962t2712r1015b2760],
16	paclitaxel	NN	O	paclitaxel	prep_of	14	SENT_216	[p9l1055t2712r1329b2775],
17	.	.	O	.	_	0	SENT_216	[p9l1055t2712r1329b2775],

1	Clin	NNP	O	Clin	nn	3	SENT_217	[p9l1377t2712r1474b2760],
2	Cancer	NNP	O	Cancer	nn	3	SENT_217	[p9l1516t2714r1702b2760],
3	Res	NNP	O	Res	_	0	SENT_217	[p9l1737t2714r1821b2760],
4	2005	CD	DATE	2005	num	3	SENT_217	[p9l1859t2714r2015b2770],
5	;	:	O	;	_	0	SENT_217	[p9l1859t2714r2015b2770],
6	11	CD	NUMBER	11	num	8	SENT_217	[p9l2063t2714r2143b2760],
7	:	:	O	:	_	0	SENT_217	[p9l2063t2714r2143b2760],
8	8097-8104	CD	DURATION	8097-8104	dep	3	SENT_217	[p9l147t2790r482b2836],
9	.	.	O	.	_	0	SENT_217	[p9l147t2790r482b2836],

1	Green	NNP	PERSON	Green	nn	2	SENT_218	[p9l147t2864r311b2911],
2	H	NNP	PERSON	H	dep	18	SENT_218	[p9l352t2865r405b2921],
3	,	,	O	,	_	0	SENT_218	[p9l352t2865r405b2921],
4	Soderkvist	NNP	O	Soderkvist	nn	5	SENT_218	[p9l445t2863r727b2911],
5	P	NN	O	p	appos	2	SENT_218	[p9l763t2865r805b2921],
6	,	,	O	,	_	0	SENT_218	[p9l763t2865r805b2921],
7	Rosenberg	NNP	PERSON	Rosenberg	nn	8	SENT_218	[p9l847t2863r1134b2926],
8	P	NN	O	p	appos	2	SENT_218	[p9l1175t2865r1217b2921],
9	,	,	O	,	_	0	SENT_218	[p9l1175t2865r1217b2921],
10	Horvath	NNP	PERSON	Horvath	nn	11	SENT_218	[p9l1259t2863r1475b2911],
11	G	NNP	O	G	appos	2	SENT_218	[p9l1513t2864r1571b2921],
12	,	,	O	,	_	0	SENT_218	[p9l1513t2864r1571b2921],
13	Peterson	NNP	PERSON	Peterson	nn	14	SENT_218	[p9l1612t2865r1845b2911],
14	C.	NNP	O	C.	appos	2	SENT_218	[p9l1883t2864r1937b2911],
15	mdr-1	NN	O	mdr-1	dep	18	SENT_218	[p9l1978t2863r2134b2911],
16	single	JJ	O	single	amod	18	SENT_218	[p9l146t2938r304b3000],
17	nucleotide	NN	O	nucleotide	nn	18	SENT_218	[p9l340t2938r630b2985],
18	polymorphisms	NNS	O	polymorphism	dep	24	SENT_218	[p9l665t2938r1092b3000],
19	in	IN	O	in	_	0	SENT_218	[p9l1127t2939r1172b2985],
20	ovarian	JJ	O	ovarian	amod	22	SENT_218	[p9l1207t2939r1406b2985],
21	cancer	NN	O	cancer	nn	22	SENT_218	[p9l1442t2952r1625b2985],
22	tissue	NN	O	tissue	prep_in	18	SENT_218	[p9l1654t2939r1822b2985],
23	:	:	O	:	_	0	SENT_218	[p9l1654t2939r1822b2985],
24	G2677T/A	NN	O	g2677t/a	_	0	SENT_218	[p9l1859t2938r2148b2991],
25	correlates	VBZ	O	correlate	rcmod	24	SENT_218	[p9l146t3013r411b3061],
26	with	IN	O	with	_	0	SENT_218	[p9l443t3013r563b3061],
27	response	NN	O	response	prep_with	25	SENT_218	[p9l601t3027r841b3076],
28	to	TO	O	to	_	0	SENT_218	[p9l874t3019r929b3061],
29	paclitaxel	NN	O	paclitaxel	nn	30	SENT_218	[p9l965t3013r1221b3076],
30	chemotherapy	NN	O	chemotherapy	prep_to	25	SENT_218	[p9l1257t3013r1677b3076],
31	.	.	O	.	_	0	SENT_218	[p9l1257t3013r1677b3076],

1	Clin	NNP	O	Clin	nn	3	SENT_219	[p9l1717t3013r1815b3061],
2	Cancer	NNP	O	Cancer	nn	3	SENT_219	[p9l1850t3015r2036b3061],
3	Res	NNP	O	Res	_	0	SENT_219	[p9l2065t3015r2149b3061],
4	2006	CD	DATE	2006	num	3	SENT_219	[p9l147t3089r304b3146],
5	;	:	O	;	_	0	SENT_219	[p9l147t3089r304b3146],
6	12	CD	NUMBER	12	num	8	SENT_219	[p9l336t3089r417b3136],
7	:	:	O	:	_	0	SENT_219	[p9l336t3089r417b3136],
8	854-859	CD	NUMBER	854-859	dep	3	SENT_219	[p9l446t3089r708b3136],
9	.	.	O	.	_	0	SENT_219	[p9l446t3089r708b3136],

1	Marsh	NNP	O	Marsh	_	0	SENT_220	[p9l149t3162r314b3210],
2	5	CD	NUMBER	5	num	1	SENT_220	[p9l355t3164r397b3220],
3	,	,	O	,	_	0	SENT_220	[p9l355t3164r397b3220],
4	King	NNP	O	King	nn	5	SENT_220	[p9l440t3164r559b3225],
5	CR	NN	O	cr	appos	1	SENT_220	[p9l598t3164r687b3220],
6	,	,	O	,	_	0	SENT_220	[p9l598t3164r687b3220],
7	McLeod	NNP	PERSON	McLeod	nn	8	SENT_220	[p9l730t3162r948b3210],
8	HL	NNS	O	hl	appos	1	SENT_220	[p9l989t3165r1073b3220],
9	,	,	O	,	_	0	SENT_220	[p9l989t3165r1073b3220],
10	Paul	NNP	PERSON	Paul	nn	11	SENT_220	[p9l1116t3162r1225b3210],
11	J	NNP	PERSON	J	conj_and	5	SENT_220	[p9l1262t3165r1292b3221],
12	,	,	O	,	_	0	SENT_220	[p9l1262t3165r1292b3221],
13	Gifford	NNP	PERSON	Gifford	nn	14	SENT_220	[p9l1332t3162r1521b3210],
14	G	NNP	PERSON	G	conj_and	5	SENT_220	[p9l1560t3164r1618b3220],
15	,	,	O	,	_	0	SENT_220	[p9l1560t3164r1618b3220],
16	Brown	NNP	PERSON	Brown	nn	19	SENT_220	[p9l1661t3165r1833b3210],
17	R.	NNP	O	R.	nn	19	SENT_220	[p9l1874t3165r1918b3210],
18	ABCB1	NNP	O	ABCB1	nn	19	SENT_220	[p9l1955t3164r2134b3210],
19	2677G	NNP	O	2677G	conj_and	5	SENT_220	[p9l147t3238r500b3291],
20	>	JJR	O	>	amod	22	SENT_220	[p9l147t3238r500b3291],
21	T/A	NN	O	t/a	nn	22	SENT_220	[p9l147t3238r500b3291],
22	genotype	NN	O	genotype	dep	19	SENT_220	[p9l541t3243r804b3300],
23	and	CC	O	and	_	0	SENT_220	[p9l848t3238r949b3285],
24	paclitaxel	NN	O	paclitaxel	nn	25	SENT_220	[p9l995t3238r1252b3300],
25	pharmacogenetics	NNS	O	pharmacogenetic	appos	1	SENT_220	[p9l1299t3238r1811b3300],
26	in	IN	O	in	_	0	SENT_220	[p9l1855t3239r1899b3285],
27	ovarian	JJ	O	ovarian	amod	28	SENT_220	[p9l1944t3239r2144b3285],
28	cancer	NN	O	cancer	prep_in	25	SENT_220	[p9l146t3327r342b3361],
29	.	.	O	.	_	0	SENT_220	[p9l146t3327r342b3361],

1	Clin	NNP	O	Clin	nn	3	SENT_221	[p9l374t3313r472b3361],
2	Cancer	NNP	O	Cancer	nn	3	SENT_221	[p9l500t3315r686b3361],
3	Res	NNP	O	Res	_	0	SENT_221	[p9l706t3315r790b3361],
4	2006	CD	DATE	2006	num	5	SENT_221	[p9l814t3315r955b3361],
5	(	CD	NUMBER	(	dep	3	SENT_221	[p9l981t3313r1183b3373],
6	letter	NN	O	letter	dep	3	SENT_221	[p9l981t3313r1183b3373],
7	)	CD	NUMBER	)	num	6	SENT_221	[p9l981t3313r1183b3373],
8	:	:	O	:	_	0	SENT_221	[p9l981t3313r1183b3373],
9	12	CD	NUMBER	12	num	11	SENT_221	[p9l1215t3315r1296b3361],
10	:	:	O	:	_	0	SENT_221	[p9l1215t3315r1296b3361],
11	4127	CD	DATE	4127	dep	3	SENT_221	[p9l1324t3315r1482b3361],
12	.	.	O	.	_	0	SENT_221	[p9l1324t3315r1482b3361],

1	Synold	JJ	O	synold	amod	2	SENT_222	[p9l148t3388r332b3451],
2	TW	NNP	O	TW	_	0	SENT_222	[p9l360t3389r467b3446],
3	,	,	O	,	_	0	SENT_222	[p9l360t3389r467b3446],
4	Dussault	NNP	PERSON	Dussault	nn	5	SENT_222	[p9l502t3388r735b3436],
5	l	NN	O	l	appos	2	SENT_222	[p9l763t3390r788b3446],
6	,	,	O	,	_	0	SENT_222	[p9l763t3390r788b3446],
7	Forman	NNP	PERSON	Forman	nn	8	SENT_222	[p9l822t3390r1028b3436],
8	BM	NN	O	bm	appos	5	SENT_222	[p9l1061t3390r1165b3435],
9	.	.	O	.	_	0	SENT_222	[p9l1061t3390r1165b3435],

1	The	DT	O	the	det	5	SENT_223	[p9l1194t3388r1297b3436],
2	orphan	JJ	O	orphan	amod	5	SENT_223	[p9l1326t3388r1521b3451],
3	nuclear	JJ	O	nuclear	amod	5	SENT_223	[p9l1554t3388r1756b3436],
4	receptor	NN	O	receptor	nn	5	SENT_223	[p9l1784t3393r2015b3451],
5	SXR	NN	O	sxr	nsubj	7	SENT_223	[p9l2042t3389r2148b3436],
6	coordinately	RB	O	coordinately	advmod	7	SENT_223	[p9l146t3463r492b3525],
7	regulates	VBZ	O	regulate	_	0	SENT_223	[p9l522t3463r770b3525],
8	drug	NN	O	drug	nn	9	SENT_223	[p9l798t3463r926b3525],
9	metabolism	NN	O	metabolism	dobj	7	SENT_223	[p9l959t3463r1279b3510],
10	and	CC	O	and	_	0	SENT_223	[p9l1310t3463r1410b3510],
11	efflux	NN	O	efflux	dobj	7	SENT_223	[p9l1440t3463r1607b3510],
12	.	.	O	.	_	0	SENT_223	[p9l1440t3463r1607b3510],

1	Nat	NNP	O	Nat	nn	2	SENT_224	[p9l1639t3465r1741b3510],
2	Med	NNP	O	Med	_	0	SENT_224	[p9l1766t3463r1885b3510],
3	2001	CD	DATE	2001	num	2	SENT_224	[p9l1907t3464r2064b3520],
4	;	:	O	;	_	0	SENT_224	[p9l1907t3464r2064b3520],
5	7	CD	NUMBER	7	num	7	SENT_224	[p9l2098t3465r2143b3510],
6	:	:	O	:	_	0	SENT_224	[p9l2098t3465r2143b3510],
7	584-590	CD	NUMBER	584-590	dep	2	SENT_224	[p9l146t3541r409b3587],
8	.	.	O	.	_	0	SENT_224	[p9l146t3541r409b3587],

1	Teodoridis	NNP	O	Teodoridis	nn	2	SENT_225	[p10l144t20r435b68],
2	JM	NN	O	jm	_	0	SENT_225	[p10l457t22r546b79],
3	,	,	O	,	_	0	SENT_225	[p10l457t22r546b79],
4	Hall	NNP	PERSON	Hall	nn	5	SENT_225	[p10l575t20r673b68],
5	J	NNP	PERSON	J	appos	2	SENT_225	[p10l697t22r727b79],
6	,	,	O	,	_	0	SENT_225	[p10l697t22r727b79],
7	Marsh	NNP	PERSON	Marsh	nn	8	SENT_225	[p10l755t20r921b68],
8	S	NNP	O	S	appos	2	SENT_225	[p10l947t21r990b78],
9	,	,	O	,	_	0	SENT_225	[p10l947t21r990b78],
10	Kannall	NNP	O	Kannall	nn	11	SENT_225	[p10l1019t20r1216b68],
11	HD	NNP	O	HD	appos	2	SENT_225	[p10l1244t22r1345b78],
12	,	,	O	,	_	0	SENT_225	[p10l1244t22r1345b78],
13	Smyth	NNP	PERSON	Smyth	nn	14	SENT_225	[p10l1372t20r1545b83],
14	C	NNP	O	C	appos	2	SENT_225	[p10l1571t21r1625b78],
15	,	,	O	,	_	0	SENT_225	[p10l1571t21r1625b78],
16	Curtoj	NNP	O	Curtoj	appos	2	SENT_225	[p10l1652t21r1841b79],
17	et	FW	O	et	nn	18	SENT_225	[p10l1869t25r1918b68],
18	al.	FW	O	al.	dep	16	SENT_225	[p10l1938t20r1996b68],
19	.	.	O	.	_	0	SENT_225	[p10l1938t20r1996b68],

1	CpG	NN	O	cpg	nn	3	SENT_226	[p10l2022t21r2144b83],
2	island	NN	O	island	nn	3	SENT_226	[p10l148t94r302b142],
3	methylation	NN	O	methylation	_	0	SENT_226	[p10l326t94r656b157],
4	of	IN	O	of	_	0	SENT_226	[p10l679t94r733b142],
5	DNA	NN	O	dna	nn	8	SENT_226	[p10l752t97r883b142],
6	damage	NN	O	damage	nn	8	SENT_226	[p10l901t94r1125b157],
7	response	NN	O	response	nn	8	SENT_226	[p10l1148t108r1389b157],
8	genes	NNS	O	gene	prep_of	3	SENT_226	[p10l1409t108r1570b157],
9	in	IN	O	in	_	0	SENT_226	[p10l1591t96r1636b142],
10	advanced	JJ	O	advanced	amod	12	SENT_226	[p10l1658t94r1923b142],
11	ovarian	JJ	O	ovarian	amod	12	SENT_226	[p10l1944t96r2143b142],
12	cancer	NN	O	cancer	prep_in	3	SENT_226	[p10l146t184r342b217],
13	.	.	O	.	_	0	SENT_226	[p10l146t184r342b217],

1	Cancer	NNP	O	Cancer	nn	2	SENT_227	[p10l374t171r561b217],
2	Res	NNP	O	Res	_	0	SENT_227	[p10l581t172r666b217],
3	2005	CD	DATE	2005	num	2	SENT_227	[p10l688t171r845b227],
4	;	:	O	;	_	0	SENT_227	[p10l688t171r845b227],
5	65	CD	NUMBER	65	num	7	SENT_227	[p10l874t171r959b217],
6	:	:	O	:	_	0	SENT_227	[p10l874t171r959b217],
7	8961-8967	CD	DURATION	8961-8967	dep	2	SENT_227	[p10l988t171r1322b217],
8	.	.	O	.	_	0	SENT_227	[p10l988t171r1322b217],

1	McLeod	NNP	PERSON	McLeod	_	0	SENT_228	[p10l149t245r367b293],
2	HL	NNS	O	hl	dep	1	SENT_228	[p10l404t247r487b293],
3	.	.	O	.	_	0	SENT_228	[p10l404t247r487b293],

1	Drug	NN	O	drug	nn	2	SENT_229	[p10l524t247r658b308],
2	pathways	NNS	O	pathway	_	0	SENT_229	[p10l694t245r970b308],
3	:	:	O	:	_	0	SENT_229	[p10l694t245r970b308],
4	moving	VBG	O	move	dep	2	SENT_229	[p10l1007t246r1213b308],
5	beyond	IN	O	beyond	_	0	SENT_229	[p10l1249t245r1454b308],
6	single	JJ	O	single	amod	8	SENT_229	[p10l1487t245r1646b308],
7	gene	NN	O	gene	nn	8	SENT_229	[p10l1677t259r1812b308],
8	pharmacogenetics	NNS	O	pharmacogenetic	prep_beyond	4	SENT_229	[p10l1847t245r2145b308, p10l146t321r390b382],
9	.	.	O	.	_	0	SENT_229	[p10l1847t245r2145b308, p10l146t321r390b382],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_230	[p10l421t320r940b382],
2	2004	CD	DATE	2004	num	1	SENT_230	[p10l963t321r1120b378],
3	;	:	O	;	_	0	SENT_230	[p10l963t321r1120b378],
4	5	CD	NUMBER	5	num	6	SENT_230	[p10l1149t322r1197b368],
5	:	:	O	:	_	0	SENT_230	[p10l1149t322r1197b368],
6	139-141	CD	NUMBER	139-141	dep	1	SENT_230	[p10l1229t321r1487b368],
7	.	.	O	.	_	0	SENT_230	[p10l1229t321r1487b368],

1	Chang	NNP	PERSON	Chang	nn	2	SENT_231	[p10l147t395r328b457],
2	TK	NN	O	tk	_	0	SENT_231	[p10l399t397r485b452],
3	,	,	O	,	_	0	SENT_231	[p10l399t397r485b452],
4	Weber	NNP	PERSON	Weber	nn	5	SENT_231	[p10l557t395r742b442],
5	CF	NN	O	cf	appos	2	SENT_231	[p10l811t396r899b452],
6	,	,	O	,	_	0	SENT_231	[p10l811t396r899b452],
7	Crespi	NNP	ORGANIZATION	Crespi	nn	8	SENT_231	[p10l974t396r1143b457],
8	CL	NN	ORGANIZATION	cl	appos	2	SENT_231	[p10l1216t396r1301b452],
9	,	,	O	,	_	0	SENT_231	[p10l1216t396r1301b452],
10	Waxman	NNP	PERSON	Waxman	nn	11	SENT_231	[p10l1373t396r1619b442],
11	DJ	NNP	O	DJ	appos	2	SENT_231	[p10l1695t397r1768b453],
12	.	.	O	.	_	0	SENT_231	[p10l1695t397r1768b453],

1	Differential	JJ	O	differential	amod	2	SENT_232	[p10l1845t395r2144b442],
2	activation	NN	O	activation	_	0	SENT_232	[p10l146t471r413b518],
3	of	IN	O	of	_	0	SENT_232	[p10l463t470r517b518],
4	cyclophosphamide	NN	O	cyclophosphamide	prep_of	2	SENT_232	[p10l562t470r1088b533],
5	and	CC	O	and	_	0	SENT_232	[p10l1137t470r1237b518],
6	ifosphamide	NN	O	ifosphamide	conj_and	4	SENT_232	[p10l1289t470r1627b533],
7	by	IN	O	by	_	0	SENT_232	[p10l1677t470r1742b533],
8	cytochromes	NNS	O	cytochrome	nn	10	SENT_232	[p10l1789t470r2146b533],
9	P-450	NN	O	p-450	nn	10	SENT_232	[p10l149t546r307b593],
10	2B	NN	O	2b	prep_by	2	SENT_232	[p10l342t546r410b592],
11	and	CC	O	and	_	0	SENT_232	[p10l444t545r545b593],
12	3A	NN	O	3a	prep_by	2	SENT_232	[p10l584t546r655b593],
13	in	IN	O	in	_	0	SENT_232	[p10l688t546r732b592],
14	human	JJ	O	human	amod	16	SENT_232	[p10l771t545r962b593],
15	liver	NN	O	liver	nn	16	SENT_232	[p10l1001t545r1113b593],
16	microsomes	NNS	O	microsome	prep_in	10	SENT_232	[p10l1147t546r1492b593],
17	.	.	O	.	_	0	SENT_232	[p10l1147t546r1492b593],

1	Cancer	NNP	O	Cancer	nn	2	SENT_233	[p10l1533t546r1720b593],
2	Res	NNP	O	Res	_	0	SENT_233	[p10l1749t547r1833b593],
3	1993	CD	DATE	1993	num	2	SENT_233	[p10l1867t546r2021b603],
4	;	:	O	;	_	0	SENT_233	[p10l1867t546r2021b603],
5	53	CD	NUMBER	53	num	7	SENT_233	[p10l2059t546r2143b593],
6	:	:	O	:	_	0	SENT_233	[p10l2059t546r2143b593],
7	5629-5637	CD	DURATION	5629-5637	dep	2	SENT_233	[p10l146t622r482b669],
8	.	.	O	.	_	0	SENT_233	[p10l146t622r482b669],

1	Ren	NNP	PERSON	Ren	nn	2	SENT_234	[p10l149t698r245b743],
2	S	NNP	O	S	_	0	SENT_234	[p10l271t697r314b754],
3	,	,	O	,	_	0	SENT_234	[p10l271t697r314b754],
4	Yang	NNP	PERSON	Yang	nn	5	SENT_234	[p10l338t697r476b758],
5	JS	NNP	PERSON	JS	appos	2	SENT_234	[p10l499t697r562b754],
6	,	,	O	,	_	0	SENT_234	[p10l499t697r562b754],
7	Kalhorn	NNP	O	Kalhorn	nn	8	SENT_234	[p10l591t696r800b743],
8	TF	NN	O	tf	appos	2	SENT_234	[p10l823t698r902b753],
9	,	,	O	,	_	0	SENT_234	[p10l823t698r902b753],
10	Slattery	NNP	PERSON	Slattery	nn	11	SENT_234	[p10l929t696r1136b758],
11	JT	NNP	O	JT	appos	2	SENT_234	[p10l1156t698r1221b754],
12	.	.	O	.	_	0	SENT_234	[p10l1156t698r1221b754],

1	Oxidation	NN	O	oxidation	_	0	SENT_235	[p10l1248t696r1520b743],
2	of	IN	O	of	_	0	SENT_235	[p10l1546t696r1600b743],
3	cyclophosphamide	NN	O	cyclophosphamide	prep_of	1	SENT_235	[p10l1620t696r2146b758],
4	to	TO	O	to	_	0	SENT_235	[p10l145t777r200b819],
5	4-hydroxycyclophosphamide	NN	O	4-hydroxycyclophosphamide	prep_to	1	SENT_235	[p10l229t771r1045b834],
6	and	CC	O	and	_	0	SENT_235	[p10l1075t771r1176b819],
7	deschloroethylcyclophosphamide	NN	O	deschloroethylcyclophosphamide	prep_to	1	SENT_235	[p10l1208t771r2146b834],
8	in	IN	O	in	_	0	SENT_235	[p10l148t847r192b893],
9	human	JJ	O	human	amod	11	SENT_235	[p10l223t846r413b894],
10	liver	NN	O	liver	nn	11	SENT_235	[p10l444t846r556b894],
11	microsomes	NNS	O	microsome	prep_in	1	SENT_235	[p10l581t847r926b894],
12	.	.	O	.	_	0	SENT_235	[p10l581t847r926b894],

1	Cancer	NNP	O	Cancer	nn	2	SENT_236	[p10l959t847r1145b894],
2	Res	NNP	O	Res	_	0	SENT_236	[p10l1166t848r1250b894],
3	1997	CD	DATE	1997	num	2	SENT_236	[p10l1276t847r1430b904],
4	;	:	O	;	_	0	SENT_236	[p10l1276t847r1430b904],
5	57	CD	NUMBER	57	num	7	SENT_236	[p10l1459t848r1543b894],
6	:	:	O	:	_	0	SENT_236	[p10l1459t848r1543b894],
7	4229-4235	CD	DURATION	4229-4235	dep	2	SENT_236	[p10l1571t847r1907b894],
8	.	.	O	.	_	0	SENT_236	[p10l1571t847r1907b894],

1	Lewis	NNP	PERSON	Lewis	nn	2	SENT_237	[p10l149t922r295b968],
2	AD	NN	O	ad	_	0	SENT_237	[p10l324t923r424b978],
3	,	,	O	,	_	0	SENT_237	[p10l324t923r424b978],
4	Lau	NNP	PERSON	Lau	nn	5	SENT_237	[p10l461t923r551b968],
5	DH	NNP	O	DH	appos	2	SENT_237	[p10l588t923r689b978],
6	,	,	O	,	_	0	SENT_237	[p10l588t923r689b978],
7	Duran	NNP	ORGANIZATION	Duran	nn	8	SENT_237	[p10l726t923r891b968],
8	GE	NNP	ORGANIZATION	GE	appos	2	SENT_237	[p10l926t922r1015b978],
9	,	,	O	,	_	0	SENT_237	[p10l926t922r1015b978],
10	Wolf	NNP	PERSON	Wolf	nn	11	SENT_237	[p10l1049t920r1179b968],
11	CR	NN	O	cr	appos	2	SENT_237	[p10l1208t922r1298b978],
12	,	,	O	,	_	0	SENT_237	[p10l1208t922r1298b978],
13	Sikic	JJ	O	sikic	amod	14	SENT_237	[p10l1334t920r1454b968],
14	Bl	NN	O	bl	appos	2	SENT_237	[p10l1488t923r1549b968],
15	.	.	O	.	_	0	SENT_237	[p10l1488t923r1549b968],

1	Role	NN	O	role	_	0	SENT_238	[p10l1587t920r1699b968],
2	of	IN	O	of	_	0	SENT_238	[p10l1731t920r1785b968],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_238	[p10l1814t920r2146b983],
4	P-450	NN	MISC	p-450	prep_of	1	SENT_238	[p10l149t998r307b1044],
5	from	IN	O	from	_	0	SENT_238	[p10l346t996r476b1044],
6	the	DT	O	the	det	10	SENT_238	[p10l519t996r607b1044],
7	human	JJ	O	human	amod	10	SENT_238	[p10l650t996r841b1044],
8	CYP3A	NN	O	cyp3a	nn	10	SENT_238	[p10l886t998r1071b1044],
9	gene	NN	O	gene	nn	10	SENT_238	[p10l1110t1010r1246b1059],
10	family	NN	O	family	prep_from	1	SENT_238	[p10l1285t996r1455b1059],
11	in	IN	O	in	_	0	SENT_238	[p10l1496t997r1540b1043],
12	the	DT	O	the	det	13	SENT_238	[p10l1583t996r1671b1044],
13	potentiation	NN	O	potentiation	prep_in	10	SENT_238	[p10l1715t997r2052b1059],
14	of	IN	O	of	_	0	SENT_238	[p10l2095t996r2149b1044],
15	morpholino	NN	O	morpholino	nn	16	SENT_238	[p10l148t1071r473b1134],
16	doxorubicin	NN	O	doxorubicin	prep_of	13	SENT_238	[p10l497t1071r829b1119],
17	by	IN	O	by	_	0	SENT_238	[p10l857t1071r921b1134],
18	human	JJ	O	human	amod	20	SENT_238	[p10l946t1071r1137b1119],
19	liver	NN	O	liver	nn	20	SENT_238	[p10l1165t1071r1277b1119],
20	microsomes	NNS	O	microsome	prep_by	1	SENT_238	[p10l1300t1072r1646b1119],
21	.	.	O	.	_	0	SENT_238	[p10l1300t1072r1646b1119],

1	Cancer	NNP	O	Cancer	nn	2	SENT_239	[p10l1676t1072r1862b1119],
2	Res	NNP	O	Res	_	0	SENT_239	[p10l1881t1073r1965b1119],
3	1992	CD	DATE	1992	num	2	SENT_239	[p10l1989t1072r2143b1129],
4	;	:	O	;	_	0	SENT_239	[p10l1989t1072r2143b1129],
5	52	CD	NUMBER	52	num	7	SENT_239	[p10l146t1148r230b1195],
6	:	:	O	:	_	0	SENT_239	[p10l146t1148r230b1195],
7	4379-4384	CD	DURATION	4379-4384	dep	2	SENT_239	[p10l258t1148r594b1195],
8	.	.	O	.	_	0	SENT_239	[p10l258t1148r594b1195],

1	Doherty	NNP	O	Doherty	nn	2	SENT_240	[p10l149t1222r372b1284],
2	JA	NNP	O	JA	_	0	SENT_240	[p10l390t1224r458b1281],
3	,	,	O	,	_	0	SENT_240	[p10l390t1224r458b1281],
4	Weiss	NNP	ORGANIZATION	Weiss	nn	5	SENT_240	[p10l480t1223r634b1269],
5	NS	NNP	ORGANIZATION	NS	appos	2	SENT_240	[p10l656t1223r747b1279],
6	,	,	O	,	_	0	SENT_240	[p10l656t1223r747b1279],
7	Freeman	NNP	PERSON	Freeman	nn	9	SENT_240	[p10l773t1224r1007b1269],
8	R	NNP	O	R	nn	9	SENT_240	[p10l1032t1224r1093b1280],
9	]	NN	O	]	appos	2	SENT_240	[p10l1032t1224r1093b1280],
10	,	,	O	,	_	0	SENT_240	[p10l1032t1224r1093b1280],
11	Dightman	NNP	ORGANIZATION	Dightman	nn	12	SENT_240	[p10l1119t1222r1395b1284],
12	DA	NNP	ORGANIZATION	DA	appos	2	SENT_240	[p10l1420t1224r1514b1279],
13	,	,	O	,	_	0	SENT_240	[p10l1420t1224r1514b1279],
14	Thornton	NNP	PERSON	Thornton	nn	16	SENT_240	[p10l1536t1222r1795b1269],
15	P	NN	O	p	nn	16	SENT_240	[p10l1820t1224r1880b1281],
16	]	NN	O	]	appos	2	SENT_240	[p10l1820t1224r1880b1281],
17	,	,	O	,	_	0	SENT_240	[p10l1820t1224r1880b1281],
18	Houck	NNP	PERSON	Houck	nn	19	SENT_240	[p10l1906t1222r2080b1269],
19	JR	NNP	O	JR	appos	2	SENT_240	[p10l2097t1224r2148b1280],
20	et	FW	O	et	nn	21	SENT_240	[p10l148t1303r197b1345],
21	al.	FW	O	al.	dep	19	SENT_240	[p10l217t1297r275b1345],
22	.	.	O	.	_	0	SENT_240	[p10l217t1297r275b1345],

1	Genetic	JJ	O	genetic	amod	2	SENT_241	[p10l302t1298r514b1345],
2	factors	NNS	O	factor	_	0	SENT_241	[p10l535t1297r719b1345],
3	in	IN	O	in	_	0	SENT_241	[p10l743t1298r787b1344],
4	catechol	NN	O	catechol	nn	6	SENT_241	[p10l812t1297r1042b1345],
5	estrogen	NN	O	estrogen	nn	6	SENT_241	[p10l1067t1303r1306b1360],
6	metabolism	NN	O	metabolism	prep_in	2	SENT_241	[p10l1333t1297r1654b1345],
7	in	IN	O	in	_	0	SENT_241	[p10l1681t1298r1726b1344],
8	relation	NN	O	relation	prep_in	6	SENT_241	[p10l1753t1297r1957b1345],
9	to	TO	O	to	_	0	SENT_241	[p10l1981t1303r2035b1345],
10	the	DT	O	the	det	11	SENT_241	[p10l2058t1297r2146b1345],
11	risk	NN	O	risk	prep_to	2	SENT_241	[p10l148t1372r236b1420],
12	of	IN	O	of	_	0	SENT_241	[p10l262t1372r315b1420],
13	endometrial	JJ	O	endometrial	amod	14	SENT_241	[p10l340t1372r672b1420],
14	cancer	NN	O	cancer	prep_of	11	SENT_241	[p10l703t1386r899b1420],
15	.	.	O	.	_	0	SENT_241	[p10l703t1386r899b1420],

1	Cancer	NNP	O	Cancer	nn	3	SENT_242	[p10l933t1373r1119b1420],
2	Epidemiol	NNP	O	Epidemiol	nn	3	SENT_242	[p10l1141t1372r1397b1435],
3	Biomarkers	NNS	O	biomarker	_	0	SENT_242	[p10l1421t1372r1710b1420],
4	Prev	NNP	O	Prev	dep	3	SENT_242	[p10l1737t1374r1850b1420],
5	2005	CD	DATE	2005	num	4	SENT_242	[p10l1871t1373r2028b1430],
6	;	:	O	;	_	0	SENT_242	[p10l1871t1373r2028b1430],
7	14	CD	NUMBER	14	num	9	SENT_242	[p10l2063t1373r2143b1419],
8	:	:	O	:	_	0	SENT_242	[p10l2063t1373r2143b1419],
9	357-366	CD	NUMBER	357-366	dep	3	SENT_242	[p10l149t1450r409b1496],
10	.	.	O	.	_	0	SENT_242	[p10l149t1450r409b1496],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_243	[p10l149t1523r314b1571],
2	S	NNP	O	S	_	0	SENT_243	[p10l346t1525r389b1581],
3	,	,	O	,	_	0	SENT_243	[p10l346t1525r389b1581],
4	King	NNP	O	King	nn	5	SENT_243	[p10l423t1524r542b1586],
5	CR	NN	O	cr	appos	2	SENT_243	[p10l573t1525r661b1581],
6	,	,	O	,	_	0	SENT_243	[p10l573t1525r661b1581],
7	Garsa	NNP	O	Garsa	nn	8	SENT_243	[p10l693t1525r845b1571],
8	AA	NNP	O	AA	appos	2	SENT_243	[p10l871t1525r963b1581],
9	,	,	O	,	_	0	SENT_243	[p10l871t1525r963b1581],
10	McLeod	NNP	PERSON	McLeod	nn	11	SENT_243	[p10l997t1523r1215b1571],
11	HL	NNS	O	hl	appos	2	SENT_243	[p10l1248t1525r1331b1571],
12	.	.	O	.	_	0	SENT_243	[p10l1248t1525r1331b1571],

1	Pyrosequencing	NN	O	pyrosequencing	_	0	SENT_244	[p10l1366t1524r1803b1586],
2	of	IN	O	of	_	0	SENT_244	[p10l1833t1523r1887b1571],
3	clinically	RB	O	clinically	advmod	4	SENT_244	[p10l1912t1523r2147b1586],
4	relevant	JJ	O	relevant	amod	5	SENT_244	[p10l148t1598r368b1646],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_244	[p10l394t1598r837b1661],
6	.	.	O	.	_	0	SENT_244	[p10l394t1598r837b1661],

1	Methods	NNS	O	method	_	0	SENT_245	[p10l868t1598r1098b1646],
2	Mol	NNP	O	Mol	nn	3	SENT_245	[p10l1123t1598r1226b1646],
3	Biol	NNP	O	Biol	dep	1	SENT_245	[p10l1248t1598r1343b1646],
4	2005	CD	DATE	2005	num	3	SENT_245	[p10l1363t1600r1520b1656],
5	;	:	O	;	_	0	SENT_245	[p10l1363t1600r1520b1656],
6	311	CD	NUMBER	311	num	8	SENT_245	[p10l1550t1600r1670b1646],
7	:	:	O	:	_	0	SENT_245	[p10l1550t1600r1670b1646],
8	97-114	CD	NUMBER	97-114	dep	1	SENT_245	[p10l1699t1600r1924b1646],
9	.	.	O	.	_	0	SENT_245	[p10l1699t1600r1924b1646],

